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ABSTRACT OF THESIS 
A new method has been established to study cartilage 
breakdown in vivo. Cartilage was implanted into air 
pouches on the backs of mice or rats and loss of 
proteoglycan measured biochemically. 
Using the air pouch it was possible to produce various 
inflammatory environments either immune or non immune 
and examine the effects of these upon proteoglycan loss. 
It was found that the various type of inflammation failed 
to accelerate proteoglycan loss from implanted cartilage. 
Subsequently a variety of drugs used in the treatment of 
the arthropathies were examined for their effect on both 
inflammation and cartilage breakdown. 
Using xiphisternum a difference could be shown between 
non-steroidal anti-inflammatory drugs (NSAID) and d-penicilla- 
mine in that, NSAID failed to protect the cartilage whereas 
d-penicillamine prevented proteoglycan loss. This type of 
cartilage was not examined further, as it was not character- 
istic of articular cartilage - being surrounded by perichon- 
drium. 
Later articular cartilage was implanted once again into 
different inflammatory situations and drug effects evaluated. 
It was found using this cartilage that all the drug used 0 
protected from loss of proteoglycan and whereas some 
inhibited inflammation (indoniethacin and dexamethasohe), 
2a 
levamisole had no effect in contrast, d-penicillamine 
potentiated the inflammatory response. Finally the 
mode of action of the drugs in this method is discussed. 
3 
ACKNOWLEDGMENTS 
I would like to express my sincere thanks to Professor D-A- 
Willoughby for giving me the opportunity to work in his 
department and for his valuable supervision and constant 
encouragement. His informed criticism and skill in being 
able to condense and clarify my often confused English 
have been invaluable. 
I wish to thank Dr A. D. Sedgwick for his support and 
advice throughout this work and for reading the manuscript. 
I would also like to thank Dr F-B-de Brito for providing 
important information relating to the work concerned with 
this thesis. 
To Mr A-R-Moore a special debt of gratitude for his 
excellent technical assistance in particular the preparation 
of the histological material- 
Above all I would like to thank my wife and daughters who 
have suffered so much during the preparation of this thesis 
and without whose support this would not have been possible. 
4 
TABLE OP CONTENTS 
Abstxact of thesis 
AcknowleAwments 
Tntroduction 
Historical review of the literature 
General intx-oduction 
Vascular perrreabilit-. V 
Tnvestiqat-ions concerninct hurwral factors involved durincr 
Paqe 
2 
3 
12 
13 
13 
16 
incream-Ki vascular permeahility in inflaiTmtion 17 
General aspects, 17 
Histamine 17 
!; -T4ydxoxytx-yrA-: aminP IS 
Polype-ptides 19 
Prostaglandins 19 
Other factors found to be involved in vascular permeability 21 
Cellular aspects of the inflamnatory response 
Tp-ucocvt-es' rywerent. from bloorl vessels into the inflanmt-orv, 
site and the sequence of cell inf lux 
Chemotaxis 
Macrophage. proliferation 
Anirml mxIels of inflanration and arthrits 
Anti-inf larrratory ancl anti-arthritic druqs 
Non-steroidal anti-iff lanmtory drugs (N, %'[Dl 
, Steroidal ant-i-inflamatorv r1rugs 
Anti-rheurratic conpomcls 
Aht. imalarials 
cold 
22 
26 
27 
29 
30 
33 
33 
35 
36 
37 
37 
5 
D-penicillaminp. 
LevaTrd. sole 
Rheumatoid arthritis 
, Svnovial ýoints 
Axt-icular cartilage 
Capsule and liqaments 
Synovial tissues 
Cartilaqe, deqraclation 
The enzyrnatix mechanism of cart-ilaqf-- Tratrix cle-qra(lat-ion 
Prostanoids 
Free radicals 
T; ynphd.. -. inc--s 
Catabolin 
TInterleukin-1 
Mnonticlear cell factor 
Materials and rethods 
Animls and waintpffmce 
Mice 
Rats 
Rabbits 
Pxperimental nyxiels, of inf Ic-mnation 
rrhe formation of different, acred pouches in the rat. 
rrhe formation of 6 day old pouches in mice 
Carraqeenan 
Sera collect-ion 
E5Q, idate collection 
Cell viabilitv test (Itypan blue technique) 
Storaqe of exudate 
Paqe 
38 
39 
40 
4n 
42 
42 
A-2 
43 
45 
45 
46 
. 46 
47 
48 
50 
51 
51 
51 
51 
51 
51 
52 
52 
53 
53 
53 
54 
6 
Arthus reaction 
Timmisation of rabbit to obtain the anti-&SA 
Isolation of ant. i-PSA from blood serum 
Preparation of the sepharose-MA coniuqated, colum 
-Isolation of anti-': Z)A in sepharose-MA coniuqated colxwn 
Release of anti-WA from colurn 
Concentration of antibodies 
Induction of active Arthus reaction in the air pouch 
Tnduction of reverse passive Arthus reaction in the pouch 
Prolonqed immune inflamation in the pouch 
Preparation of the pertussis-adjuvant eim. 1sion 
Animl sensitisation 
PreparatJon of pure hordetella pertussis vaccine 
. Fb. rrration of I and 6 day partussis-inf lame 
a pouch 
Sera and e-Imclaba- collectil on 
Non-sensitised animals 
Ouantitive assessment of air pouch inflammt-ion 
Fýxudate volume 
Total leucocyte count 
Exudate smears 
May--C, runwald-Giensa 
Cartilaqe 
Muse xiphisternal cartilaqe 
Rat articular cartilaqe 
Muse articular cartilaqe 
Preparation of rIpArl cartilaqp- 
Cartilaqe inmmisation 
Cartilaqe inplantation 
Paqe 
54 
54 
54 
55 
56 
57 
58 
59 
59 
r ,, n 
A0 
60 
I 
61 
61 
61 
61 
62 
62 
62 
63 
63 
6 
64 
64 
64 
65 
7 
Niouse intact xiphiterniin 
Millipore half chamber 
Rat articular cartilaqe 
Subcutaneous implantation 
Histoloqy 
Dpimnst-ration of the anatomical site of increased vascular 
permeability and the number of vessels involved 
Haematoxylin and eosin 
MB ftrtiusj Scarlet, blue) technique for fibrin 
Alcian blue, methyl qreen-pyronin'teciftique 
Toluidine blue technique 
is S-scxliun sulphate uptake Iýv cartilaqe cells in vitro 
Autoradioqr-aphy 
Radial imunodifusion Mr determination of ct-l-qlycoprotein 
Preparation of buffer and agar 
PreParation of anti-se. nim agar plate 
Assay Of I0<-l--q1ycoprot-., --in 
ProtemlYcan assay 
Formate buffer solution 
1, q Dirmthy1methylene blue (DIV stock solution 
DMB working solution 
Digest solution for cartilage sanple 
Cartilaqe digestion 
The spectrophotarpetric determination of theproteoqlycan 
Standard curve 
Paqe 
65 
65 
r) 
66 
66 
r) 7 
67 
68 
69 
70 
71 
72 
73 
73 
73 
74 
76 
76 
76 
76 
76 
77 
77 
77 
Therapeutic. aqp-nts used durinq these studies 
'Tx0methacin 
Aspirin 
Benoxaprofen 
Piroxicam 
Dexamthasone 
Hydrocortisone acetate 
HYdrocortisone sorlium succinate 
D-penicillamine 
Uevarusole 
Assessment of gastric irritancy 
Macroscopic' 
Microscopic 
Sfatistical tests 
Results 
Autologous cart-ilacre implantation in the six-da, 
of the rm. use 
Location of irrplanted Cartilage in the pouch 
Fistolocrical obsertrations 
Norral mouse Aphisternun 
Td, vinq intact cartilage 
Dead intact cartilage 
TAvinq minced cartilage 
Biochanical assessrrent- of cartilage deqrarlat-ion 
Millipore half charber technique 
)uch uu 
Paq, -- 
78 
79 
79 
79 
79 
80 
RO 
8n 
so 
81 
81 
81 
81 
82 
83 
84 
84 
85 
85 
87 
87 
87 
89 
94 
9 
Effect. of teatm-Pant with cI. ruqs on numbers of cells mqratinq 
into the mouse six day pouch and loss of proteoglycan from 
jxplanted. xiphisternal fraqments 
Non-steroidal anti-inflamatory dxuqs 
Anti-rheumatic rlruq 
Effect. of local achinistxat. ion of hydrocortisone salts on 
proteoqlycan content. of xiphisternal fragments irrplante-d 
into six day pouch of the muse, 
'Tbe disadvantages of usinq the muse as a source of carf-ýlaqe 
Mouse xiphist. ernum 
Muse articular cartilaqe 
Rat articular cartilage 
'TIIe biocheracal determination of the proteoqlycan (sulphated 
qlycosaminocilycans) of articular cartilaqe 
DeveloPrmnt. of new model of prolonqed inflanmation on 
the rat six day pouch 
HistOlOgical obsermatioms 
Normal rat air pouch 
Carraqeenan-inflammed six day pouch 
Effect. of drug treatment. on carraqeenan-induced prolonged 
inf lanmtion 
Indormthacin 
D7penicillamine 
T, munisole 
Dexamethasone 
Leucocytes differential counts 
Pacle 
94 
94 
95 
99 
102 
102 
103 
103 
105 
105 
110. 
110 
113 
115 
115 
120 
123 
123 
126 
10 
Page 
Tzplantation of articular cart-i-lacTe 1,1018 
-Implanation of 
living cartilage 128 
Cartilage viability 128 
Dplantation into normal air pouch 132 
Implantation into subcutaneous tissue 132 
TiTplantation of dead cartilage 134 
Studies into the umunogenicity of cartilage 137 
St-iidies ifito alloqraft and isocIraft inplantat-ion 140 
Iryplantation, of articular c artilage after one week of 140 
irritant injection 
Histological observations of articular cartilage implanted 
into cliff erent situations 143 
Normal mouse femoral head cart-i. laqe 143 
Normal rat femoral head cartilage lAr, 
1=1antation into non-inflar. Tned situatioms 146 
TrPlantation into inflarr-el pouches 148 
Effect of dmg-treatmnt on the prot-ýJyqan cont-ent of 
-implanted articular cartilage 
149 
Indomethad-n _1,49 
D-penicillamine . 
149 
Dexamethasone 152 
T, evamisole 152 
Effect of drug treatment on proteoglycan content of articular 
cartilage implanted in subcutaneous tissue 159 
Histolbqical observations following drug txeatzre-nt. iso 
Tmnme inflarmtion in the rat air pouch 162 
162 
Active Artbus reaction 
11 
Paqe 
Reverse Passive Arthus reaction 164 
Prolonged immme inf lamration in the rat. six day pouch 165 
Histoloqy observations- 172 
Air pouch histOloqy 172 
T, yrrphoid tissues 176 
Ef fect of druq fx-eatrrent on perwssis induced prolonged 
j-nf Ian mt-ion 176 
Indanethacin 177 
-D-penicilla m. n(-- 180 
Toevamisole 180 
Dp-, mmet-hasone 185 
Trmcocytes differential comt-s. 185 
Tirplantation of articular cartilage into, pertussis in-f lameJ 
s-L, 5,. day pouches 187 
Effect Of cly-Liq treatment on prot 
ca&-ilaqe inplanted into pertussis-inf larryd pouches 
Indarret-hacin 
D-penicillamine 
Devamthasone 
Levamisole 
Histoloqical observations follcyoyinq c3ruq treaim-ent 
Determination of alpha-1-acid qlycoprotein_ 
rertussis qroups 
Carraqeenan qroups 
Elf f ect of dniq treat3rent. on the levels of -1-GP 
lvcan content of articular PKIC 
Discussion 
References 
190 
190 
193 
193 
193 
200 
200 
203 
203 
203 
205 
235 
12 
INTRODUCTION 
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HISTORICAL REVIEW OF THE LITERATURE_ 
GENERAL INTRODUCHON 
Florey (1970) pointed out the difficulty in finding an 
acceptable definition by most pathologists for the term 
"inf lanTmtion". This author considered the definition of 
Burden-Sandenescv, (1871) as the most suitable, in which inflammation 
is described as "the succession of changes which occur in a living 
tissue when it is injured, provided that the injury is not of 
such a degree as to at once destroy its structure and vitality". 
Ebert (1965) expressed inflammation as "the process that begins 
following a sublethal injury to tissue and ends with complete 
healing' 
. Mre recently, Ryan and 
Majno (1977) defined inflammation 
as "the response of living tissue to local injury, that leads to 
the local accumulation of blood cells and fluid, and the overall 
process, seen against the broad perspective of evolution# is a 
useful one - its primary significance being (in all likelihood) 
that of a d6fence against microscopic invaders". 
Inf lammation. was known to the ancients by the appearances 
it Produced in the skin and other surfaces of the body. The four 
main cardinal signs in this situation were summarised by the 
Ronan encyclopaedist, Cornelius Celsus, (BC 30 - AD 38), as 
ruber (redness), tumor (swelling), calor (heat) and dolor (pain). 
This definition is so precise that it has still not been inproved 
upon, except that now a fifth sign of inflammation has been added. 
This is functio laesa (loss of function). This was originally 
attributed to Galen (AD 130 - 200), the first person who wrote 
extensively on inf lammation, but this was since proved to be 
untrue and this was in fact contributed by Rudolph Virchow 
(1821 - 1902) in his cellular pathology, published in 1958 
1 4t 
(Ryan and Majno , 1977). 
Boerhaave (1668 - 1738) laid much emphasis on the change 
of state of the blood vessels in inflammation. He believed that 
there was an "excess of blood in the inflamed part, due to 
increased hydrostatic pressure and to the friction of the red 
arterial blood in the smallest canals". 
The work of Cowper, Hallen and Spallanzani in the 17th 
and 18th centuries, established that the redness of the inflamed 
Part was due to the distension of the small blood vessels, and 
not, as first believed, to the passage of blood into vessels 
not normally containing it or to the passage of blood into the 
vessels. 
John Hunter (1794) re-introduced the important conception 
formerly adumbrated by Galen, that inflammation is not a disease 
but a useful process, and can be initiated by any injury, for 
instance an injury caused by pressure, friction, heat, cold or 
"air in woundsn. 
William Addison 1843 was the first to undertake 
microscopic studies of inflamration. The microscope allowed 
the Observation of blood flow and its corpuscles in the web of 
the frog's foot. Addison showed that blood vessels responded 
to irritant by becoming engorged. He observed the extra- 
Vascular appearance of white corpuscles in pus and that wiiite 
cells in the inflamed fooE could be immobilised along the inside 
of the blood vessels. 
Ebrther interest was taken in the involvement of cells and 
inflammation when Augustus Waller (1816 - 1870), in an 
additional postscript to his essay "Microscopic examination of 
some of the principal tissues of the animal frame, as observed 
15 
in the tongue of the living frog or toad", described pus as 
originating fran the extravasation of the colourless or 
spherical corpuscles frcm the capillaries. Waller had described 
diapadesis ofleucocytes, that is their emigration frcm the 
blood vessel to the tissue. 
A great step forward in understanding inflamnation and in 
diffusing knowledge of it, was taken by Cohnheim (1867) when 
he observed, and gave detailed and accurated. descriptions of, 
the events to be seen during inflanTntion of the transparent 
tissue, such as the web and tongue of the frog. Mach of 
COhnheim's work was carried out on frog mesentery, the alveolar 
cornea of the frog and rabbit having been discarded as unsuitable 
tissue for the study of inflanmtion. The dilatation, especially 
of small arteries, and the loss of axial flow within them, was 
observed by Cohnheim in the inflamed mesentery. Mite corpuscles 
appeared to take up a more general disposition throughout the 
lumen, adhering to the vessel walls, through which their 
migration into extravascular tissue was closely followed. 
COhnheim was aware of the growing inportance of the vascular 
events in inflanmtion, which led. him to propose that "without 
blood vessels there is no inflanmtion". 
In 1862, Haeckel observed that the blood vessels of tethys 
(a gastropod mollusc) could phagocytose particles. This was 
followed by the classical work of Matchnikoff (1883), who was 
responsible for developing the concept that phagocytic cells 
form the defence mechanism of the rretazoan body. 
The concept that inflamTation is a process involving both 
vascular and cellular cmponents has remained with us to the 
present day definition. Spector (1977) defines inflarrmtion as 
ic 
"the response of the living microcirculation and its contents 
to injury". 
VASCULAR PERMEABILITY 
Numerous studies have been done to examine the increased 
vascular permeability seen in inflammation. The relevant 
investigations have been presented in tabulated form. 
Investigations into the rrechanism of increased vascular perffeabilitY 
Author Year Author's contribution to the understanding 
of vascular permeability. 
Starling 1896 showed that protein in solution exerts 
osmotic pressure and the endothelial 
merrbrane is highly permeable to water and 
salts, but not protein. 
Florey 1925 colloids pass through the cytoplasm of 
endothelial cells. 
Chanbers and 1947 endothelial cells contract during increased 
Zweifach vascular pernpability, giving rise to 
interendothelial cell gaps. 
Pappenheimer 1953 developed the molecular sieve theory. 
Permeability depends upon pores in 
capillary wall. 
Mainor Palade 1961 used electron microscopy to observe the 
and Schoeffl blood tissue movenmt of carbon particles 
induced by histamine, in the cremster 
muscle. Found vascular leakage occurred 
in venules of 20-30p diarmter and attributed 
leakage to the formation of gaps between 
endothelial cells. 
Cotran and Majno 1964 delayed, prolonged vascular leakage (eg, 
that caused by bacteria or x-ray) was 
mainly confined to capillaries, for which 
certain unknown mediators appeared 
responsible. 
Majno and 1967 proposed the activation of a contractile 
Leventhal mechanism within venular endothelial cells 
during increased vascular permeability 
induced by histamine, 5HT and bradykinin 
17 
Renkin, Carter 1974 histamine and bradykinin stimulate 
and Joyner turnover rate of endothelial vesicles. 
Investigations humoral factors involved during 
increased vascular penTeability in inf lanmtim 
General aspects 
Author Year Author's contribution to the under- 
standing of humoral factors 
Eichwald 1864 described the presence of peptone, a 
Hofmeister 1880 proteolytic enzyrm, in pus. 
Opie 1906 dermnstrated two proteases (leuco 
1922 protease and lyniphoprotease) in pleural 
exudates of dogs. 
Krogh 1920 dilatation of capillaries in the frog 
tongue, induced by application of iodine, 
was abolished by pre-treaturent with 
cocaine - inplicated the axon reflex in 
the mechanism of vasodilatation. 
Rous, Gilding 1930 referred all vasodilatation to the action 
and Smith of a single chemical substance liberated 
within the tissue. 
HISTAMINE 
Barger and 1910 demonstrated that histamine is produced 
Dale 191l by various organ extracts. 
Dale and 1910 described some of the pharmcological 
Iaidlaw 1911 properties of histamine, which included 
1918 contraction of smooth rmscle. 
Sollwan 1916 intradermal histamine produced a state 
similar to urticaria, characterised by 
formtion of a localised weal. 
Dale and 1918 described vasodilator action of histamine. 
Richards Intravenous injection of histamine 
produced a marked reduction in blood 
pressure and synptcm resernbling those 
of anaphylactic shock. 
18 
Blocm 
Lewis 
zweifach 
Spector and 
Willoughby 
1921 histamine induced oedema formation. 
1927 described the "triple response" which 
characterised various types of injurious 
stimuli, and in which histan-Line was 
implicated. 
1953 suggested that increased vascular 
perneability, following application of 
histamine to rat mescappendix, may be 
a result of contraction of endothelial 
cells. 
1957 demonstrated the role of histamine in 
the early stages of turpentine induced 
pleurisy and thermal injury in rats. 
Anderson, Glover 1977 showed that histamine inhibits neutrophil 
and Rabson 
Wm-eyer and 
Johnstm 
Robinson 
Fantuzzi et al 
Erspamer 
FluiTphrey and 
Jaques 
Parratt and 
West 
Spector arxi 
Willoughby 
Collier 
chemotaxis. 
1978 showed the ability of histaniine to inter- 
fere with superoxide anion (Qz) production 
from human phagocytes. 
1982 showed that histamine inhibits granulo- 
cyte adherence. 
1984 histamine inhibits lysosomal enzyne release 
frm human neutrophils stimulated by 
a synthetic chemtactic peptide (N-formyl- 
rnethionyl leucyl phenylalinine). 
5-HYDROXYTRYPTAMINE (5HT) 
1954 isolated 5HT from enterochranaffin ' 
tissue of the gastro-intestinal tract. 
1954 shdved that platelets were a rich source 
of 5HT. 
1957 inhibited 5HT-induced foot oedema in 
a, b rats by pre-treatment with 2-brcmo-d- 
lysergic acid, an antagonist of 5HT. 
1957 dewonstrated the presence of 5ffr in 
early pleural exudates induced by 
turpentine in rats, but were unable to 
suppress the reaction with 5HT 
antagonists. 
1958 demonstrated the wide distribution of 
5ffr in blood, spleen, central and 
peripheral nervous system. 
19 
POLYPEPTIDES 
Menkin 1936 proposed a chemical mediator Ileuco- 
taxine I (a polypeptide) which could 
alter capillary permeability. This 
polypeptide demnstrated, in turpentine 
pleural. exudate, was found to have no 
similar properties in ccnmn with 
histamine. 
Duthie and 1939 leucotaxine thought to be a mixture 
Chain of polypeptides. ý 
Rocha e Silva, 1949 discovered lbradykinin'. This substance 
Beraldo and was released by the action of trypsin 
Rosenfeld or snake venom on plasma substrate. It 
was able to induce the slow contraction 
of guinea pig ileum. 
Spector 1951 described the isolation from inflammatorY 
exudates and hydrolysate of fibrin (by 
pepsin) of polypeptide fractions, scim 
of which were able to induce vascular 
permeability. 
Elliot, Horton 1960 bradykinin, purified and classified as 
and IA--As a, b an octapeptide-induced, increased 
vascular permeability in guinea pigs 
and rabbits, and caused pain when applied 
to the exposed base of cantharidin 
blister in man. , 
lzwis 1961 
Zweifach 1966 
participation of bradykinin in functional 
dilatation and inf lamation. Believed 
that bradykinin ues formed and destroyed 
in the interstitial fluid. 
observed topical application of brady- 
kinin lead to pronounced increase in flow 
through blood vessels at high concen- 
trations. Increased permeability in post 
capillary venules independent of 
histamine. 
Kaplan, Mayer 1972 showed that kinins are chermtactic 
and Austen for neutrophils. 
Nesjletti and 1979 found that kinins are potent prosta- 
Malik glandin-releasing agents. 
PROSTAGLANDINS 
Bergstrcm, Duner, 1959 showed infusion of prostaglandins into 
Von Euler, Pernow forearm produced erythema. 
and Sjovall 
20 
Horton 1963 
Willoughby 1968 
Willis 1969 
Crunkhorn and 1971 
Willis 
Di Rosa, Giroud 1971 
and Willoughby 
Velo, Dunn, 1973 
Giroud, Timsit 
and Willoughby 
Williams and 1973 
Morley 
Moncada, 1976 
Needleman, 
Buting and 
Vane 
moncada, Higgs 1977 
and Vane 
Davidson, Ford - 1978 
Hutchinr. or., SrA; th 
and Walker 
oming, 1980 
Hamerstrom and 
Sarmelsson 
prostaglandins increased vascular 
penTeability in guinea pigs. 
prostaglandins PGF2 C( produced veno- 
constriction, antagonist of vascular 
penreability induced by histamine, 5HT,, 
bradykinin and lyq: )h node permeability 
factor. 
identified PGE in rat inflamatory 
exudate. 
PGEl and PGE2 increased vascular 
permeability and were as potent as 
histamine, bradykinin or 5HT. 
proposed sequential release of mediators, 
histamine, 5HT, kinins and prostaglandins 
during non-inmme inflan=tion. 
suggested that prostaglandins; F2C4 
acts by controlling increased vascular 
permeability in inf lammtion. 
found that prostaglandins were less 
active than histamine and bradykinin at 
increasing vascular permeability, and 
that they were able to potentiate the 
action of these mediators. In general, 
potentiation was greater with bradykinin 
than histamine. 
demonstrated that thrarboxanes were 
involved in vasoconstriction and were 
the major prostaglandin-related 
mediator of platelet aggregation. 
showed that prostacy lin (PG12) caused 
vasodilatation and inhibited platelet 
aggregation. 
prostacylcin potentiates histamine and 
bradykinin in carrageenan. paw oedema. 
demonstrated that the rrajor cmponent. 
of slow reacting substance of anaphylaxis 
are the leucotrbnos C4 and D4. 
21 
other factors found to be involved in vas'cular pe ility 
Author Year Author's contribution 
Miles and 1955 showed permeability factor dilute 
Wilhelm. (PF dil) wMcýincreased vascular 
Wil 1' elm, Miles permeability and was activated when 
and Mackay guinea pig plamm activated. 
Spector 1956 demonstrated a permeability factor 
associated with the more soluble 
globulins. Present in active exudate. 
Ratnoff and TP-pow 1963 showed that purified CII esterase increases 
vascular perrreability of guinea pig skin. 
Willoughby 1964 described lyrrph node perrreability factor. 
and Spector This factor extracted from lyrrph nodes, 
and was found to increase the vascular 
penreability. 
Cochrane and 1968 described two cleavage peptides, C3 a 
Muller-Eberhard and C a, which increased vascular ;; ýýility by inducing histamine 
release. 
Willoughby, 1968 depletion of serum complement caused 
Polak and Turk decreased vascular permeability responses 
in allergic and non-allergic inflanmtion. 
Pick et al 1969 showed the supernatants of lymph node 
cells (from quinea pigs injected with 
tubercle baccilli) incubated with purified 
protein derivative, produced intense 
inflammatory reactions when injected into 
guinea pig skin (skin reactive factor). 
Dumonde et al 1969 interaction of specific antigen. BCG 
with sensitised lyrrýoqytes produced a 
soluble factor, which increased vascular 
permeability. They proposed the name 
lymphokine for this factor. 
Williams and 1974 described the vascular permeability 
Morley produced by factors released from 
sensitised lymphocytes. These factors 
have been named lymphokines. 
McManus et al 1981 intravenous injection of platelet 
activating factor (PAN results in 
acute, transient increase in systemic 
vascular permeability. 
zz 
Author Year Author's contribution 
Hunphrey 1982 intradermal administration of PAF 
induces leucocyte adhesion and 
subsequent vessel infiltration 
accmpanied by vessel hyperpernmbility 
leading to regional exudation of 
plasrm (extravasation). 
Williams et al 1984 showed that interaction between neutro- 
phils and microvascular endothelial 
cells leads to cell emigration and 
plasma protein leakage. 
Brain et al 1985 described a cal-citonin gene-related 
peptide as a potent vasodilator. 
MIDLAR ASPECM OF -THE INMAMMATORY RESPONSE. 
In 1871, Virchow errphasised the importance'of cells in 
inflammation. He postulated that infl&miation was a result of 
increased activity of cells searching for a suitable source of 
food in the surrounding. tissue. Virchow postulated that vascular 
changes seen were o nly secondary. This concept was different to 
that held by Cohnheim (1867) who propsed that inflamratory cells 
Originated from the blood stream. 
In 1882, Metchnikoff stressed the role of leucocytes in 
inf lannation and their emigration and phagocytosis as a means of 
ren=ing noxious irritants. At the end of the 19th century, 
there was great controversy concerning the origin of inflammatory 
cells. Metchnikoff had used the term Imicrophagel to designate 
the polymorphonuclear cell in the blood and tissue, in order to 
distinguish them frm the larger nononuclear phagocytic cells - 
the macrophages. 
A considerable amount of information has been published on 
physiology and origin of the polymorphonuclear leucocyte since 
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the clays of Metchnikoff. The large numbers of granules present 
in the cytoplasm of these cells have been shown to contain 
different hydrolytic enzymes, such as acid phosphatase, acid 
and neutral hydrolases and peroxidases (Ackerman, 1968; 
Wetzel, Spicer and Horn, 1967; Bainton and Farquhar, 1968). 
Abundant glycogen deposits have been found in these cells with 
little or no smooth or rough endoplasmic reticulum. present 
(Scott and Still, 1968; Watson and Tielemans, 1971). 
Goud, Schotte and Van Furth (1975). show-ed that polymorpho- 
nuclear leucocytes were derived fran bonemarrow stem cell and 
that they were a separate cell line frcm the mononuclear phago- 
cytic cell, the myeloblast and monablast having very different 
characteristics. Several factors have also been shown to 
regulate polymorphonuclear cell release and production 
(Bierman, 1964; Kampschnidt et al, 1977; and Baun et al, 1978). 
As these cells are'short lived, with no capacity for mitotic 
division (Spector and Wyme, 1975), they die in large numbers 
during inf lanTmtion. 
A chronic inflammatory infiltrate, especially if granulo- 
MtOusr consists of cells derived from three lines - the niono- 
nuclear phagocyte, the lymphoid and the fibrobla$t. Mononuclear 
phagocytes are seen as n-acrophages, epitheloid cells or giant 
cells. According to Spector and Willoughby (1974), the true 
architectural unit of chronic infl&m-ation is almost always the 
n-acrophage and its derivatives, the epitheloid cell and the giant 
cell. . 
Mallory (1898), Pernar (1924) and Foot (1925) proposed 
that the macrophage of the inflammtory reactions was derived 
fran the endothelial cells of blood capillaries. Sabin, Doan 
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and Cunningham further reinforced this view in 1925. Using 
the hanging-drop technique described by Lewis (1925,1926), 
they claimed to see the development of Iclasmatocytes' 
(macrophages) fran the endothelium of chick embryo. 
The idea that lynphocytes were capable of transforming 
into macrophage during an inflammatory reaction was first 
put forward by Metchnikoff (1888), and then by Maximow (1927). 
Downey (1917) had supported this view by demonstrating the 
ability of alleged lymphocytes to phagocytose vital dyes in 
the circulation, which he temporally arrested between a 
double ligature. 
Lewis (1925,1926), by using the hanging-drop technique, 
was able to observe the development of niacrophages from mono- 
cytes. The hanging-drop technique consists of a drop of blood 
or plasma being placed onto a small glass coverslip, which is 
then inverted and sealed over a hollow, ground slide, and 
examined under the microscope.. 
Clark, Clark and Rex (1936) were able to show that endo- 
thelial cells were not transformed into leucocytes during micro- 
trauma induced in a tadpole's tail by injection of croton oil. 
They believed that the nuclei of polymorphonuclear leucocytes 
'rounded up', giving rise to the relatively high numbers of 
apparently mononuclear cells observed in the latter stages of 
the reaction. 
Ebert and Florey (1939) used a modified Sandison-Clark 
(rabbit ear) chamber to study the extravascular developrrent of 
the blood monocytes. The method consisted of fixing two glass 
coverslips on both sides of a hole which had been punched 
through the ear of a rabbit. 7hey concluded from their experiments 
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that monocytes could develop and becaTe indistinguishable from 
tissue histiocytes. 
Volkman and Gowans (1965 a, b) studied the inflammatory 
reaction induced by subcutaneous inplantation of glass cover- 
slips in rats linked by parabiosis, in an attenpt to find the 
origin of inflanuiatory macrophages. They were able to show 
that exudate cells were derived from the blood. In further 
studies, they demonstrated that lynPhocytes did not transform 
to racrophages. They also showed that lynphocyte depletion, 
either by drainage of the thoracic duct or by x-irradiation 
at 400 rads, did not alter the rmcrophage components of the 
cellular exudate. However, x-irradiation at 750 rads resulted 
in decreassý emigration of rracrophages into the inf lamd area, 
and this effect was prevented when the tibial bone marrow was 
shielded. However, by injecting labelled bone marrow cellso 
spleen cells, lyrrph node and thymus cells, they concluded that 
bone marrow, and to a lesser extent the splenic cells, were the 
major source of macrophages; emigrating from the circulation 
into the inflamed site. 
Spector, Walters and Willoughby (1965) used rat leucocytes 
labelled with either colloidal carbon or tritiated thymdine 
or with both markers. Since monocytes are phagocytic and have 
a higher rate of DNA synthesis than lymphocytes, this is 
reflected in a much higher uptake of tritiated thymidine and 
the intensity of ingested carbon particles. On the basis of 
these principles, these authors found the mononuclear cells 
of acute inflammatory exudates originated almost entirely from 
circulating mnocytes, not lynphocytes. Spector and Willoughby 
(1968) demonstrated the lack of lynphocyte participation in the 
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reaction to inacmplete Freund's adjuvant in the rat. They 
also investigated the reaction to cmplete Freund's adjuvant 
which was closely similar to that of inccuplete Freund's 
adjuvant until four weeks, when foci of small round cells 
resembling lymphocytes appeared. Lesions of this type and 
age only were found to admit cells from the lymph nodes. 
Everett and Tylor (1968) also supported the development of 
nacrophages from blood n-onocytes; in inf lammatory exudates - 
Sutton and Weiss (1966) demonstrated the formation of 
epitheloid and giant cells fran avian mnocytes. Mariano 
and Spector (1974) studied the same subject,, in vivo, following 
the subcutaneous implantation of glass coverslips into n-Lice. 
They concluded that lymphocytes do not participate in giant 
cell formation. With. the aid of the electron microscope, they 
presented evidence supporting the concept of rracrophage fusion 
as a mechanism of giant cell fonratim. it was also established 
that emigration of. fresh mononuclear cells from the circulation 
was required to maintain the process. 
Leu es' rravement fran blood vessels into the inf lamrratory 
site and -ie secruence of cell influx 
Author Year Autlior Is contribution 
Addison 1843 described the process of cell migration 
through blood vessels, ie, diapedesis 
Arnold 1873 showed leucocytes migrating through 
areas of the inflamed capillary wall. 
Opie 1910 showed that polymrphs migrated during 
the early stages of inflanmtion followed 
by mononuclear cells. 
Clark, Clark 1936 studied the emigration of leucocytes 
and Rex through inflan-ed vessels using the 
transparent tail of the tadpole and 
the rabbit ear chanber technique. 
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Page and Good 1958 
Paz and Spector 1962 
Hurley, Ryan 1966 
and Friedman 
Sultzer 1968 
Chemotaxis 
suggested that*the successful migration 
of wononuclear cells was dependent 
on the presence of polymorphonuclear 
cells at the inflamed site. 
suggested that polyrnorphonuclear cells 
and morxmuclear cells migrate con- 
currently, the polymorphs dying or 
moving away leaving the mononuclear cells. 
postulated separate mechanisms exist to 
regulate the migration of different 
cell types. . 
proposed the hypoUiesis that 'one 
rrechanism' induced both cell types to 
emigrate. 
Author Year Author 's contribution 
Pfeffer 1884 introduced the term 'chymitwds' 
(chemtaxis) to describe the phenaTena 
in which chemicals or biochemical 
substances attract and determine the 
direction of migrating cells. 
Mussart and 1890 showed that cellular breakdown products 
Bordet released substances which could attract 
granulocytes. 
CcrrTrandon 1919 showed the change from randan 
undirectional rrovement upon introduction 
of cluffps of bacteria. 
Menkin 1936 proposed that inflanratory cell free 
exudates fran turpentine pleurisy 
contained a substance which induced 
vascular perneability and leucocyte 
infiltration. 
Mmkin 1938 named this substance Ileucotaxine' 
because of its chewtactic properties. 
Ketch6l and 1955 showed that sare serun proteins 
Favour increased leucocyte migration.. 
Hurley and 1961 suggested that chemotaxis and leucocyte 
Spector emigration in vivo were separate 
phencapena. 
')s 
Boyden 1962 
Ward, Cochrane 1965 
and Muller- 
Eberhard 
Comely 1966 
Snyderman, Shin, 1969 
Phillips, Gerwurtz 
and Mergenhagen 
Kaley and Weiner 1971 
Kaplan, Mayer 1972 
and Austen 
Turner, Campbell 1975 
and Lynn 
Goetzel, Wood 1977 
and Gormn 
Ebrd-Hutchinson, 1980 
Bray, Doig, 
Shipley and Smith 
Goetzel et al 1980 
Luger et al 1983 
developed a novel technique for 
estimating the chemotactic effect 
of soluble substance. 
antibody antigen caTplexes and 
zymosan in the presence of fresh serun 
induced migration of polymorphs 
through a millipore filter. 
chemotactic factor(s) associated with 
lysoscmal fraction of leucocytes, 
which did not require the presence of 
serurn. 
majority of chemotactic activity in 
whole guinea pig serum, after treatment 
with endotoxin, was due to a product 
cleaved fran C'5. 
prostaglandin E1 chemotactic for poly- 
morphs. 
human plasma kallikrein directly and 
selectively attracted human neutrophils 
fram, mixed leucocyte populations. 
esterified arachidonic acid present in 
plasma membrane rray be a precursor of 
L 
chemotactic factors. 
human platelet lipoxigenase generated 
product of arachidonic acid 12-L-OH-5, 
8,10,14, eicosa-tetraenoic acid 
(12 HM) selectively chemotactic for 
polyrmrphs and mononuclear cells. 
leucotriene B, chemotactic both in vitro 
and in vivo towards both polymorphs and 
mononuclear cells. Equal in potency 
to C5a. 
showed that platelet activating factor 
induced stimulation and chemotaxis of 
neutrophils. 
interleukin-1 is chemotactic for polyý 
n-orplnnuclear leucocytes. 
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Macrophage proliferation 
Many studies have been done to investigate factors involved in 
rracrophage proliferation. Ihe table below sumarises the work 
of various authors on macrophaqe-proliferation in vitro. 
Author Year Author Is contribution 
Virolainen and 1967 factors derived frcm cultures of 
Defendi L-cells, n-Litogenic for peritoneal 
n-acrophage. 
Adolph et al 1975 inflaimiatory exudate harvested from 
the rat pleural cavity four hours after 
injection of dextran. 
Hadden, Sadlik 1975 lyfrphokine factor released by contact 
and Hadden of sensitised lymphocyte with antigen. 
Giroud, Pelletier 1977 factors in acute non immunological 
and Girre exudate from four hours pleurisy were 
able to stimulate rracrophage DNA synthesis. 
Giroud et al 1977 peritoneal macrophages stimulated to 
divide after treatment with serum from 
animals presenting acute inflam-nation 
elicited with dextran or calcium 
pyrophosphate, crystals. 
Conner, Ford- 1980 Macrophage mitogenic factor present in 
Hutchinson and normal rat serum. 
Smith 
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ANIMAL MODELS OF INFLAMMATION AND ARTURITIS 
Many animal models of acute (polymrphonuclear leucocyte 
dominated) and chronic (mononuclear leucocyte dominated) 
inflanmtion have been developed. Few of these models allow the 
collection of inflanmtory exudate formed as the result of 
increased vascular permeability. Induction of experimental 
pleurisy in the rat was found to be the most suitable animal 
model for providing an acute inf lamn-atory exudate. However, 
experimental pleurisy was not found to be a suitable model for 
the study of chronic inf lam-nation, where the inf laomation resolved 
after a shorter period of time. 
Many animal models of chronic inflammation, such as cotton 
pellet granulcma (Meier et al, 1950), adjuvant arthritis 
(Pearson, 1956) and the subcutaneous implanted coverslip 
(Ryan and Spector, 1970), although being useful for the 
screening of therapeutic agents, do not readily provide a source 
of exudate represent ative of chronic inflammation. 
On the other hand, the subcutaneous air pouch model 
Of Selye (1953) would sceem to provide a more suitable cavity for 
providing a chronic inflammation. Selye (1953) proposed that the 
formation of a cavity by the subcutaneous injection of air acted 
as a mould for the subsequent formation of a granulcrnatous 
e, into which this internal cavity could easily be 
transformed by the injection of irritants, such as croton oil 
and formalin. Subsequently this model was rodified to allow 
its. use as a routine screen for anti-infl&mutory agents 
(Robert and Nezamis, 1957), and this was followed by the intro- 
duction of carrageenan as the injected irritant (Benitz and 
Hall, 1963). 
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Since its introduction, the carrageenan air pouch mthod 
has been widelY used as an acute model'of inflanration for the 
screeninq of anti-inflamnatory agents, such as indomethacin 
(ýýall and Youlton, 1974). However, only Tsurufuji et al (1978) 
have examined the ef fects of anti-inf lanmtory drugs on the chronic 
stages of this model. 
Edwards, Sedqwick and Willouqhby in 1981, showed that the 
air pouch of mouse and rat at six days after initial air injection 
developed a lining structure with m. ny of the features of synovial 
membrane, as judged by electron microscopy and light microscopy, 
using haematoxylin and eosin and Van Gieson stains, esterase 
activity and imnmofluorescent staining for Ia antigen. 
Sedgwick et al, 1983, showed that the six day pouch of the rat 
responded in a special way to different inflamTatory stinuli, 
however, these authors only examined the acute phase. 
The table below sumarises some of the main animal models used 
for the study of inflanration and arthritis. 
Model Authors Notes 
Etog tongue Cohnheim Observations provided classical 
1867 description of vascular changes of 
acute inflapmtion. 
Frog Arnold showed leucocytes miqratinq through 
mesentery 1873 areas of the inflan-ed capillary 
wall (leakaqe between endothelial 
cells). 
Pleurisy Spector and These authors showed the precise role 
(various Willoughby of mediators of vascular permeability. 
irritants) 1957 This model was used to study acute 
inflanmtion and anti-inflammtory 
. jents. 
Despite the extensive use ac 
of this'mDdel, the evaluation of the 
inflanratory reaction is usually 
confined to the ni--asuremnt of exudate 
volume. However, some investigators 
have made quantitative measurements of 
cell migration (Hurley et al, 1966; 
Amrendola et al, 1975). 
Thenral Wilhelm and Studied acute vascular response, 
injury Mason, 1958 we-diators and types of blood vessels. 
Paw oedenia Winter, Risley Used as assay to study acute inflam- 
(carrageenan and Nuss ration and in the search for anti- 
Mst 1962 inflamnatory activities of different 
favoured agents. This model is sirriple and 
irritant) precise, but is relatively slow, and 
only a single datum is obtainable frcm 
each rat. 
Peritonitis Van Furth Used for quantitative studies on the 
(various et al kinetics of mononuclear phagocytes 
irritants) '1973 during acute inflamation. Despite the 
sinplicity of the technique, the peri- 
toneal cavity has been poorly errployed 
to assess the effect of anti-inflamTatory 
drugs on cellular exudation. 
Cotton pellet Meier, Schuler Sinple and widely employed method to 
granulcma and Desaulles study chronic inflanrmtion and 
1950 granuloma forrration. 
Air pouch Selye Model of both acute and chronic inflan-r 
1953 nation, possible to study cell kinetics 
and vascular response. 
Adjuvant Pearson Iranunological rcdel, considered for 
induced 1956 a long t3ffe as the closest to human 
arthritis disease, used as a screen for anti- 
inflarroatory and anti-arthritic drugs. 
Moncox ticular Durnonde and A model of chronic arthritis produced 
arthritis Glynn by injection of fibrin into the joints 
1962 of rabbit previously immmised by intra- 
dermal injection of fibrin in Freund's 
corrplete adjuvant. other antigen 
my also be used. 
subcutaneous Ryan and Used to study adhesion and turnover 
glass Spector of cells and response to therapeutic 
-coverslip 1970 agents. 
Collagen Trentham, ImTunological model used in rats, 
type-II Townes and similar to adjuvant arthritis, but 
induced Kang the immmogen (collagen type-II) 
arthritis 1977 would seem more appropriate. The 
arthritis was induced by injection of 
type-II collagen in either complete or 
inconplete Freund's adjuvant. 
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ANN-INFLMMTORY AND ANTI-RHELMTIC DRUGS 
Non-steroidal anti-inflam-ratory drugs (NSAID) 
In 1763 an Oxforshire clergyman, FAT=O Stone, presented 
a paper. entitled ..... 
"An account of the success of the Bark 
of the Willow in the cure of Agues". Stone reccmTmded a 
decoction of the bark of the white willow for treating languish 
and intermitting disorder', a description of what we understand 
to be malaria. In 1874, TJ Maclagen wrote "nature seeming to 
produce the remedy under climatic conditions similar to those 
wiiich give rise to the disease, among the salicaceae I determined 
to search for a remedy for acute rheumatism. The bark of many 
species of willow contains a bitter principle called salicin; 
this principle was exactly what I wanted. " Maclagen was the first 
physician to treat rheumatic fever with salicylates, their 
successful use in the symptomatic relief of chronic rheumatoid 
arthritis and gout being proclaimed the following year by Parisian 
physician, German see, who was the first to describe the anti- 
rheumatic properties of these compounds. A further century was 
to pass, however, before 'new' non-steroidal compounds became 
widely used in clinical medicine. 
In 1963, Winter, Risely and Nuss described the anti-inflanratory 
action of a new compound called indamethacin. Indomethacin was, 
be 
found to/effective in suppressing carrageenan paw oedema and 
cotton pellet granuloma in rats. There were many attempts to 
link the anti-inflammatory action of aspirin and aspirin-like 
drugs with the ability to inhibit endogenous, mediators of 
inflammation. Aspirin was labelled an anti-defensive drug by 
Collier in 1969, owing to its ability to inhibit the defensive 
Al 
reactions of the body, such as fever, pain and inflammtion. 
This author proposed that its anti-defensive action might 
arise from antagonism of kinins, slow reacting substance A 
and C, prostaglandin F2 c4 , arachidonic acid, adenosine 
triphosphate or acetylcholine. 
In three pioneering papers, NSAID were shown to inhibit 
prostaglandin biosynthesis in guinea pig lung hCRogenates 
(Vane, 1971), perfused dog spleen (Ferreira et al, 1971) 
and in human platelets (Smith and Willis, 1971). This inhib- 
itiOn was confix=)d in other systems, both in vivo and in vitro 
(Vane, 1974; Flower and Vane, 1974 a, b). Vane (1971) has 
Postulated that NSAID exert their Pharmacological actions through 
inhi bition of prostaglandin. biosynthesis in tissues. This proposal 
was to serve as a mainspring in the synthesis of mny NSAID with 
the ability to inhibit prostaglandin synthesis. It has since 
been reCognised that PGE2 is cytcprotective for the gastro- 
intestinal tract, suggesting that many of the cyclo-oxygenase 
inhibitors lead to adverse side-effects (Rainsford et al, 1980). 
New developments in the field of NSAID were initiated by 
HarrIberg and Samuelsson (1974). 7heseworkers described manmalian 
lipoxygenase enzyme as providing a ccrrpetitive route for the 
oxygenation of free arachidonic acid, this'enzyme being 
unaffected by either aspirin or indcmthacin. The products of 
lipoxygenase pathumy were subsequently implicated as mediators 
of inflammation. 12-hydroxy-5,8,10" 14, eicosatetraenoic 
acid (12 HEM) was found to be, chemotactic for polymorphs 
(Geotzel et al, 1977), in caqoany with the hydroperoxy acids 
(HPErE) and the corresponding HM (Goetzel and Sunn, 1979). 
More recently, leukotriene B, another lipoxygenase product 
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(5,12 hihydroxy 6,8,10,14 eicosatetraenoic' acid) has been 
shown to be more chewtactic then either the HrM Is or HPEW... Is 
(Ford-Hutchinson et al, 1980). 
Recognition of lipoxygenase products as important rmdiators 
in the inflamnatory process lead to the development of agents 
wftich inhibit their synthesis. Riqgs et al, 1979, described 
a ccRmund, BW755C, wMch inhibits both cyclo-oxygenase and 
lipoxyqenase, and another patent anti-inflanTmtory agent, 
benoxaprofen, was developed. This was able to inhibit both enzyrws 
but with preferential activity against lipoxygenase (Walker and 
Dawson, 1979). 
Steroidal anti-inflanvatory druqs 
Hench et al, in 1949,, proposed that an anti-rheumatic substance 
-X- was released during pregnancy and jaundice, which was one of 
the adrenal horn-ones. They showed that certain clinical and bio- 
chemical features of rheumatoid arthritis could be markedly 
irrProved by daily adrenal hormne. Steroids were found to inhibit 
both Polymorphonuclear and nononuclear leucocytes' migration 
(Thc"PsOn and Van Furth, 1970; Watnick et al, 1974). Anti- 
inflanuatory steroids were also found to inhibit polymorphonuclear 
leucocytes' adherence (MacGregor, 1976) and chewtaxis (Rivkin et 
al, 1976). Lysoscmal enzyrms and free radicals release were also 
inhibited by steroidal anti-inflanvatory (lahmeyer and Johnston, 
1978; Smith and Iden, 1980). 
Glucocorticoids are indirectly able to inhibit phospholipase 
A2 and thereby prevent the biosynthesis of a number of pro-inflam- 
mtory nediators, such as the prostaglandins, thrcmboxanes and 
leukotrienes (Nijkanp et al, 1976; Tam et al, 1977). 
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This action depends upon steroidal interaction with 
specific recep tors, and the modulation of ribonucleic acid 
(RNA) and protein synthesis with the target cell (Danon and 
Assoulin, 1978; Flower and Blackwell, 1979; Carnuccio et al, 
1980). 
The anti-phospholipase effect of corticosteroids was found 
to be exerted by a 'second messenger' synthesised and secreted 
by the cells in response to steroid stimulation. In 1980, 
Blackwell et al isolated this material fran rat peritoneal macro- 
phages and showed it to be a protein with a molecular weight of 
15,000 daltons. lbey subsequently named the material Macrocortin. 
In 1980, Hirata. et al isolated a protein with similar properties 
and a molecular weight of 40,000 daltons from glucocorticoid- 
treated rabbit neutrophils, and this protein was named TApanodulin. 
In 1980, Blackwell et al showed that macrooortin exists as a 
pre-formed store within the rat peritoneal rracrophage and its 
secretion is induced by glucocorticoids. 
Anti-rheumatic carpounds 
Anti-rheumatic drugs are defined as those drugs which have 
shown efficacy as disease-modifying anti-rheumatic drugs (DMARD) 
(Stecher and Carlson, 1984). In order to be classifed as DMARD, 
a drug need not necessarily effect a cure, but rather nust 
retard or stop the underlying progression of the disease (Roth, 
1982). The term DWD has replaced the term SAARD, or slow-acting 
anti-rheumatic drugs, which appeared in the literature for a 
brief period. 
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Antimalarials 
Aminoquinolone antinalarials have been used to treat 
rheumatoid arthritis since 1951 (Zvaifler, 1971). Freedman (1956) 
showed that after sixteen weeks of treatnent, patients treated 
with chloroquinesulphate were significantly better than a control 
group. Chloroquineýis neither analgesic nor anti-inflammatory 
in animal models and its mode of action is unknown. - It accumulates 
in lymphocytes and reduces the responsiveness of lymphocytes 
of patients with rheumatoid arthritis to phytchaemagglutunin 
(Panayi et al, 1973). There was a fall in the titre of 
rheumatoid factor (antibody to normal tissue gamma globulins 
present in 80% of rheumatoid sera) in patients on chloroquine, 
and it is oLconsiderable interest that there was a significant 
correlation between changes in rheumatoid factor and changes in 
clinical state. Such a correlation has not been found with other 
drugs of this type. ''I Iý 
Gold 
It was not until 1961 that 
. 
the question of gold I s'ef f icacy 
was finally answered, when the Enpire Rheumatism Council (1961) 
conducted a well controlled double-blind study with gold sodium 
thicrralate in a large patient population. The results from this 
study showed that, by practically all criteria, inprovement was 
observed. The mode of action of gold ccn-pounds is still uncertain. 
Gold ccnpounds have been suggested to be therapeutic by virtue 
of inhibition of lysoscmal enzyme activity (Di Martino and Walz, 
1977) and release (Finkelstein et al, 1977), inhibition of prosta- 
glandin synthesis (Stone et al, 1975) or an imTtmosuppressive 
action. 
38 
, The most recently considered hypothesis is that gold 
caTpounds are immnosuppressive. This view is supported by the 
observation that gold sodium thiorralate inhibited the development 
of adjuvant-induced arthritis in rats (Walz et al, 1971), depressed 
mitogen-induced lynphocyte blastogenesis (Harth et al, 1977; 
Sin= et al, 1977) and clinically appeared to depress Jxrimunc- - 
globulin synthesis after long term therapy (Iorber et al, 1974). 
D-penicillamine 
The use of penicillamine in the treatment of rheumatoid 
arthritis was pioneered two decades ago by Jaffe (1963). 
D-penicillamine has been demonstrated to be effective in the treat- 
ment of rheumatoid arthritis (Multicentre Study Group, 1978). 
A number of observations in treated patients have suggested that 
D-penicillamine might exert an immunosuppressive action and, thus, 
act by suppressing the on-going immune response that underlies the 
chronic inflammation. In this regard, therapy with D-penicillamine 
Often results in decreased rheumatoid factor titres (Jaffe, 1965), 
irrmunoglobulin levels (Bluestone and Goldberg, 1973) and concen- 
trations of circulating immune conplexes (Jaffe, 1965). 
There has been considerable speculation that the efficacy of 
penicillamine in rheumatoid arthritis is due to its copper 
chelating and copper mobilising properties (Arrigoni-Martelli, 1982). 
Other studies have suggested an effect on collagen biosynthesis 
(Trentham et al, 1978), lymphocytes (Merryman and Jaffe, 1978), 
mononuclear phagocytic function (Devrines et. al, 1982), ocnplement 
(Mellbye and Munthe, 1977), antibody responses (Hunneyball et. al, 
1978) and cell mediated immunity (Stecher et al, 1981). As is 
the case for the other DMARD, the niechanisrn of action of 
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D-penicillamine has not been defined. 
Levamisole 
Levamisole, an antihelminthic agent with immunostirrulating 
activity, has been used experimentally for the treatment of 
rheumatoid arthritis since 1974 (Ansell, '1978; Huskisson et al, 
1976). Levarnisole has been shown to produce an effect in some 
patients with rheumatoid arthritis measurably superior to placebo 
or the first-line drugs, and with a delayed onset s IMI'lar to gold 
or penicillamine (El-<Mbarey et al, 1978). 
. The mode of action of levamisole is still unclear, 'although 
several hypotheses have been propsed. (Goldstein, 1978)-and 
numerous effects on monocytes have been demonstrated (Wynne et al, 
1981; Barada et al, 1982). 'The occurrence of sudden unpredictable 
agranulocytosis limits the uncontrolled practical use of 
levanisole as an anti-rheumatic, despite the'fact that the drug 
appears to prevent progression' of the disease (Stecher and 
Carlsm, 1983). 
Rheumatoid arthritis 
The rheurratic disease has been recognised. since the 
5th century before Christ, under the general title of arthritis. 
The term 'rheumatism' was probably introduced by Galen in 
medieval times. In the works of Hippocratesr rheumatic fever 
is briefly described under the generic nano arthritis. 
Guillaume de Baillou (or Ballonuis) was the first to use t: he 
term rheumatism, in the sense of an acute polyarthritis which 
has no connection with gout, and he is, therefore, often referred 
to as the Father of Rheumatism. In 1676, Thomas Sydenham, 'the 
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greatest clinical physician of his century, qave the first full 
description of acute rheumatism. William Heberden (1802) was 
one of the first to point out that acute rheumatism is largely 
a disease of childhood. It was Bouillaud (1836), the French 
physician, in his work "Nouvelles researches sur le rheumatism 
articulaire", who first established a fundan-ental basis upon 
wiiich modern ideaý of the disease are based. Salicylate treat- 
ment was introduced by Maclagan of Dundee in 1876, and aspirin 
in 1899. 
Rheumatoid arthritis is a chronic symmetrical polyarthritis. 
Although the principal manifestations occur in the joints, it is 
a multi-system disease. It is associated with the presence of 
rheumatoid factor in the blood, although it is not clear whether 
this is cause or effect (Berry, 1983). Despite innumerable 
sophisticated microbiological investigations, no infectious 
agents - bacterial or viral - have been identified to the general 
satisfaction of workers in the field (Sokoloff, 1984). 
Synovial joints 
7he general anatcmical features of a typical synovial joint 
are, articular cartilage lying on sub-chondral bone plate and 
non-articular surfaces within the joint covered by synovial 
tissue. The whole joint is enclosed by the capsule, which is 
continuous with the periosteum covering the bone (Vemon-Roberts, 
1980). 
Articular cartilage 
The articular surface of each bone is covered by a layer 
of hyaline cartilage, wbich acts as a resilient cushion. It 
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is fixed to the underlying sub-chondral bone by collagen fibres. 
Cartilage contains relatively few cells (chondrocytes) but a 
lot'of extraceliular material. 7his extracellular matrix consists 
largely of fibres (Collagen) and ground substance (proteoglycans). 
Cartilage has no nerve or blood supply, and therefore receives 
nutrients via diffusion from the synavial fluid, sub-chondral 
bone or the surrounding menbrane (Hascall, 1981). Articular 
Cartilage exhibits the properties of being both firm and flexible. 
This flexibility or resilience to compressive forces can-be 
directly related to proteoglycan content (Kempson et al, 1970) 
and the rigidity. and tensile strength is related to Collagen 
content (Kerrpson et al, . 19'73). 
Cartilage proteoglycans are complex glycoproteins composed 
of a protein core comprising 7-12% of the total weight, to which 
a large number of polysaccharide chains (glycosaminoglycans) are 
covalently linked, giving a molecular weight of approximately 
6 2.5 x 10 . In hyaline cartilage proteoglycans, the constituent 
glycosaminoglycans are chaidroitin sulphate and keratan sulphate 
(Faltynek and Silbert, 1978). Most proteoglycans are present 
in the extracellular matrix asm. iltimolecular aggregates. Aggregates 
consist of many proteoglycan subunits bound to a single molecule 
of hyaluronic acid by an ionic interaction. The chondrocytes 
produce the matrix during growth and, despite their small numbers, 
maintain the tissue during adult life. The ability of chondro- 
cYtes to regulate their surrounding matrix, and to respond to 
changes in that matrix by both anabolic and catabolic processes, 
is critical for tissue maintenance and function in both normal 
and pathologic tissues (Kimura et al, 1980). 
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Capsule and liqaments 
The joint is enclosed by a fibrous tissue capsule attached 
to the bone near the periphery of the articular cartilage and 
in continuity with the periosteum. 'Thickening of the capsule 
forms named ligaments which serve to stabilise and strengthen 
the joint and to limit certain moverrents. 
Synovial tissues 
The capsule is lined by synovial tissue, which invests all 
the non-articular surfaces within the joint. The synavial 
tissue norrmlly possesses variable numbers of folds and finger- 
like synovial villi and omprises a thin synovial layer, which 
form the lining of the nm-articular joint surface and an under- 
lying subsynovial supporting layer cmposed of fibro-fatty 
connective tissue of varying thickness which merges with the 
capsule. The cells (synoviocytes) of the synovial layer are 
divisible into two principal types type A cells have the 
appearance of cells engaged in phagocytic activity, whereas the 
type B cells have the appearance of cells engaged in synthetic 
activity (Barland et al, 1962). 
Cartilage degradation 
Irreversible cartilage destruction in rheumatoid arthritis 
is usually associated with a chronic hypertrophic synovitis, 
the rheumatoid pannus; that invades over and into the cartilage, 
eroding the cartilage matrix mainly under 
its advancing edge 
(Harris, 1981). The superficial lining layers of that pannus 
consist of synovial cells of both the phagocytic or macrophage- 
like-W-type and the fibroblastic-(B)-type (Barland et al, 1962). 
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Its deeper portions, that extend to the cartilage, contain, 
together with proliferating blood vessels, abundant fibroblasts 
and a heavy infiltrate of mononuclear phagocytes, B and T lyrrpho- 
cytes and plasma cells, with only rare occasional granulocytes 
(Kobayashi and Ziff, 1975; Ishikawa and Ziff, 1976). Cartilage 
invasion occurs at the cartilaqe/pannus junction by an ingrowth 
of racrophage-like cells and fibroblasts accaTpanied or not 
by proliferating small blood vessels (Poole et al, 1976 and 
Woolley et al, 1977). 
The above nentioned observations suggest that n-acrophaqes 
and fibroblasts, and possibly also the related synovial cell 
types, are among the main effector cells of irreversible 
cartilage erosion in rheumatoid arthritis. Under cell culture 
conditions, each of these cell types has the capacity to produce 
and secrete enzymes lysinq the rain constituents of the cartilage 
matrix - collagenase (Wahl et al, 1974; Bauer et al, 1975; Werb 
and Burleigh, 1974 and Dayer et al, 1976), and proteoqlycan- 
degrading metal-dependent neutral proteinase (Hauser and Vaes, 
1978; Huybrechts-Godin and Vaes, 1978; Peeters-Joris et al, 
1981). 
The enzymatic mechanism of cartilage matrix degradation 
7he table below sunnarises the min observations of 
enzymatic cartilaqe degradation. 
Author Year Author's contribution 
Barnett 1956 showed that when hyaluronidase was 
injected into rabbit joint, which is then 
vigorously exercised, there was a loss of 
articular cartilage ground substance. 
Thwas 1956 showed that there was a droop in the 
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rabbit's ears following intravenous 
injection of papain, and there was 
chondroitin sulphate in the rabbit's 
blood and urine. 
Dinqle 1962 proposed that lysoscmal enzymes might 
deqrade the matrix of articular cartilaqe. 
HamTerman et al 1967 showed that rheumatoid synovial nymbrane 
contains much higher content of lysoscral 
enzymes than the normal nymbrane. 
Janoff et al 1970 showed, that neutrophil granule enzymes 
degraded glycosaminoglycan of cartilage 
matrix. 
Malenmd et al, 1975 demnstrated that at least part of the 
proteoglycan, degrading activity of the 
neutrophil, granule function is due to 
elastase and cathepsin. 
Kobayashi and 1975 proposed thatthe major cause of cartilage 
Ziff erosion in rheumatoid, arthritis is a 
degradation of matrix by nacrophages and 
possibly by fibroblasts. 
Kenpson et, al 1976 showed that cathepsin B, is active against 
collagen as well as pmteoql. ycan. 
Barrett et, al 1977 reported that the neutrophil serine 
proteinases; degrades collagen and proteo- 
glycan of the articular cartilage. 
Werb et, al 1977 reported that adherent rheumtoid synovial 
jen cells produced collaqenase and plasminoc 
activators. 
Dingle 1979 showed that the synovial menbrane has both 
acid enzyrnes (the cathepsins B, D and N) 
and the neutral rrietalloproteinases and 
collagenase, serine proteinases were 
also found in low activity. Significant 
activities of cathepsins B, D and F were 
found in articular cartilage, thouqh 
there were only trace activities of 
neutral proteinases such as elastase, 
cathepsin G and plasmin. 
Dayer et al. 1979 showed that high levels of, collagenase 
and prostaglandin E2 were released into 
culture medium fram adherent rheumatoid 
synavial cells isolated from the super- 
ficial layer of synovium. 
Barrett 1981 suggested that the agents of cartilage 
rratrix degradation are proteinases. 
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bL-Guire 1982 suggested that collagenase is the 
only specific enzyme that acts at 
neutral pH to degrade the native 
helix of collaqen. 
Prostanoids 
It has been suggested that prostaglandins play a role in 
cartilage metabolism in inf lararation (Trange, 1980) as protective 
(Zurier and Ballas, '1973) and destructive (Teitz and Chrisman, 
1975) agents. 7hey are secreted in increased concentrations 
by untreated rheumatoid synovium and cultured rheumatoid 
synovial cells (Robinson et al, 1975). It has been shown in 
vitro that rheumatoid synoviu-n secretes substances that inhibit 
proteoglycan synthesis by fraqments of articular cartilage 
(Lippiello et al, 1978) and it is likely that this effect is 
mediated by prostaglandins or related substances, since this 
inhibition is suppressed by indcmethacin. In 1982, Metrovic 
showed, using cultured bovine articular chondrocytes, that 
PGE 2 
inhibits, whereas PGI 2 stimulates proteoglycan and protein 
synthesis respectively. 
Free radicals 
Polymorphonuclear leucocytes and macrophages have been shown 
to release in vitro superoxide radical (Goldstein et al, 1975 
and Johnston et al, 1976), which may initiate lipid peroxidation 
in synovium and cartilage, causing darrage to both tissues via 
the generation of highly toxic intermediate substances and 
hYdroxyl radicals (Hemler and Lands, 1980 and Polqar and Taylor, 
1980). Hydroxyl radicals rray induce changes in cell membranes 
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causinq cell necrosis and release of proteolytic enzymes, and 
my depolymerize hyaiuronic acid, proteoqlycans and collagen 
fibres, leading to fibrillation of articular cartilage and 
further loss of the rratrix n-acramlecules, (Greenwald et al, 
1976). 
Lvmphokines 
Various factors secreted in vitro by the lymphocytes, poly- 
norphonuclear leucocytes and rnacrophaqes have been described and 
probably play an important role in vivo, particularly in synovial 
inflammation (Kelly et al, 1981 and Wallach, 1978). These 
factors my attract polymorphonuclear leucocytes and macrophages, 
stimulate phagocytosis, cell division, the production and release 
of proteolytic enzymes and prostaglandins, or stimulate proteo- 
glycan biosynthesis (Castor and Whitney, 1978). 
Catabolin 
Catabolin is the name coined by Dingle and colleagues (1979) 
for a protein, or a family of proteins, capable of stirmilatinq 
intact living cartilage to degrade its extracellular matrix. 
Catabolin does not inpair the viability of the chondrocytes, nor 
does it inuediately modify the rnitotic activity of these cells. 
Catabolin is an acidic protein with a molecular weight of 
21,000, produced by pig mononuclear cells when they are cultured 
with concanavalin A (Saklatvala et al, 1983). Recent studies 
have confirmed that purified porcine mononuclear cell catabolin 
is a form of interleukin-I (Saklatvala et al, 1984). 
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Interleukin-1 
Over the past twenty-five years, there has been an ever- 
exparuling interest in the mediators that control the inTme 
response (Lawrence and Landy, 1969). One of these is produced 
by rracrophages and was first called lyrrphoqýte activating 
factor (Gery et al, 1971), but is now designated interleukin-1 
(Mizel and Farrar, 1979). Mizel and his colleagues have shown 
that interleukin-1 is a single polypeptide chain of molecular 
weight 12,000 - 16,000 daltons, and it is produced by the muse 
macrophage cell line. This macrophage-derived mediator 
(interleukin-1) has uany in vitro biologic activities, including 
the augmentation of lectin stirmlated thymcyte proliferation 
(Gery et al, 1972), enhancement of production of lygphocyte- 
derived lymphokines, such as interleukin-2 (Smith et al, 1980), 
chemotactic factors (Oppenheim. et al, 1979), migration inhibition 
factor (Yamamoto and Onoue, 1979), 'prcrmtion of in vitro anti- 
body production by B-lymphocytest and function as a second signal 
that may serve to amplify 3zounologic reactions (wood, 1983). 
Interleukin-1 is mitogenic for cultured fibroblasts (Schmidt et 
al, 1982) and chemotactic for polymporphonuclear leucocytes 
(Luger et al, 1983). It was found that interleukin-1 induces 
fever when injected into rabbits (Rosenwasser et al, 1979) and 
is inhibited by antiserm to endogenous pyrogen (Murphy et al, 
1980). It has been shown that interleukin-1 stimulates hepato- 
cytes to produce acute phase proteins (Sztein et al, 1981). 
Mizel and his colleagues (1981) have shown that interleukin-1 
activates the production of collagenase and prostaglandins by 
synovial cells. Gowen et al in 1984, have shown that human 
interleukin-l-like material mediates cartilage breakdown and 
48 
production of collagenase and. prostaglandins by human chondro- 
cytes. Interleukin-1 also mediates bone resorption (Gowen et al, 
1983). 
Mononuclear cell factor' 
In 1977, Dayer, Russell and Krane, demonstrated that human 
mononuclear cells in culture produce a factor which can stimulate 
the production of collagenase by the adherent rheumatoid cells. 
Dayer, Robinson and Krane (1977) found another factor produced 
by mononuclear cells, and its production was enhanced by phyto- 
haemagglutonin. This factor stimulates the production of prosta- 
glandin E2 and has a molecular weight similar to that of the 
first factor. In 1980, Meats and his colleagues found that the 
culture mediums fran explants of normal. and rheumatoid human 
synovium contained a factor which is capable of stimulating the 
production of prostaglandin E2 and plasminogen activator by 
chondrocytes of human articular cartilage. 
Deshmukh-Phadke et al (1980) reported that rabbit peritoneal 
macrophaqes, when activated with lipopolysaccharides, release a 
factor which stimulates the chondrocytes to produce collagenase 
and the neutral proteases. This factor has a molecular weight 
ranging fran 13,000 - 15,000 daltons. Another factor produced 
frcm stimulated rabbit peritoneal macrophages, and with a molecular 
weight of 30,. 000 daltons, was found by Ridge, Crnosky and Kerwar 
in 1980. Addition of this factor to cartilage in culture, resultý. 
in the synthesis of collagenase and neutral proteases, both in 
latent form which can be activated by either trypsin or plasmin. 
In 1980, Meats et al discovered another factor, named thý! 
synovial factor. Synovial factor is identified as an activity 
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present in the nvadium of cultured explants of human normal or 
rheumatoid synovial tissue, that stinulated the production of 
prostaglandin E2 and plasminogen activator by isolated human 
chondrocytes. Elford and his colleagues in 1985, showed that 
mononuclear cell factor and synovial factor are closely related 
to, or are identical with, interleukin-1. 
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MATERIALS AND METHODS 
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A. ANIMAT. S AND MAINMANCE 
Mice 
Adult male outhred SAS/4 mice weighing between 30-40 grams 
were used. The mice were obtained from the colony at 
St Bartholcnrev's Hospital, and were housed in plastic cages. 
The mice were kept in a ter. perature-control led envirorm-ent. and 
-fed special dietary pellets, FFG(M) diet for scientific 
research animals, (E Dixon & Sons, Ware Ltd) and fresh water 
ad libitum. 
Rats 
Adult male outhred Wistar rats weighing between 200-250 grams. 
were used. These animals were obtained from the colony at 
St Bartholcny-vls Hospital. Adult male inbred Fisher rats of 
the same weight were also used and were obtained from 
Charles River UK Ltd, Kent, UK. Their housing and dietary 
regime was similar to that of the mice. 
Rabbits 
Adult male rabbits of the New Zealand Mdte strain weighing 
between 3-4 kg were used. They were obtained fran Animal 
Suppliers (London) Ltd, Pottersheat Road, Welwyn, Hertfordshire, 
and they were housed in galvanised steel cages (241 x 18' x 18'). 
They were fed on special 'diet 18' (Dixon & Sons, Ltd) and 
al Rved fresh water ad libitum. 
B. EXPERIMENrAL MODELS OF INETAMMATION 
Bl The forration of different aged pouches in the rat 
The air pouch as described by Edwards et al (1981) was used. 
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Animals were anaesthetised with anaesthetic ether (May and 
Baker, Ltd, Tondon) and their dorsal surface cleaned with 
70% alcohol and shaved. 'Using a 20 ml disposable syringe 
(Gillette) and 25G x 15/16 gauge needle, 20 ml of air was 
injected subcutaneously into the tissue of the back in the 
midline to produce an air pouch. Pouches older than 1 
days had 10 ml of air injected into the pouch every 3 days to 
keep the cavity open. 
B2 The formtion of 6 day old pouches in mice 
The dorsal surface of lightly anaesthetised mice were cleaned 
with 70% alcohol and shaved. Using a5 ml disposable syringe 
(Gillette) and a 25G x 15/16 gauge needle, 5 ml of air was 
injected subcutaneously into the dorsal surface of each animal. 
Later, 2.5 ml of'air was injected into the pouch after 3 days 
to keep the cavity open. 
B3 Carrageenan 
produce inf larwation in the pre- Carrageenan was used to 
formed air pouches of mice and rats. Carrageenan, viscarin 
402 (lot 272500) was kindly provided by marine Colloids Tnc, 
Springfield, USA. This was dissolved in a sterile solution 
Of 0-9% sodium chloride containing Benzylpenicillin 
100 units/Ml (sodium, BP Glaxo, Greenford, England) and 
Streptcmycin 100 ug/rnl (sulphate, BP Glaxo, Greenford, 
England). The solution was stirred continually at 37 0C 
so that it was homogenous. A concentration of either 1% or 
2% W/V was used for injection. Mice received 1 ml of 1% 
carrageenan into pouches, whilst rats received either 2 rnl of 
2% (high dose) or 2 ml of 1% (low dose) of carraqeenan. 
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B3a Sera collection 
Blood was collected from the tenninal bifurcation of the 
aorta of rats. Anirals were anaesthetised with ether and the 
abdcw-n was opened with sterile scissors. The viscera were 
rermved to reveal the aorta. A 21G x1 'Gillette' needle 
was fixed to a 10 ml disposable syringe and carefully inserted 
through the aortic bifurcation with the ccmTon iliac arteries 
and the blood was collected in the syringe. I-Th avoid haew- 
lysis, blood was poured carefully along the side of a 10 ml 
Sterilin container (Sterilin, Teddington, Middlesex, England) 
After one hour at room tenperature, the sanple was centrifuged 
at 300g for ten minutes and the ser= was ranoved with a 
sterile plastic pipette (Alpha Laboratories Ltd, Eastleigh, 
Hants, England). Sera was subsequently stored at -20 0 C. 
B3b Exudate collection 
Exudate was collected frcm all animals receiving an 
inflammatory insult. Anaesthetised animals were killed by 
cervical dislocation and an area of the pouch was cleaned'with 
70% alcohol before being shaved. A small incision was made 
using Sterile scissors. 7he exudate was collected using a 
sterile plastic pipette and poured into 30 ml sterile Sterilin 
containers. Heparin solution (Sigma Chen-Lical Company) was 
added to the collecting tubes (50 units/ml. final concentration). 
The exudate volume, together with the total leucocyte count, 
was assessed for each animal. 
B3c Cell viability test (Trypan blue technique) 
The viability of cells were tested using trypan blue. Cne 
volume of cell suspension was mixed with one volume of trypan 
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blue solution (0.1%) for five minutes. A smear was n-ade 
and the percentage of cells with blue colouration was noted. 
This gave an index of cell death. 
B3d Storage of exudate 
Exudate was centrifuged at 8OOg for ten minutes at 40 C 
and the free exudate stored at -20 0 C. Smears were prepared 
frcm the sedimented cellular pellets. 
B4 Arthus reaction 
B4a Preparation of anti-bovine serum albumin (anti-BSA) 
M Immunisation of rabbit to obtain the anti-BSA 
The anti-MA was obtained from rabbits. Rabbits were first 
inmmised by injecting 10 mg of BSA (Sigma Chemical Carpanyr 
USA) in 0.5 ml of sterile saline, mixed well in the syringe 
with 0.5 ml of complete Freund's adjuvant (Difoo Laboratories, 
USA). The hind foot pads received 0.15 ml each and the 
remaining 0.7 ml was divided between three skin sites - each 
flank and over the neck. The injections were repeated every 
week for eight weeks. After the final week, blood was ren-oved 
from the rabbit via the ear vein. The blood was centrifuged 
at 1000 xG for twenty minutes to obtain the serum. 
(ii) Isolation of anti-BSA frcm blood senun 
Twenty-f ive millilitres of sermn were mixed gently with 
anhydrous sodium sulphate (Na So - 18g/100 ml serum) using 
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a Pasteur pipette. This precipitated the globulin. 
After mixing, the solution was incubated for 45 minutes at 
37 0 C. The precipitate was then centrifuged at 6,000 - 10,000 
rpm for twenty minutes. The supernatant was discarded and 
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precipitate dissolved conpletely in distilled water. The 
clear solution obtained was then dialysed at 40 C in 20 m 
Visking tube (GallenkarTp) in phosphate buffered saline, 
pH 7.4, in a, five litre flask. Dialysis went on for 30 hours 
with six changes of buffer in between. After dialysis, the 
solution was passed through the sepharose-BSA conjugated 
colurm. 
Preparation of the sepharose-BSA conjugated colum 
a) 4g of sepharose 4B activated with cyanobromide 
(Pharmacia, Fine Chemical, Uppsala, Sweden) was 
washed through with 800 ml of 1.0 rrM hydrochloric 
acid (HC1) in a sintered glass funnel. 
b) The sepharose was washed through with 800 ml of 
0.1 M sodium bicarbonate to remove acid. 
C) BSA (90 mg) was prepared in 15 ml of 0.1 P4 sodium 
carbonate and optical density was measured at 
280 nm to obtain a reading for 90 mg BSA. 
d) Sepharose was mixed with BSA solution in a small 
beaker and stirred gently for 16 hours at 40C. 
e) The supernatant was removed and optical density 
was rmasured again to rake sure that sepharose 
binding sites were saturated. more BSA was added 
if necessary. 
f) Sepharose-BSA was placed into a sintered glass 
filter funnel and washed through in sequence with 
the following: - 
200 ml 0.1 M sodium bicarbonate (NaHCO 3) 
800 ml phosphate buffered saline (pH 7.4) 
800 ml glycine - HCI buffer (pH 2.3) 
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g) A suspension of the sepharose-BSA conjugate in 
PBS was prepared in a small beaker and then poured 
into the column whose mouth had been plugged with 
clean glass wool. The sepharose-BSA was ramried 
down gently with a glass rod, so as to pack firmly. 
h) Finally, the column was washed with 1.0 litre of 
PBS pH 7.4 
CaTposition of buffers: 
phosphate buffered saline (pH 7.4) 
sodium chloride (Na Cl) 42.5 g 
disodim hydrogen phosphate 
(Na HPO 12H 0 (M/15)) 96.5g (242 
potassiun dihydrogen phosphate (KH 2 PO 4 (M/15) 8.7g 
make up to 10 litres with distilled water 
glycine - HC1 buffer (pH 2.3) 
glycine M/10 2.25 g 
sodium chloride M/10 1.76 g 
hydrochloric acid M/10 200 ml 
nake up to 10 litres with distilled water 
UV) Isolation of anti-BSA in sepharose-BSA conjugated colurm 
9-be colum was surrounded by a jacket of circulating cold 
anti-freeze glycol at 40C. Attached to the top of the colmn 
was a long rubber tube leading to a volumetric flask containing 
the buffer. The solution which had been dialysed over night 
was applied with a Pasteur pipette gently to the sepharose-BSA 
gel. When the sample had been absorbed onto the column, th6 
column was washed through with PBS (pH 7.4). The rate of 
elution was 10 seconds per drop. After the first 40 ml of 
cluent had been collected, the rate of elution was increased 
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to 8 seconds per drop. A further 40 ml of eluent was 
collected and a small quantity of the solution (1 in 10 
dilution) was tested for its optical density (280 m). 
When there was no protein in the eluent the anti-BSA 
could be released from the column. 
M Release of anti-BSA from column 
When all the unwanted protein had been eluted, glycine- 
HC1 buffer (pH 2.3) was applied to the column slowly. The 
rate of elution of the buffer was 10 seconds per drop. With 
the acidic buffer passing through, the anti-BSA was released 
fram the BSA and collected. Men 25-30 ml of eluent had 
been collected, a small quantity was taken out and diluted 
50 times. The optical density (280 nm) of the diluted 
solution was measured so as to check the protein concentration 
and, thus, obtain the total amount of antibody collected. 
Using 1.0 cm square cuvettes, 13 absorbance units = 10 mg/ml, 
(rabbit antibody). 
Antibody is normally expressed as Vg N2 
rrass of antibody 
6.25 
pg N2 
Egr if O-D reading is X, then actual O. D of solution is 5OX 
(because of dilution of 50X). 
13 absorbance units 10 mg/ml 
10 x 1000 pg/ml 
10 x 1000 pg N21Ml 
6.25 
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5OX c-Esorbance units 10 x 1000 x 5ox 
P9 N2/Ml 
6.25 x 13 
After collecting the anti-BSA in glycine - HCl buffer (pH 2.3), 
the pH was adjusted to 7.0 writh glycine - NaOH buf fer (pH 11.3). 
At pH 7.0, the solution contained scre precipitate. The 
solution was then dialysed over night in PBS (pH 7.4) with four 
changes in between. 
Glycine- NaOH buffer (pH 11.5) 
Glycine -M/10 1.84 g 
NaCl M/10 1.43 g 
NAOR M/10 1.02 g 
Make up to 500 ml. 
(vi) Concentration of antibodies 
After dialysis, the solution was filtered (millipore filter 
- 0.45 W, Bedford, Massachusetts, USA), to remove the 
precipitate. The supernatant was then concentrated. The 
concentrating apparatus consists of a separating funnel, a bent 
graduate pipette and a5 litre flask, connected tightly. - The 
protein solution was put into 7m visking tubing which was 
secured by strong rubber bands at the junctions. After making 
sure that there was no leak, the flasK was evacuated by an 
electric purrp (care was taken not to burst the visking tube) 
The flask was then left to concentrate at 40C for 12 hours. 
After concentration, the antibodies were diluted out 1: 1 
and then dialysed over night in PBS with three changes of 
PBS in between. 
After dialysis over night, the solution was filtered 
(millipore 0.45 pm). A small quantity of the filtrate was 
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diluted with PBS (1: 50) and optical density uas nieasured. 
The total amount of antibody was calculated. Aliquots of 
the antibody were placed into small test tubes and stored at 
-260 C. Each aliquot was calculated in such a way, so that 
one test tube would give enough antibodies for one group of 
six aninals. This was necessary to avoid unnecessary thawing 
and freezing, which rray lead to denaturation of protein. 
B4b Induction of active Arthus reaction in the air pouch 
Rats were sentitised by weekly injection of 0.4 ml emulsion 
containing 0.2 ml saline and 5 mg bovine serum albumin (BSA: 
essentially globulin-free, from Sigma Chemicals Co, Ltd, 
London) mixed with an equal volume of ccrrplete Freund's 
adjuvant; 0.2 ml emulsion was injected into each of the rat 
hind paws, using 19G 1.21" gauge needle. After three weekly 
injections, the animals were left for four days, anaesthetised 
with ether and then injected with 20 ml air into the 
subcutaneous tissue of the back. Pouches older than one 
day had 10 ml air injected into the same c-Avity to keep 
it open every three days. At different time intervals (1, 
and 6 days) after the initial air injection, animals were 
re-anaesthetised with ether and 1 ml sterile saline containing 
1 mg BSA was injected into the pouch. Groups of animals were 
killed at cU ff ertat t; mes after antigen challenge, and 'the total 
leucocy-te number and volume of exudate in 'the pouch was 
measured. Exudate cell smears were stained with May-Gr8nwald- 
Giemsa and differentially counted. 
B4c Induction of reverse passive Arthus reaction in the pouch 
Groups of rats were injected with 20 ml air in their backs. 
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Six day old pouches received 10 ml air after three days from 
inducing the pouch to keep the cavity open. At different 
tin'e intervals (I# and 6 days) after initial air injection 
5 mg bovine serum albumin (BSA) in a volume of 0.2 ml phosphate 
buffered saline (PBS) was injected intravenously via the tail 
vein into each rat. Twenty minutes later, rats were 
challenged with purified anti-BSA (1.0 ml of a solution 
containing 5 mg protein N2 /Iml PBS) by injection into the 
preformed different acred air pouches. After six hours of 
sensitization, animals were killed and the total leucocyte 
number and volume of exudate in the pouches were neasured. 
B5 Prolonged immme inflanr. ation in the pouch 
B5a Preparation of the ssis-adiuvant emulsion 
Bqual volums of bordetella pertussis vaccine (Wellccrre) 
and Freund's incorrplete adjuvant (Difco, USA), were mixed 
in a sterile beaker using a hcm)geniser until a homogenous 
white emulsion was formed. The emulsion was tested for 
hcm: )geneity by placing one drop of emulsion in a 
beaker containing water. If the drop did not disperse in 
water, this indicated a hcmogenous, well formed emulsion. 
B5b Animal sensitisation 
Outhred rats were anaesthetised with ether and 0.5 ml 
emilsion containing (10 x 1010) organisms was injected into 
each of the rat hind paws, using a 19G 1-1" gauge needle 2 
(Gillette) fixed on a2 ml disposable syringe. 
B5c Preparation of pure bordetella pertussis vaccine 
Visking tutm3(Gallenkarrp) was washed with distilled water 
and boiled in a beaker containing distilled water for ten 
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minutes. One end of the visking tubing was knotted and 
the vaccine was introduced from the other end. The tubing 
was placed in a5 litre flask containing PBS. The vaccine 
was dialysed for 24 hours at 40C. This procedure was to 
remove the preservative from the vaccine. 
B5d Formation of I and 6 day pertussis-inf lamed pouch 
To fom the six day pouch in the sensitised animals, 20 ml 
air was injected into the dorsal subcutaneous tissue of the 
anaesthetised rat (according to the method described by Bdwards 
et al, 1981) six days after sensitisation. Three days later, 
a further 10 ml air was injected into the air pouch to keep it 
open. Twelve days after sensitisation, the animls were 
challenged with 1 ml dialysed vaccine, injected into the pre- 
formed pouch using a disposable syringe and a 25G x 15/16 
gauge needle. To form a one day pouch in the sensitised 
animls, 20 ml air was injected eleven days after sensitisation. 
B5e Sera and exudate collection 
The same procedures used to collect sera and exudate frcm 
carrageenan-inflarred animals were applied to animals of 
pertussis-immme inf lannation. 
B5f Non-sensitised anirmls 
Non-sensitised animals were challenged as for sensitised 
animals and used as controls. 
B6 Quantitative assessuent of air pouch inf lammtion 
B6a Exudate volurre 
Volume of the collected exudate was measured using a 
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graduated test tube. 
B6b Thtal leucocyte count 
r1btal leucocytes of the collected exudate were counted 
using a Coulter counter (Coulter Electronics Ltd, England). 
40 VI exudate was put in a Coulter pot and three drops of 
Zap-oglobin (Coulter Electronics Ltd, England) were added 
to haermlyse any red blood cells that might be present in 
the sample. 20 ml Isoton-II (Coulter Electronics Ltd, England) 
were added and the contents were mixed and read using a 
Coulter counter. Random samples were che cked for accuracy 
using an irrproved neubeur haemocytorreter. Exudate leucocytes 
were diluted with a 1% acetic acid solution containing crystal 
violet crystals. The diluted sample was counted using an 
irrproved neubeur haemocytcmeter and light microscope. When 
an exudate contained a high number of cells, the sarrple was 
diluted in phosphate buffered saline. 
B6c Exudate smears 
Smears were made in duplicate from the pellets remaining 
after the storage of the centrifuged exudate. The Smears 
were left to dry in air, stained with May-GrOnwald-Giemsa. 
May-Grffi-hold-Giemsa 
After fixation, cell smears were washed in water, then stained 
with May-GrOnwald (BDH Chemical Ltd, Poole, England) diluted 
1: 1 in water for five minutes, and then in Giemsa (BDH Ltd) 
1: 10 for fifteen minutes. Samples were again washed in 
distilled water, then air dried. 
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C. CARTILAGE 
Cl Mouse xiphisternal cartilage 
Autologous xiphisternun was used as a source of cartilage. 
To obtain this, a mouse was anaesthetised with ether and 
the area around the xiphisternm was cleaned with 70% alcohol 
and shaved. A small incision was made in the upper abdcminal 
area using sterile scissors to reveal the muscular layer. A 
small region of the muscular layer (0.7 cm) overlying the 
xiphisternum. was cut and a light pressure applied until the 
xiphisternum was revealed. it was removed with great care by 
cutting at the point where the sternal bone is connected to 
the cartilage. The wound was then sutured with chrcru, *c catgut 
and the overlying skin edges closed with 7.5 m Michel Clip 
(Thackray Ltd, Iýondon). The cartilage was prepared for 
implantation by removing any adipose tissue and attached 
sternal bone. The cleaned cartilage (0.5 cm approximately) 
was washed four tires in medium 199 containing benzy1penicillin 
(100 units /ml) and streptomycin (100 pg/ml) before being 
implanted into the pouch. when minced cartilage was used, the 
intact xiphisternun was cut into six pieces (0.15 cm diameter 
approximately) in a petri dish containing medium 199 with anti- 
biotics, as above. 
C2 Rat articular cartilage 
Cartilage was obtained fran the femoral heads of donor rats. 
Donor animals were anaesthetised with ether and killed by 
cervical dislocation, and their hind dorsal surface was cleaned 
with 70% alcohol and shaved. The skin layer was removed with 
sterile scissors. An incision was made using a sterile scalpel 
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blade (no. 22) diagonally across the gluteus maximus muscle 
to reveal the sciatic nerve. Pressure. was applied to the knee 
and the femoral head was dislocated frcrn its position. The 
cartilage cap was carefully removed from the femoral head 
using sterile bone forceps. The cartilage was washed in 
sterile medium 199 (Flow Laboratories, Fngland) containing 
100 units/ml benzylpenicillin and 100 Vg/ml. streptomycin, 
before being used for irplantation. Cartilage fran both sides 
of donor animals was used. 
C3 Mouse articular cartilage 
In experirrents where mouse articular cartilage was used, 
the same procedure was used as in rats, except that the area 
of irrplantation was closed with a 7.5 ran Michel Clip. Because 
of the smll size'of mouse femoral cartilage, only whole 
intact cartilage was used for irrplantation. 
C4 Preparation of dead cartilage 
Cartilage sanples were placed in a small sterile polythene 
bag and wrapped carefully. This was placed in a 250 ml beaker 
containing the freezing mixture (solid carbon dioxide and 
isoPentane) for fifteen seconds. The freezed bag was placed 
directly in a beaker containing warm water (35 0 5) to thaw 
cartilage. This process was repeated for five cycles. 
C5 Cartilage irimmisation 
Some groups of rats were imninised against femral head 
cartilage. Cartilage caps were obtained, as described 
previously, and finely minced using a sterile scalpel blade. 
The minced cartilage was suspended in sterile saline in a 
clean beaker. The cartilage suspension was mixed with an 
( 
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equal volume of inccrnplete Fruend's adjuvant (Difco, USA) 
then hcmogenised using a clean hcmogeniser until a good thick 
white enulsion was formed. 0.25 ml enulsion was injected 
into each foot pad of outhred Wistar rats using a 19G 1-: t" 
gauge needle (Gillett) and a1 ml disposable syringe. 
C6 Cartilage implantation 
C6a Mouse intact xiphisternum, 
The air pouch was cleaned with 70% alcohol and shaved. 
A small incision was niade in the cavity using sterile scissors 
and the incision opened by blunt dissection. The autologous 
intact xiphisternum. was inserted into the pouch using sterile 
forceps. Inrie-diately the opening was closed with a 7.5 m-n Michel 
Clip (Thackray Ltd, London). The wounded area was cleared 
daily with 70% alcohol until the wound healed. 
C6b Millipore half chamber 
This technique was developed for experiments where minced 
xiphisternal fragments were used. Without using this technique, 
the cmPlete retrieval of the implanted pieces was difficult. 
A sterilised millipore filter (pore size 5 pm) was attached to 
a millipore ring (13 mn diameter) with millipore MF cement 
(Millipore Corporation, Bedford, Massachusetts, USA). ne 
fragments of cartilage were then placed in millipore half 
chambers, and implanted into the preformed air pouch as usual. 
C6c Rat articular cartilage 
In experiments where the articular cartilage were used, 
the same procedures were used as in mice, and the incision 
was closed with a 12.5 x 2.5 om Michel Clip. There was 
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no need to use the millipore half chamber technique in 
experiments where riinced articular cartilage was used, 
because its convenient size allowed retrieval. 
C6d Subcutaneous implantation 
Cartilage was implanted into the subcutaneous tissue of 
some rats, without prior air pouch formation, through a 
small incision on the hind flank. The tissues were parted 
by blunt dissection and closed with a Michel Clip. 
D. HISTOLCGY 
Samples of air pouch, superficial inguinal lymph nodep 
spleen and in-planted cartilage were removed from one animal 
in each experimental group. Tissues were fixed in 10% 
buffered formal saline (pH 7.0). 
This contained: 
Na 2 HPO4 
NaHýý4 
NaC1 
HCHO 
162.0 g 
87.5 g 
212.5 g 
2.5 ml 
This was'nade up to 25 litres with distilled water. 
Tissues were processed for paraffin wax enbedding according 
to the following schedule: 
70% alcohol 11 hour 2 
90% alcohol l-'i hour 
100% alcohol 1 hour (four changes) 
Toluene 11 hour (two changes) 2 
Molten 560C paraffin wax (two changes) 
1-j' hour each 
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The alcohol used was 74 OP industrial alcohol. Blocks 
were vacuum-irrpregnated with molten wax for half an hour 
before being enbedded in fresh wax. Sections were cut 
at 5pm on Leitz base-sledge micro toine , floated onto a 480C 
water bath and picked directly onto glass microscope slides. 
Sections were stained with Harris haemtoxylin and eosin, and 
by the alcian blue methyl green pyronin technique. The 
toluidine blue technique was used to stain cartilage sarnples 
and the MSB technique was used to stain fibrin. 
Dl Demonstration of the anatcmical site of increased 
vascular pern-eability and the number of vessels involved 
A colloidal suspension of carbon (Gunther Wagner, Pelikan 
Werke, Hanover, Germany - Batch C11/1431a) was administered 
intravenously at a dose of 1.0 ml/100 g body weight, fifteen 
minutes before killing the animals. A piece of the pouch 
lining tissue attached to the skin was then excised and fixed 
in formal saline. The fixed skin was subsequently dehydrated 
in ethanol and cleaned in cedar wood oil for 48 hours (Spector, 
Walters and Willoughby, 1965). Using this method, the 
vascularity of different aged linings could be assessed. 
TO study the resorptive capacity of linings for particular 
matter, 0.2 ml colloidal carbon suspended in 5 ml saline was 
introduced into air pouch for 30 minutes before killing. The 
tissue was then fixed in formal saline and ýmbedded in 
paraffin for histology. 
D2 Haernatoxylin and eosin 
Sections were de-waxed with two changes of xylene for two 
minutes each, then hydrated with descending concentrations of 
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alcohol (absolute, 90% and 70%) to tap water. Sections were 
stained with Harris haematoxylin for five minutes, then washed 
in tap water and differentiated in 1% acid alcohol for 
approximately 30 seconds. At this stage, a microscopical 
check was made for direct nuclear staining. Sections were 
washed with tap water for five minutes and stained with 1% 
aqueous oesin for three minutes, then dehydrated with 
ascending alcohol concentrations (70%, 90% and absolute). 
Sections were cleared in two changes of xylene and mounted in 
chlop1ionium. resin. 
Results 
Nuclez& stained with blue colouration and cytoplasm with 
shades of pink. 
D3 MSB (Martius, scarlet, blue) technique for fibrin 
D3a Reagents 
Martius yellow (acid yellow 24) C. I. 10315 
Brilliant crystal scarlet (acid red 44) C. I. 16250 
Soluble blue (methyl blue) (acid blue 93) C. I. 42780 
D3b Preparation of solutions 
i) martius yellow (acid yell6q 24) 0.5 g 
phosphotungstic acid 2.0 g 
95% alcohol 100 mi 
ii) brilliant crystal scarlet (acid red 44) 1.0 g 
glacial acetic acid 2.0 ml 
distilled water 100 mi 
iii) phosphotungstic acid 1.0 g 
distilled water 100 ml 
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iv) m2thyl blue (acid blue 93) 0.5 g 
glacial acetic acid 1.0 mi 
distilled water 100 ml 
V) glacial acetic acid 1.0 mi 
distilled water 100 ml 
D3c Technique 
Sections were taken to water, mercury pigment was removed 
with iodine thiosulphate treatment, and nuclei were stained 
by the celestin blue-haematoxylin sequence. Sections were 
differentiated in 1% acid alcohol,. then washed well in tap 
water and were then rinsed in 95% alcohol. Sections were stained 
in Martius yellow solution for two minutes, then rinsed in 
distilled water and were then stained in brilliant crystal 
scarlet solution for ten rdnutes and rinsed in distilled water. 
Sections were treated with phosphotungstic acid solution until 
no red ren-ained in the collagen and then rinsed in distilled 
water. Methyl blue solution was used to stain sections until 
collagen was sufficiently coloured, then they were rinsed in 
1% acetic acid and deydrated through alcohols. Finally, 
sections were cleared in xylene and mounted with chlophonium 
resin. 
D4 Alcian blue, methyl green-pyronin technique 
Na Reagents 
1% alcian blue in 0.1 M hydrochloric acid (pH 1.0) 
methyl green-pyronin , 
- solution A: A 2% aqueous solution of methyl green 
was rrade and all the mthyl violet was extracted with 
chloroform. The solution was washed with several 
changes of chloroform in a separating funnel until 
the chloroform remained colourless. Fran the chloro- 
form washed solution, the following was freshly 
prepared: - 
2% aqueous methyl, green (chloroform washed) 10.0 ml 
5% aqueous pyronin Y 17.5 ml 
distilled water 250.0 ml 
- solution B: Acetate buffer solution, pH 4.8, was 
prepared by mixing 119 ml 0.1 M sodiun acetate with 
0.1 M acetic acid. Theworking solution was prepared 
by mixing equal volumes of solution A and B in a 
Coplin jar. 
D4b Technique 
Sections were taken to water and then stained with alcian 
blue for two minutes and then washed with distilled water. 
Sections were stained for 30 minutes with the working solution 
of methyl green and pyronin, then rinsed with distilled water 
for a few seconds and blotted lightly until dry. Sections 
were dehydrated with acetone for not more than one minute, then 
rinsed with equal parts of acetone and xylene and cleared in 
pure xylene. Finally, sections were n-ounted with chlophoniu-n 
resin. 
D5 Toluidine blue technique 
D5a Reagent: veronal acetate buffer (pH 4.5) containing 
0.25% W/V toluidine blue. 
Veronal acetate buffer 
Stock (A); veronal acetate stock solution. 
l.? 4 g sodium trihydrate (AW136) and 2.94 g sodium barbitone 
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(MW206) were dissolved in 100 ml distilled water. 
Stock (B); 0.1 M HC1 (M36.46). 
0.85 ml hydrochloric acid was dissolved in 100 ml distilled 
water. Veronal acetate buffer solution was prepared by mixing 
5 ml stock A, 10.5 ml stock B and 7.5 ml distilled water, and 
the pH of the solution was adjusted to 4.5.57.5 n-g toluidine 
blue was added to the veronal acetate buffer solution. 
D5b Technique 
Sections were taken to water, then stained with the buffered 
toluidine blue solution for 30 seconds and washed with 
distilled water. Sections were dehydrated rapidly, then 
cleared in pure xylene and mounted with chlophonium resin. 
D5c Results 
Metachrcmatic areas of red purple. 
Orthochron-atic areas of blue. 
D6 
35 
S-sodium sulphate uptake by cartilage cells in vitro 
The 35 S-sodiun sulphate supplied in sterile aqueous 
solution (The Radio-Chemical Centre, Amrsham, UK) was used 
to detect the synthesis of DNA by cultured cartilage. The 
isotope solution was diluted in n-editun 199 to give af inal 
concentration (in culture vessel) of 15 pci/ml. Cartilage 
was remved from the air pouch at the end of the hrplantation 
period and then incubated in the culture vessel (Sterilin Ltd, 
Middlesex, England) for twelve hours. The cultures were 
washed thoroughly with n-edium 199 to rermve residual radio- 
activity. 
The tissue was fixed for one hour in 3: 1 absolute alcohol 
to acetic acid, and then buffered 10% forml saline for 
24 hours before normal tissue processing. Sections were cut 
and the same procedures used to prepare the histological 
sarTples were applied. 
-D6a Autoradiography 
Glass slides were thoroughly cleaned by soaking in a 
solution corrprising potassium dichromate (100 g) and 
concentrated sulphuric acid (100 ml) made up to a final volume 
of one litre with distilled water. When the slides were 
perfectly wettable by water, they were washed and dipped into 
a solution containing gelatin (5 g) and chrom alum (0.7 g) 
made up to one litre with distilled water. The slides were 
drained and allowed to dry. The tissue sections were then 
mounted directly on these slides, which, when prepared in this 
way, had the property of forming a good wet adhesion with the 
applied radiosensitive emulsion. Paraffin sections were de- 
waxed in xylene and taken to water through absolute, 90% and 
70% alcohol. Autoradiographic stripping film (AR 10, Kodak) 
was cut into strips (2.5 an x 3.5 cm) and floated onto a 
solution sucrose (200 g) and potassiLun bromide (0.1 g), which 
was made up to one litre with distilled water. One volume 
of this solution was diluted with nine volumes of distilled 
water and mixed thoroughly before use at roorn temperature 
(16 - 210 C). The emulsion was left on the solution for at 
least three minutes and then floated onto the sections, with 
the radiosensitive slides facing the sections. The sections 
were then dried thoroughly and stored in the dark for seven 
days at -200 C, allowing exposure of the radioactive material 
to the radiosensitive film. After exposure, the film was 
developed in a solution conposed of metol (BDH), 40 g for five 
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minutes and washed for one minute in water. This was 
followed by fixation in MB Amfix (May and Baker), of which 
one volume was diluted in four volumes of distilled water. 
Sections were then washed in a large bowl of water, then air 
dried over night. Then the autoradiographs were re-hydrated 
by washing in water, stained with Harris' haeipatoxylin for 
fifteen minutes, differentiated in acid alcohol for ten 
seconds and 'blue' in tap water for twenty minutes. Then 
they were air dried and mounted in polymunt. 
E. RADIAL IMMUNODIFUSION MR DETERMINATION OF C4 1- GLYCOPROTEIN 
This method is based on the original technique of Mancini 
et al (1965) with a few minor modifications. 
El Preparation of buffer and agar 
Barbiturate buffer was prepared by dissolving 9g sodium 
diethyl barbiturate in 200 ml distilled water; 65 ml 1/10M HCl 
were added together with 0.5 g sodium azide as preservative. 
The total volume was then adjusted to one litre to give a 
buffer of pH 8.6 and an ionic strength of 0.1. Stock agar 
was prepared by adding 3g special Agar Noble (Difco) to 
100 ml barbiturate buffer and heated on a boiling water bath 
until dissolved (distilled water was added to replace loss due 
to evaporation). When cool, the stock agar was kept at 40 C 
until used. 
E2 Preparation of anti-serum agar plate 
Agar plates of din-ensions 15 crn x 10 cm x1 mm were used 
for the determination of oc 1- glycoprotein (co( 1 GP) in 
anirral serum and inflarnTatory exudate. For this, 7.5 g stock 
agar was weighed and 7.5 ml distilled water was added. This 
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mixture was melted on a boiling water bath and then allowed 
to cool to 600 C. Anti-serum to rat ýý 1 GP (kindly supplied 
by Dr M Billingham, ICI Chemicals, Macclesfield, Cheshire) 
was then added to the agar mixture. The anti-serum was diluted 
to 1: 600, -ie, 0.25 ml in 15 ml. The ten-perature of the mixture 
was then kept at 60 0C by the use of a ten-perature controlled 
water bath prior to pouring into the plastic dishes (Hyland). 
The agar/anti-serum mixture was pipetted into the 1 m-n deep 
washed plastic dishes by the use of a hot Pasteur pipette, and 
allowed to set in the horizontal position for about twenty 
minutes. 
E3 Assay of c< 1- glycoprotein 
A series of 3 iTm wells were made in the agar plate using a 
gel cutter of 3 iTm diameter, and the agar was sucked out under 
I vacuum. 3p1: 20 dilutiori'of"the-assay . sample (in saline) 
was added to each well. Four standard sera of known c4 1 GP 
concentration were added to appropriate wells to construct. 
a standard curve (fig. one ) for calculating the unknowns. 
The standards supplied were 8,4,2, and 1 pgc4 1 GP/ml 
obtained from severely inflamed rats with arthritis. These 
were diluted 1: 20 before use and 3 pl of the diluted 
standards and unknown were applied to the wells in the plates. 
The concentration of the protein is directly proportional 
to the (diameter') of the precipitation ring. The plates were 
left to reach equilibriun for at least 96 hours. The 
diameter of the precipitation ring was then measured using 
a magnifying eye-piece fitted with a millimeter scale 
divided into 0.2 nm divisions. 
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Fig. 1 
Standard curve for a-l-acid glycoprotein assay 
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PROTBOGLYCAN ASSAY 
The amount of proteoglycan in the cartilage specimens 
was determined by the method of Farndale et al (1982) with 
a few minor modifications. This method is based on the 
metachraratic effect produced by binding acidic polymers 
to the basic dye, resulting in a shift of absorption 
maximum fran 625 m to 535 m. 
F1 Reagents 
Fla Formate buffer solution 
This solution was prepared as follows: - 2g sodiun formate 
(Sigma) and 2 r. q forndc'acid (90%) wer(ý added together in 
a 1000 ml volumetric flask, and the volum ccnpleted to 
1000 ml with distilled water. The solution was shaken well and 
the pH adjusted to 3.5 with a pH mter. 
Flb 1,9 Dimethylmethylene blue (DM13) stock solution 
16 mg DMB (Serva Feinbiochemica, Heidelberg, Germany) was 
dissolved in a 100 ml. volumetric flask with 5 ml ethyl alcohol. 
The volume was adjusted to 100 ml with formate buffer solution. 
The stock solution of DMB was shaken well and stored in a brown 
bottle at room temperature for up to one week. 
Flc DMB working solution 
The stock solution of DMB was diluted to 10-folds (1: 9) 
with forrmte buffer and used on the sam day. The A535 of 
this solution must be between 0.29 - 0.31 for a good result. 
Fld Digest solution for cartilage sanple 
326 mg N-acetylcysteine and 744 mg EDTA (disodium) were 
dissolved in 100 ml 0.5 M phosphate buffer (pH 6.5) in a 
77 
1 litre volumetric flask. The volum of the solution was 
adjusted to 1000 ml with distilled water. 
F2 Cartilage digestion 
The rat cartilage samples ýýere digested in 2 ml of the 
digestive solution with 20 pj papain (type III, Sigma 
Chemical Co Ltd, London) in a 10 ml Bijou bottle (Scientific 
Supplies Co Ltd, Vine Hill, London). The samples were 
incubated at 600 C for two hours. The arrount, of the digestive 
solution and the papain required for the mouse -dphisternal 
and fermral cartilage were l. ml and 10 pl respectively. 
F3 The spectrophotanetric determination of the proteoglycan 
40 ý11 of the rat cartilage digest was added to 2.5 ml DMB 
working solution in a suitable spectrophotomter cuvette, and 
the contents were mixed by inversion several tin-es. The 
spectrý6photcmter was zeroed against a blank sanVle of the 
DMB standard solution. Optical density was read at a wave- 
length of 535 rn on absorbance scale 1.0. The volume of the 
muse xiphisternum digest was 250 pl and was 750 pl for the 
muse ferwral head. 
F4 Standard curve- 
The A535 value was conpared with a standard curve (fig 2) 
using the same volure of (40 pl) 0.5 M phosphate buffer 
(pH 6.5) containing 1-8 pg whale chondroitin 4-sulphate 
(Miles Laboratories Ltd, Slough, UK), mixed with the sarm 
volure of dye. 
G. THERAPEUTIC AGENTS USED DURING THESE STUDIES 
All drugs were suspended in water and the drug suspensions 
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Fig. 2 
Standard curve for proteoglycan assay 
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were freshly prepared before use. Rats received a single 
daily oral dose of drug for different tirm intervals, 
suspended in 1 ml water. Mice received the same dose for 
seven consecutive days in 0.2 ml water. 
Gl Non-steroidal anti-inflammtory carpounds 
Gla Indormthacin 
IndaTethacin c4 - (1-P-Chlorobenzoyl-5-mtho, ýW-2-mthylindol- 
3-yl) - acetic acid, C 19 H 16 ClNO 4"ý 357.8.25 n-g white powder 
enclosed in capsule was obtained from Merd,,, Sharp and Dohm. 
A dose of 1.0 and 3.0 mg/kg was used throughout this study, 
suspended in water and administered orally. 
Glb Aspirin 
Aspirin, acetylsalicylic acid, C9H80 4= 180.2.300 mg 
tablets were obtained frcm Bayer, Germny. 100 mg/kg 
and 200 n-gAg doses of drug were suspended in water and 
administered orally. 
Glc Benoxaprofen, 
Benoxaprofen (2,4, Chloro-phenyl, alpha rnethyl 5, 
benzoxazole acetic acid) was kindly supplied by. Lilly & Co, 
Ltd. The drug was suspended in water and administered orally 
at a dose of 10 rngAg and 25 mgAg. 
Gld Piroxicam 
Piroxicam, 4-hydroxy-2-nethyl-3-(pyrid-2-ylcarbamyol)-2h- 
1,2 - benzothiazine, 1,1 - dioxide, C 15 H 13 N3 045 = 331.3. 
This was obtained from Pfizer, USA, in 250 rng capsules. The 
drug was suspended in water and administered at-a dose of 
5 MgAg and 10 nig/kg orally. 
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G2 Steroidal anti-inflarrmtory drugs 
G2a Dexarrethasone 
Dexam-thasone, 9 0ý- Fluoro - 16 mthylprednisolone; 
c 22 H 29 FO 5= 392.5.2 rg tablets were obtained from Organon 
Pharrmceutical Co. Doses of 0.1 mgAg and -0.2 nigAg were 
suspended in water and administered orally. 
G2b, Hydrocortisone acetate 
Hydrocortisone acetate, 21-acetox-y-11B, 17 cý- dihydroxy- 
pregn -4-ene-3,20-dione; C 23 H 32 06= 404.5. The drug was 
obtained from Organon Pharmaceutical Co., and suspended in 
mediun 199. A dose of 1.0 and 5.0' -pig/mouse was prepared 
and injected into the pouch lining tissue in a volume of 
0.1 ml or injected directly into the air pouch in a volume 
of 1 inl. 
G2c Hydrocortisone sodium succinate 
Hydrocortisone 21 - sodium succinate, sodium 21 (B-Carbo)W- 
prOpionyloxy)-11B, 17w, -dihydroxypregn-4-ene-3,20 dime; 
C 25 H 33 NaO 8= 484.5. The drug was obtained frcm Oganon 
Pharmaceutical Co., and dissolved in niedium 199. A dose of 
1.0 rng and 5.0 rrKj/muse was prepared and injected in the sam 
route used with hydrocortisone acetate. 
G3 Anti-rheumtic drugs 
G3a D-penicillamine 
D-penicillan-dne, D-3-mrcaptovaline; CýH,, N02S ý 149.2. 
250 M tablets were obtained frm Dista Pharrmceutical Co. 
A dose of 25 M/kg and 50 rng/kg was suspended in water and 
administered orally. 
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G3b Levamisole 
Levamisole (C 11 H 12 N2S: (I) - 2,3,5,6 - 
tetrahydro-6- 
phenyl-imidazo (2-1-b) thiazole hydrochloride = 240.8. 
This was kindly supplied by Janssen Pharmaceuticals Ltd. 
The drug was suspended in water and doses of 2.5 MAq and 
5.0 nqAg were administered orally. 
H. ASSESSMENT OF GASTRIC IRRITANCY 
H1 Macroscopic 
Following the treatment of animals with non-steroidal 
anti-inflammatory agents, rats were assessed for evidence of 
gastric irritation. After killing the animals, the abdomen 
were cut open and the viscera was removed. The stomach, 
duodenum and ileum were placed in a beaker containing phosphate 
buffered saline (PBS). Portions of these tissues were cut 
and the contents removed by washing with a. pasteur pipette and 
PBS. The tissues were examined by putting them on clean 
glass plates. Each tissue was assessed for evidence of 
ulceration. 
H2 Microscopic 
Areas of stomach, duodenum and ileum were fixed in 
formal saline, embedded in paraffin wax, and the cut 
section was stained with haematoxylin and eosin. Sections 
were examined for microscopic evidence of ulceration. 
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I. STATISTICAL TESTS 
Calculation of the mean, standard deviation and standard 
error of the mean. 
11 Mean 
where ; ý, X is the sum of X and n is the 
n 
number of observations. 
12 Standard deviation 
SD =/ ! sý 
(K - X)2 
n-i 
13 Standard error of the mean 
SD 
SEM =- this gives a measure of its 
precision. 
14 Significant tests between two sample means 
The student t-test of significance was used. 
t xi X2 with nl + n2 -2 degree of 
freedan 
By convention it is taken that a difference between sanple 
and control mean with a probabiiity of P ý/, 
0.05 is 
probably significant, P<0.01 is significant and 
P<0.001 is highly significant. 
voo. 
RESULTS 
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Autol f 
the rrouse 
The mouse six day pouch was used as an in vivo model to 
study the mechanisms of cartilage degradation. In experiments 
where transplantation is studied, inbred or athymic animls 
saodd be used to avoid the problems of implant rejection. In 
the present study to overcome the rejection of cartilage, 
outhred mice were used as donorsand recipients. Xiphisternun 
was found to be a suitable source of autologous cartilage 
because it is easily removed and its removal 
causesrelatively small injury to the anirml. 
Mouse xiphisternun was carefully removed from the 
anaesthetised animal (see methods) and the different tissues 
attached to it were removed. Samples of removed cartilage were 
divided into two groups - alive and dead - and each grouP 
contained intact (%%? nole) or minced samples. Care was taken 
throughout to ensure control cartilage was taken from animals 
of the same weight and age. 
The autologous samples were hTplanted in the mice preformed 
six day pouches. Some of the air pouches were inflamed with 
1 ml 1% carrageenan solution and the others were non-inflamed. 
At different time intervals after implantation, the irrplants 
were removed and their loss of proteoglycan analysed, both 
histologically and biochemically. 
Location of irrplanted cartilage in the pouch 
Cartilage, whether intact or finely minced, once intro- 
duced into the pouch, was randomly distributed on the lining 
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tissue. In non-inflarred pouches, the cartilage was found 
firmly attached to the lining tissue even one day after 
implantation. In contrast, when the cartilage was implanted 
into pouches previously inflamed with carrageenan, it remained 
free in the cavity throughout the experimental pe#od. 
Histological observations_ 
Norrral mouse xiphisternum. 
The concentration of proteoglycan in cartilage can be 
demonstrated by the intensity of staining with toluidine blue. 
Using this stain, it can be seen that the concentration is 
not evenly distributed throughout the tissue. In the thicker 
part, the matrix separating the chondrocytes has a relatively 
high amount of proteoglycan. In contrast, the matrix surrounding 
the cells further away from the sternum, and especially at the 
periphery of the tissue, has a lower concentration of proteO- 
glycan. In cross section, the cartilage appears to have two 
distinct regions, a central region with well-defined'lacunae 
and the peripheral perichondrium, rade up of blood vessels, 
adipose tissue and fibroblasts (fig 3). 
Living intact cartilage 
No : major differences either in histological appearance 
or n-etachron-atic reactivity were observed in intact cartilage 
obtained frm mice 1,3,5,7 or 14 days after inplantation 
in norml air pouch. 1-<: )ss of proteoglycan, as judged by 
weaker staining with toluidine blue, was seen at the area 
where the tissue had been separated from the sternum. 
Occasionally, small areas of depletion were also seen at the 
free ends and in areas which faced fibrous connective tissue. 
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Fig. 3 Norml mouse xiphisternum. Toluidine blue. 
Magnification x 100. 
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Induction of inflammtion in the air pouch, using carrageenan, 
was not found to change the intensity of toluidine blue 
staining in the in-planted cartilage. 
Dead intact cartilage 
Dead intact cartilage implanted into inflamed or non- 
inflamed air pouches showed relatively greater and faster 
loss of proteoglycan than living intact cartilage. Further- 
more, even in the absence of carrageenan, the majority of this 
tissue was seen to be surrounded by polyrmrphonuclear and mono- 
nuclear cells. Severe loss of proteoglycan could be detected 
in this tissue five days after implantation and by fourteen 
days, almost ccrnpTete loss of metachromatic staining was 
observed. 
Living minced cartilage 
Living minced cartilage fragments irrplanted into air 
pouches showed an obvious loss of metachromatic staining, 
even three days after implantation. Conplete loss of meta- 
chromasia could be seen in pieces obtained from the free ends 
of the xiphisternum, and frequently these cartilage fragments 
were found to be surrounded by polymorphonuclear and mono- 
nuclear cells, even in the absence of carrageenan. Cartilage 
obtained from animals five and seven days after inplantation 
showed further loss of proteoglycan and by fourteen days, 
severe loss of staining was observed. 
The presence of inflanmtory cells surrounding the 
cartilage fragments suggests that the degradation of this 
tissue stimulates an inflanTratory reaction. In general, those 
fragments iffplanted into carrageenan-inflamed pouches showed 
an accelerated loss of metachromasia, particularly in the areas 
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Fig. 4 Minced xiphisternum 6 days after implantation into 
a carr-agecnan air pouch. Toluidine blue. 
Magnification x 100. 
close to inflanr. -atory cells (fig 4) . 
Biochemical assessment of cartilage degradation 
Cartilage irplants were assayed for total proteoglycan. 
Biochemical analysis of samples showed a similar pattern of 
results to those found using histological techniques. Table (1) 
figure (5) show the anx)unt of proteoglycan found in living 
intact and minced cartilage after implantation into normal 
and inflamed pouches. After seven and fourteen days of 
implantation, intact cartilage showed little change in levels 
of proteoglycan. The highest proteoglycan loss from intact 
implants was detected at fourteen days after implantation 
into carrageenan-inflamed pouches, and that was about 12%. 
At seven days of implantation, minced xiphisternal fragr. -ents 
showed a loss of about 24%, this was observed in norTral 
pouches. Implantation into carrageenan-inflaned pouches for 
seven days caused a loss of 47%. Minced xiphisternal fragments 
implanted for fourteen days into normal and inflamed pouches 
lost about half its proteoglycan content . Proteoglycan 
determination of dead cartilage samples showed a rapid and 
massive loss of proteoglycan from implants. Table (2) 
figure (6) show a time course for the release of proteo- 
glycan from dead intact xiphisternal implants. The loss of 
proteoglycan from dead intact samples implanted into normal 
or inflamed pouches was nearly the same. As the time of 
implantation increased, the loss also increased until it 
reached its maxin= at fourteen days, where almost total loss 
could be detected. 
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Loss of proteoglycan in dead intact xiphisternurn at different time 
intervals after implantation into 6 day old air pouch. 
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Millipore half charnber technique 
Mouse xiphisternLun is a tiny cartilaginous tissue and 
it is small both in size and weight. In experiments where 
minced xiphisternal fragments were used, the intact xiphi- 
sternum was cut into six pieces. Because of the difficulty 
in retrieving the small pieces of cartilage, a method was 
developed based on the inillipore half chambe, ( . This method 
allowed location of the cartilage fragnents. Using this 
technique, there was 100% retrieval at the end of the 
inplantation period. Implanting the millipore half chanber 
into the pouch could subject the implanted cartilage pieces 
to an additional infla mma tory situation. This could be 
avoided by using the sane procedure with the animals of the 
control group. 
Effect of treatment with drugs on nuTbers of cells migratin 
into the mouse six day pouch and loss of proteoglycan frcm 
irrplanted xiphiSternal fragments 
Anti-inflanvatory and anti-rheumatic drugs were tested 
on the migration of leucocytes and the loss of proteoglycan 
from xiphisternal fragments implanted in carrageen-inflamed 
six day pouch. 
Non-steroidal anti-inflammtory drugs 
Four non-steroidal anti-inflammtory drugs were tested 
and these were aspirin (100 and 200 mgAg), inda-nethacin 
(1.0 andS. o mgAg), benoxaprofen (10 and 25 ngAg) and 
piroxicam (5 and 10 rngAg). The drugs were given daily 
orally in a volume of 0.2 ml for seven days, comnencing at 
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the tilre of carrageenan injection. 
The effects of drugs on leucocyte migration and loss 
of proteoglycan from xiphisternal fragments are illustrated 
in table (3) and (4), f igure (7 It was found 
that the system was not as reproducible as a similar system 
used in rats, fluctuations in cell numbers between individual 
mice producing high standard errors. 
The total cell count in the control group was 5.5 x 10 
6 
after seven days of irritant injection. All the tested anti- 
inflanuatory drugs were found to reduce the nun-ber of 
inflanmtory cells migrating to the inflan-ed pouch. The 
significant effect was observed. only with the high doses of 
aspirin (3 x 10 
6 ), indortr-thacin (2.9 x 10 
6) 
and benoxaprofen 
(2.8 x 10 
6 ). Piroxicam showed a significant reduction with 
both the low (3 x 10 
6) 
and the high (2.9 x 10 
6 Ydose. 
Results obtained from this study showed that there was 
no relationship betweenthe anti-inflanroatory action of the 
tested drugs and the loss of proteoglycan, from the autologous 
hTplants. In-plants obtained from pouches of control animals 
showed a loss in proteoglycan content of. about 28.8%. Non- 
steroidal anti-infla nma tories failed to reduce the loss of 
proteoglycan, from the implants after seven days of daily 
treatment. Implants obtained from drug treated groups showed 
nearly the same profile of proteoglycan loss observed with 
the control group. 
Anti-rheumtic drug 
D-penicillamine was given in a dose of 25 mg/kg and 
50 rrg/kg orally daily for seven days, conTrencing at the tim 
of irritant injection. D-penicillaraine was found to have no 
DRUG Dose n-gAg leucocyte r 
number x 10" 
Carrageenan 1 Ml of 1% 5.5 + 1.1 
Aspirin 
200 3.0 + 0.3** 
100 3.5 + 0.7 
Indcmethacin 
3 2.9 + 0.6** 
1 3.5 + 0.8 
Benoxoprofen 
25 2.8 + 0.5** 
10 3.7 + 1.0 
Piroxicam 
10 3.0 + 0.9** 
5 2.9 + 0.6 
D-penicillamine 
50 7.0 + 0.1 
25 4.2 + 
Table (3) Effect of daily treatment for 7 days with a single oral 
dose of different drugs on the number of cells migrating 
into the inflamed 6 day pouch. 
Mean values + S. E. M. 
10 mice per group 
P<o. 01 
Drug Dose 
mgAg 
Proteoglycan. 
content (pg) 
change 
Norfml xiphisternum 11.8 + 1.08 - 
Carrageenan 1 ml of 1% 8.4 + 0.44 -28.8 
Aspirin 200 8.08 + 0.6 -31.6 
100 8.48 + 0.64 -28.2 
Indomethacin 3 8.48 + 0.44 -28.2 
1 8.52 + 0.76 -27.9 
Benoxaprofen 25 8.28 + 0.84 -29.95 
10 8.76 + 0.52 -25.9 
Piroxicam 10 8.56 + 0.72 -27.3 
5 8.52 + 0.48 -27.9 
D-penicillan-dne 50 10.92 + 0.64** -7.5 
25 9.16 + 0.76 -22.4 
Table (4) Effect of daily treatment for 7 days with a single 
oral dose of different drugs on the loss of proteoglycan 
frcrn xiphisternal fragments in-planted into carrageenan 
inflamd 6 day pouches. 
Mean values + S. E. M. 10 mice per group. 
** P<0.01 
8 
7 
6 
10 0 
x 
I. - (1) 
.0 
2 
1 
1 
16 
12 
8 
4 
a 
a 
b 
b 
C 
C 
d 
d 
e 
e 
a= Aspirin b= Indomethacin c= Benoxaprofen d= Piroxicam e= D-Penicillamine 
Fig. 7 
Effect of daily treatment for 7 days with Aspirin (100,200mg/kg); Indomethacin 
(1,3mg/kg); Benoxaprofen (10,25mg/kg); Piroxicam (5,10mg/kg); D-Penicillamine 
(25,50mg/kg); on number of cells and loss of proteoglycan from xiphisternal fragments 
implanted into carrageenan inflamed 6 day pouch of the mouse. 
anti-inflamTatory action, however, there was insignificant 
reduction in the number of migrating cells observed with 
25 mgAg treatment (4.2 x 10 
6). 'A dose of 50 mgAg 
D-penicillamine was found to increase the numbers of migrating 
leucocytes insignificantly (7 x 10 
6 ). At this dose (50 mgAg) 
D-penicillarune showed a significant (P < 0.01) protection 
to the ir. planted fragments and the proteoglycan loss was only 
7.5%. However, 25 mgAg D-penic-illamine failed to protect 
the inplanted cartilage significantly. 
Effect of local administration of hydrocortisone salts on 
proteoglycan content of xiphisternal fraqments implanted into 
six day pouch f the mouse 
In this study, autologous xiphisternal fragments were 
introduced into n-Lillipore half chambers (see methods) and then 
implanted into carrageenan-inflamed pouches. Hydrocortisone 
sodium succinate (1 and 5 mg/animal) and hydrocortisone 
acetate (1 and 5 mg/animal) were diluted to appropriate 
concentrations with medium 199. These drugs were injected 
either directly into the air pouch or into the air pouch 
lining tissue, at the sarne time as cartilage implantation. 
Hyrdocortisone was prepared in a volLm-e of 1 ml for direct 
pouch injection, or 0.1 ml for lining tissue injection. 
Seven days after implantation, the cartilage pieces were 
removed for proteoglycan analysis. 
Table (5)f igure (8) show the results for 
experiments in which the loss of proteoglycan from cartilage 
fragments of control animals was ocnipared with that of animals 
treated with hydrocortisone salts. Minced autologous 
cartilage transplanted into control animals lost 39% of its 
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proteoglycan content. In comparison, cartilage transplanted 
into the soluble hydrocortisone sodiun succinate-treated 
animals, showed decreased loss in proteoglycan. Results 
were given for drugs given either. into the cavity or into 
the lining tissue. Proteoglycan loss was reduced in a dose 
dependent manner when this form of hydrocortisone was given 
by either route. Maxinm protection was found with 5 mg 
hydrocortisone sodium succinate injected directly into the 
cavity. 
When the insoluble hydrocortisone acetate was used, it 
was found that there was enhancement of the loss of proteo- 
glycan from cartilage fragments when administered directly into 
the pouch at a dose of 5 mg/animal. As the concentration of 
drug was lowered, no enhanced loss of proteoglycan could be 
detected. When injected into the lining tissue, hydrocortisone 
acetate significantly reduced proteoglycan loss at a dose 
of 5 nig/animal. 
The disadvantages of using the mouse as a source of cartilage 
Mouse xiphisternLun 
The use of mouse xiphisternu-n as autologous implant into 
the six day pouch gave an indication of the mechanism (s) 
involved in cartilage degradation. However, the presence of 
perichondriun in this type of hyaline cartilage was always 
a major problem. Perichondrium could affect the process of 
cartilage degradation and also interfere with the effects of 
therapeutic agents on this process. In order to avoid the 
problems of perichondrium, cartilage samples were always 
minced before implantation. 
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Mouse articular cartila 
Cartilage degradation is always observed in diseases 
affecting the joints, so it is of great importance to use 
articular cartilage as implant. Articular cartilage is a 
modified type of hyaline cartilage, where there is no 
perichondriun in its structure (Barnett, 1968). Different 
sources of cartilage from the mouse were examined. 
The cartilage cap of the femoral upper end was found to 
be most appropriate. However ' the removal of the tiny 
cartilage cap from the bony head was technically impossible. 
'Ibis technical problen, could affect the biochemical deter- 
mination of proteoglycan of the cartilage cap by the inter- 
ference of that present in the bony head. 
Moreover, it was very difficult to detect the small 
amount of proteoglycan in the assayed samples, unless the 
assayed volume was increased massively (750 pl). Using such 
a large volume of the digest was found to affect the 
spectrophotcr, netric assay by diluting the 2.5 ml dimethyl- 
methylene blue working solution. These problems required the 
use of another source of articular cartilage. 
Rat articular cartilage 
Rat femoral head cartilage cap was found to be an ideal 
source for implantation. It is a reasonable size which enables 
easy removal from the bony head and allows the anatomical 
examination of degradation, ie, histological zonal loss of 
proteoglycan (fig 9). Also it contains enough sulphated 
glycosar. unoglycans to be detected even with a smll volune of 
sample (40 41) affording a very reproducible system. 
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Fig. 9 Rat femoral head cartilage. Toluidine blue. 
Ma&nification x 25. 
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The biochemical determination of the proteoglycan (sulphated 
glycosaminoglycans) of articular cartilage 
Few alterations were introduced into the original method 
described by Farndale et al, 1982. The alterations were 
mainly applied to the procedures of cartilage digestion. The 
amount of digesting enzym (papain) was increased frm 10pl 
to 20 pl, and so was the tim of incubation, which was 
increased from one to two hours. The temperature of incubation 
was lowered frm 65 0C to 600 C. Evaporation of solution 
from the digestive containers during incubation was a big 
problem, which could affect the whole-assay, especiallywhen 
the plastic coulter pots were used. The glass bijou bottles 
with their tight lids were found to prevent evaporation 
completely. Introducing the above rentioned irrprovements 
was a crucial factor in developing the assay. 
Development of new model of prolonged inf lam-nation in the rat 
six day pouch 
Development of new models of prolonged inflammation was 
found to be very important to study the mechanism (s) of 
cartilage degradation from rat articular cartilage. To study 
these mechanisms, articular cartilage must be implanted into 
inflammatory and non-inflammatory situations. our previous 
work showed that the mouse six day pouch was not a good 
inflanrnatory model when injected with carrageenan, ie, was 
not reproducible. Sedgwick et, al, 1983, showed that the 
rat six day pouch responded in a "special" way to different 
inflannatory stimuli, however, these authors only examined 
the acute phase. 
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The viscarin type of carrageenan was found to induce 
a good inflammtory response in wistar rats. Previously, 
it has been shown to produce both acute (Capasso, Dunn, 
Yamamoto and Willoughby, 1975) and chronic (Robertson and 
Swartz, 1953) inflamTetory response inthe rat. 
In this study, two different concentrations of carrageenan 
were used - 1% and 2%. Two concentrations were used to 
establish whether the inflamatory response produced was 
dependent on the quantity of carrageenan. Volumes of 2 ml 
physiological saline containing carrageenanw--re injected into 
pouches of different groups of animals, six days after 
the initial injection of air. At different time intervals 
following the injection of carrageenan, volumes of exudate 
were measured, total cell nuTbers were counted, exudate smears 
for differential counts were prepared and samples from normal 
and inflamed pouches were prepared for histology. 
Results illustrated in table (6) figure 10) and 
represent a comparison made at different time intervals, 
between the effects of injection of 2 ml of either 1% or 2% 
carrageenan solution on the type and total leucocyte number 
mgrated to the pouch. Total cell nunbers in the pouches 
injected with 2% carrageenan. were greater than those obtained 
from 1% carrageenan treated pouches. The peak of the cellular 
response was seen two days after irritant injection, the 
6 total cell nuinbersbeing 311.8 x 10 . 1% carrageenan gave 
a total cell count of 306.6 x 10 
6, 
again peaking at two days. 
A significant (p < 0.001) increase in the total cell number 
was observed at 7,14 and 21 days after injection of 2% solution. 
Tbtal cell nuThers were 187.7 x 106 , 213.8 x 10 
6 
and 140.0 x 10 
6 
at 7,14 and 21 days respectively. 
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Fig. 10 
Leucocyte type M observed in the six day pouch of rat at 
different time intervals following injection of 1 or 2% carrageenan 
solution (2ml). 
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Fig. 11 
Total leucocyte number (x 10") observed in the 6 day pouch at 
different time intervals after injection of 1 or 2% carrageenan 
solution. 
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Differential cell counts made on exudate smears showed 
a predominance of polymorphonuclear leucocytes (polymrphs) 
at the first and second days; the ratios of polymorphs to 
mononuclear leucocytes (mononuclears) at one and two days 
were96: 4 and 89: 11. One, two and three weeks after irritant 
injection, mononuclear leucocytes predominated, and the ratios 
were 45: 55,24: 76 and 17: 83 respectively. The differential 
cell counts on -smears of exudate obtained from both 
concentrations of carrageenan showed no obvious difference. 
Trypan blue exclusion tests showed that more than 90% of 
the accumulating cells were viable. 
The volumes of exudate obtained from the air pouches of 
different groups showed no significant differences. However, 
pouches treated with 2% solution were found to contain slightly 
larger exudate volumes than those treated with 1% solution. 
This was seen at 1,2 and 7 days, while the reverse was observed 
at 14 and 21 days. Table (7) figure ( 12 ) represent a 
conparison between the ef f ects of the two dif ferent concentrations 
of carrageenan on the volumes of exudate measured from pouches 
of different groups. The volume of exudate reached its maximum 
at 14 days following the injection, being 37.2 and 35.5 ml for 
1% and 2% solutions. 
Histological observations 
Norrml rat air pouch 
Histological examination showed the non-inflamed six day 
air pouch tissue to have a lining layer of flattened =no- 
nuclear cells lying on a collagenous bed approxirmtely 50 Pm 
deep and orientated parallel to the pouch surface-Below thi's 
ill 
Time after 
carrageenan 
injection 
1% carrageenan 2% carrageenan 
1 day 3.3 + 0.18 4.6 + 0.34 
2 days 4.8 + 0.34 6.5 + 0.37 
7 days 28.5 + 2.04 31.0 + 1.71 
14 days 37.2 + 2.3 35.5 + 1.9 
21 days 31.6 + 2.41 29.4 + 1.94 
Table (7) Volme of exmdate (ml) observed in the 
6 day pouch at different time inter- 
vals after injection of 1% or 2% 
carrageenan solution. 
Mean values + S. E. M. 
8 rats per group 
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Fig. 12 
Volume of exudate observed in the 6 day pouch at different time 
intervals after 2ml injection of 1 or 2% carrageenan solution. 
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was a region rich in blood vessels and lynphatics. A 
variable amount of adipose tissue was also present in this 
layer. Mast cells were found throughout the pouch lining; 
they were apparent on haematoxylin and eosin stained 
preparations, but were well demonstrated with Alcian blue. 
These cells were particularly associated with the vasculature. 
Deep to the vascular layer was loose connective tissue of 
relatively low cell density, again orientated parallel td. the 
pouch surface. This layer of loose connective tissue was 
approxin-kately twice the thickness of the upper layer and over- 
lay subcutaneous muscle. Fibrin, as judged by MSB staining, 
was not a feature of the pouch lining. There was a suggestion 
that the pouch became more fibroblastic with time, but the 
general appearance was not found to change significantly 
throughout the three week period (figure 13 ). 
Carrageenan-inflan-o--d six day pouch 
Air pouches inflamed with carrageenan showed polymorph 
infiltration of the lining one and three days after injection. 
Polymorphs were seen adhering to the blood vessel walls 
and n-Ligrating through the upper connective tissue to the pouch 
lining. There was little or no fibrin. After one week, there 
was dense cellular infiltrate superficial to the pouch lining, 
extending to a depth of approximately 100 ým. These cells 
were loosely arranged and several appeared stellate. 
Van Gieson staining showed an increase in collagen fibres 
in this superficial layer. At two weeks, a distinct surface 
layer of large eosinophilic cells from 1-3 cells thick was 
seen. This surface layer of cells was still present at three 
weeks. Increasing numbers of vacuolated n-ononuclear cells 
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Haematoxylin and eosin. Map7dfication x 200. 
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were seen in the connective tissue over the three week 
period. Up to seven days, these vacuolated cells were 
Alcian blue positive. The cells were morphologically distinct 
from mast-cells and-appeared to be macrophages. They were 
also Alcian blue. positýve. Later, by two to threeweeks, - 
some areas of vacuolated cells were seen to form homgenous 
masses, which stained poorly with Alcian blue and other histo- 
logical reagents that have been used. These masses were both 
inside the lining and also seen as separate structures 
aherent to the lining surface. At two weeks, clusters of 
114Tphatics and plasma cells were seen in association with 
the vacuolated cells (f igure 14a & 14b). 
Effect of drug treatn-ent on carrageenan-induced prolong 
inflam-nation 
In this study, the effects of four different drugs on 
carrageenan-induced inflamnation in the six day pouch were 
investigated. These ccrqmunds were administered to rats 
daily orally comTencing at the tirm of carrageenan injectioni 
for three, seven and fourteen days. Indomethacin was given 
at a dose of 1 rng/kg or 3 mg/kg, the steroid (dexarmthasone) 
was given at a dose of 0.1 n-g/kg or 0.2 mg^g. D-penicillamine 
was given in a dose of 25 mqAg and 50 mgAg and finally 
levamisole was given in both 2.5 mgAg or 5.0 mgAg doses. 
Indomethacin 
The results illustrated in table (8) figure ( 15 
are for experiments where the effect of indanethacin 
(1 or 3 mgAg) on the exudate and cells migrating to the 
inflamed pouch was investigated. 3 mgAg indcmethacin 
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Fig. 14b Rat air pouch 2 weeks after injection of carrageenan, 
showing plasma cells and foamy macrophage-s. Iblematoxylin 
and eosin. Magnification x 800. 
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induced a significant (P < 0.001) inhibition in both the 
exudate volume (4.27 ml) and total cell number (95 x 10 
6) 
accumulating in the pouch. The low dose of indomethacin 
(1 mg/kg) only reduced significantly (P < 0.001) the volume 
of exudate (4.45 ml) while there was a slight insignificant 
decrease in the total cell nuTher. At 7 and 14 days of 
indomethacin treatment, both the tested doses had Y-educed 
the volume of exudate and total cell number significantly 
(P < 0.001). At the end of these experiments, the animals 
were killed and their gastro-intestinal tracts were examined 
for ulceration. No ulcers were detected either macroscopically 
or microscopically. 
D-penicillamine 
D-penicillamine was found to have a paradoxical effect 
on the inflammation induced by carrageenan in the six day 
pouch of the rat when tested throughout this study. Effects 
of D-penicillamine on inflammation induced by carrageenan are 
summarised in table (9) figure (16 ). Three days after 
continuous daily administration of a single dose of 25 mglkg, 
the volume of exudate and total cell. nurber were found to be 
reduced significantly (P < 0.001), while both cell numbers 
and exudate volumes were found to be reduced insignificantly 
after treatment with 50 mgAg. Seven days after carrageenan 
injection, exudate volumes and total cell numbers (mean 
values) measured from pouches of control groups were 27 ml 
6 
and 138 x 10 
Continuous administration of a single oral dose of either 
25 rngAg or 50 mgAg for seven days, failed to reduce the 
inflamnation. A slight increase in the volume of exudate 
(29.5 ml) and total cell number (144 x 10 
6) 
was seen following 
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Fig. 16 
Effect of daily oral administration of d-penicillamine 
(25 & 50mg/kg) on carrageenan (2ml of 1%) induced 
inflammation in the 6 day pouch. 
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the administration of 50 mg/kg. The significant (P <0.001) 
increase was observed only with the high dose of D-penicill- 
amine after four-teen days of daily treatment. Exudate volume 
increased from 39 ml in control groups to 48 ml, in 50 mgAg 
treated groups. The total cell number observed after fourteen 
days in the control group was 125 x 10 
6, 
which became 
214 x 10 
6 
after treatment with 50 mgAq. The pro-infl&Tuatory 
effect of D-penicillamine was also observed with 25 mgAg dose 
after fourteen days of continuous treatment. Howia-ver, this 
effect was insignificant. 
Levamisole 
Results illustrated in table ( 10 ) figure (17 ) are 
for experiments where a single dose of 2.5 or 5.0 n-q/kg 
levamisole was administered daily orally for different periods 
to carrageenan treated rats. Three, seven and fourteen days 
following carrageenan injection, exudate volumes and total 
cell numbers were 8.2 ml and 166 x 10 
6; 25.7 ml and 169 x 10 
6 
6 33.9 ml and 158 x 10 , respectively. Levamisole was found 
not to affect inflaiwation induced by carrageenan in the six 
day pouch of rats. Volumes of exudate and total leucocyte 
counts measured from pouches of aninals treated with either 
2.5 or 5.0 rng/kg levamisole, were found not to change signif- 
icantly from values obtained from the control groups. 
Dexarrethasone 
In this study, the steroidal anti-inflamnatory dexameth- 
asone was found to reduce the inflannation produced in the 
six day air pouch. The anti-inflammatory effect of 
dexamthasone was observed with both the tested doses of the 
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Effect of daily oral administration of levamisole 
(2.5 & 5mg/kg) on carrageenan (2ml of 1 %) induced 
inflammation in the 6 day pouch. 
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drug (0 -1 and 0.2 mqAg). The ef fect induced by this drug 
was strong enough to block the detection of any measurable 
inflamatory exudate. Moreover, the external pouch tissue 
was thin, when carpared with norrml or carrageenan treated 
pouches. 
Leucocytes dif ferential counts 
A ca-rparison was rrade in table ( 11 ) to show the effect 
of the drugs on the ratio of polymorphs to mononuclears 
observed in the carrageenan inflamed pouches. The ratios of 
polymrphs to mnonuclears at three, seven and fourteen days 
in the control group were 94: 6,43: 57 and 26: 74. The 
predominance of polyrmrphs at three days rerrained nearly 
unchanged, and this was observed with all the tested drugs. 
At seven days, differential counts rrade on exudate smears 
obtained from control groups showed that mononuclears were 
the predcminant cells (57%). Indomthacin in both 1 mg and 
3 mgAg at seven days, turned the dominance towards poly- 
rmrphs (71% and 76%) and so did levamisole in both 2.5 mg 
and 5.0 rkAg (83% and 81%). D-penicillamine at seven days 
was found to increase the nunber of mnonuclear cells migrating 
to the inflarmd pouch. This effect was dose-dependent. 
Fourteen days after carrageenan injection, Mnonuclears 
constituted about 74% of the migrated leucocytes in the 
pouches of the control aniTmls. Indcoethacin in both 1 -mg 
and 3 mgAg, levamisole (2.5 and 5.0 M/Ag) and both doses 
of D-penicillamine (25 M and 50 MAg) were all found to 
change the ratio towards polymorphs. 
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Implantation of articular cartilage 
Rat femral cartilage caps were obtained from anirrals 
according to the technique described earlier. Groups of 
samples were subjected to a process of repeated freezing 
and thawing, in order to prepare dead samples. Other 
groups were cut into six pieces for experiments where minced 
cartilage was needed. The rest of the samples remined 
intact (whole) with no further killing (freezing and thawing) 
or mincing. 
Irrplantation of living cartilage 
Results illustrated in table (12 ) figure ( 18 
represent the change in proteoglycan contents of minced and 
whole living sanples, inplanted into different situations 
for different tirms. The proteoglycan contents of control 
sanples (mean values) were 196.5 pg (one week), 159.5 pg 
(two weeks) and 207.0 pg (three weeks). 
Cartilage viability 
One of the problems with studying implanted cartilage 
was to make sure that the cartilage was still viable after 
removal from pouches. Cartilage was examined for histological 
changes. Also, autoradiographic studies with 
35 
so 4 
incorporation showed silver grains overlying nests of cells 
in the hyaline cartilage and matrix components imTediately 
adjacent to labelled cells. The cells of the epiphyseal 
disc were well labelled but few grains were associated with 
the hypertrophoid chondrocytes in their calcified matrix. 
Intensity of labelling was ýound to vary among the cells of 
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Fig. 18 
Amount of proteoglycan (pg) in living whole and minced rat 
femoral head cartilage at 1,2 and 3 weeks following implantation 
into subcutaneous tissue (B), non-inf lamed 6 day pouch (C), 1 and 
2% carrageenan inflamed pouch (D, E), Group (A) represents normal 
rat cartilage. 
non-implanted control cartilage and also to vary to a similar 
degree in implanted cartilage. ' Incorporation of labelled 
sulphate did not appear to diminish with increasing time of 
implantation (figure 19). 
Inplantation into normal air pouch 
Minced living cartilage was in-planted into groups of 
normal six day pouches. Another group was implanted with whole 
(intact) living samples. At one week minced fragments lost 
about 5.6% of proteoglycan content and the loss was about 
63% and 73% after two and three weeks of implantation. After 
one week the whole implanted samples showed an increase in 
proteoglycan content of about 9.9%. After two and three weeks 
the implanted cartilage lost about 49.5% and 71% of proteo- 
glycan content. 
Irrpl . antatim into subcutaneous tissue 
were 
Groups of aninals/treated with 2 ml 1% carrageenan 
solution , injected into their pouches f ive days af ter the 
initial air injection, and other groups were treated with 
the san-e volurne of 2% solution. Pieces of whole and minced 
living cartilage were irrplanted into different groups of 
carrageenan treated pouches one day after irritant injection. 
One week after inplantation, minced san-ples obtained from 
1% carrageenan solution treated pouches lost about 8.6% 
of their proteoglycan content. The loss was about 22% 
fran those sarrples obtained from pouches treated with 2% 
carrageenan solution. The reverse was observed with whole 
sanples, recovered after one week of irrplantation, where 
133 
Fig. 19 Autor-adiograph of articular cartilage removed from 
a2 week carme-, eenan air pouch. Labelled sulphate 
incubation. Magýiification x 800. 
.L) 1± 
there was nearly no loss observed in 2% carrageenan treated 
pouches (0.25%), while those samples recovered from 1% 
solution treated pouches lost about 5.8% of their contents. 
Two weeks following implantation into 1% carrageenan 
solution treated pouches, minced and whole samples lost 
about 54% and 33% of proteoglycan contents. The loss of 
proteoglycan observed with samples recovered from 2% solution 
treated pouches was about 79% for minced and 57% for whole 
samples. The loss of proteoglycan from minced and whole 
cartilage recovered from 1% and 2% solution treated pouches 
after three weeks' implantation, was nearly the same, suggesting 
that the inflammatory response was not too small to induce 
proteoglycan loss. 
To conclude, it was found that after two and three weeks 
of implantation into normal and inflamed situations, minced 
and whole living cartilage lost large amounts of their 
proteoglycan contents, and that the loss was significant 
(P < 0.001). 
Implantation of dead cartilage 
Results summarised in table ( 13 ) figure (20 ) are 
for experiments where the proteoglycan contents of dead whole 
samples implanted into different situations for different 
times, were compared with those of normal non-in-planted 
cartilage. Dead implanted samples showed significant loss 
throughout the implantation periods (one, tL-jo and three weeks). 
The highest rates of loss were observed at three weeks with 
samples in-planted into subcutaneous tissues and normal air 
pouches. These were 79% and 76% respectively. After three 
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Fig. 20 
Amount of proteoglycan (pg) in dead whole rat femoral head 
cartilage at 1,2 and 3 weeks following implantation into sub- 
cutaneous (B), non-inflamed 6 day pouch (C), 1 and 2% carr- 
ageenan inflamed pouch (D, E). Group A represents normal 
rat cartilage. 
-L.: ) I 
weeks, samples recovered from 1% and 2% carrageenan treated 
pouches showed a loss of 38% and 49%. However, that loss 
was smaller than that observed with samples recovered from a 
non-inflamed situation. 
Studies into the immmogenicity of cartilage 
Femoral upper end cartilage caps obtained frm wistar 
rats were finely minced and suspended in sterile saline. 
The cartilage suspension was mixed with an equal volume of 
Freund's adjuvant and then hcrnogenised until a good emulsion 
was formed. Groups of wistar rats were imTunised for three 
and four weeks with cartilage/adjuvant emulsion. Samples of 
whole cartilage caps were implanted for two and three weeks 
into preformed six day pouches of animals imninised for three 
weeks. Another group of animals inmunised for four weeks were 
implanted with cartilage samples in the air pouches. Table 
(14 )f igure ( 21 ) show a caqparison of the loss of 
proteoglycan f rom cartilage implanted for two and three weeks 
into air pouches of normal and iu=ised animals. 
After two and three weeks of implantation, implanted 
samples showed a signif icant loss in their pr6teoglycan 
content. It was found that the loss of proteoglycan from 
cartilage obtained frm normal and immunised animals did not 
differ significantly. However, the proteoglycan loss 
observed after implantation into a normal situation was slightly 
larger. Cartilage implanted into normal pouches lost about 
42% of proteoglycan content after two weeks and the loss was 
about 58% at three weeks. It uas also found that the length 
of the period of imTunisation was not an important factor. 
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Fig. 21 
Comparison of the loss of proteoglycan by whole femoral head 
cartilage following implantation for 2 and 3 weeks into normal 
6 day air pouches induced on cartilage immunised and non- 
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The loss observed with in-plants recovered after two weeks 
fran three week immmised anin-als was 51% and 48% frcm 
four week imunised anin-als. 
Studies into allograft and isograft implantation 
Whole and minced living articular cartilage obtained from 
inbred Fisher rats were implanted into six day pouches of 
rats from the same strain. Some of the air pouches were normal 
and the others were treated with 1% carrageenan solution. 
The loss of proteoglycan frcrn inbred Fisher implants was 
compared with that from outhred wistars. The conparison is 
made in table ( 15 ) figure ( 22 ). In both the tested 
groups, minced cartilages showed greater loss than the whole 
ones. Whole and minced implants recovered from both groups 
showed a significant loss (P < 0.001) when compared with 
normal cartilage. Implants recovered from outhred animals 
showed slightly greater insignificant loss over the inbred 
implants. 
Whole implants recovered from normal pouches of inbred 
and outhred animals lost about 45% and 49% of proteoglycan 
content. After implantation for two weeks into inf lamed 
pouches of inbred and outhred animals, the loss was 30% and 
33% respectively, suggesting that inflammation was not the 
only factor affecting cartilage degradation. 
Inplantation of articular cartilage after one week of irritant 
injection 
Groups of rats with preformed six day pouches were 
injected with 2 ml 1% carrageenan solution, six days after 
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Fig. 22 
Proteoglycan loss M from femoral head cartilage, whole (W) or 
minced (M) of inbred Fisher and outbred Wistar rats following 
implantation for 2 weeks into normal 6 day air pouch or 1% 
carrageenan inflamed pouch. 
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the initial air injection. Seven days following carrageenan 
injection, groups of living whole femoral head cartilage 
were implanted into the inflamed pouches for one and two 
weeks. The changes in'the proteoglycan content of the 
implanted cartilage after one and two weeks in that 
situation were suranarised in table ( 16 ) figure ( 23 
Biochemical assessment of the proteoglycan content of the 
in-plants showed that there was nearly no change (+ 0.25%) 
at one week of implantation. At two weeks, in-plants lost 
about 15.7% of proteoglycan content, however, this loss waS 
insignificant. It seem that implantation seven days after 
irritant injection affords the implanted cartilage some 
protection, where the loss was about 15.7%. From the 
previous experiments, it was found that implantation of 
cartilage for two weeks, 24 hours after irritant injectiont 
caused a proteoglycan loss of about 33%. 
Histoloqical observations of articular cartilage imlanted 
into different situations 
Norral mouse femoral head cartilaqe 
The femoral head cartilage was hyaline in character 
and approximately four cells thick. As the cartilage examined 
had been obtained from adult animals, there had been fusion 
of the epiphyseal discs so that cartilage abutted directly 
onto bone. The nuclei were round and well stained with haena- 
toxylin and they were approximately 6 pm. in diameter. 
Shrinkage of the matrix around the chondrocytes (presumably 
due to tissue processinq) caused the articular surface to 
appear bumpy. 
artilage ct proteoglycan 
content (pg) 
% change 
experiment 
normal cartilage 3.82 + 0.11 - 
implantation for 3.83 + 0.23 +0.26 
one week 
implantation for 3.22 + 0.29 -15.71 two weeks 
Table (16)Proteoglycan content (pg) of femoral head 
cartilage following inplantation for one 
and two weeks into six day pouches one 
week. after carrageenan injection. 
Mean values + S. E. M. 
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Fig. 23 
Proteoglycan content (pg) of femoral head 
cartilage following implantation for I&2 
weeks into 6 day pouches after one week 
of carragcenan injection. 
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Nornal rat femoral head cartilage 
The rat fery)ral head cap consisted of heruspher 
' . 1-1 1,1 ' cartilage with three main layers -a superficial layer, of,,. * J 
hyaline cartilage, a layer of hypertrophied chondrocytes 
in a calcified matrix, and the epiphyseal disc. The hyaline 
cartilage was approximately 8-12 cells thick, the cells being 
typically arranged in nests of two ov four cells sitting 
in a lacunae. The nuclei were round, approximately 8 ýtm 
in diameter and the cytoplasm was indistinct. Metachrcmatic 
staining with toluidine blue was particularly strong at 
the edges of lacunae and fairly uniform over the rest of 
the matrix. At two sites there was a change in chondrocyte 
morphology towards a more fibroblastic appearance and a 
similar graded loss of metachrcn-atic staining. These sites 
were at the insertion of Teres' ligament and at the cartilage 
soft tissue junction at the base of the hemisphere. Below 
the cartilage was the layer of hypertrophied chondrocytes 
occupying greatly enlarged calcified lacunae, with little 
intervening matrix. Both cell nuclei and cytoplasm were 
indistinct. This layer formed the bulk of the cartilage 
hemisphere and showed strong metachromatic staining. Below 
this layer were the cells of the epiphyseal disc, which 
consisted of columns of tightly packed cells with round 
nuclei approximately 8 pn diameter and with basophilic 
cytoplasm (figure 9). 
Implantation into non-inflamed situations 
The histological observations of implants obtained fran 
subcutaneous tissues or non-inflamed air pouches were 
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essentially the same. At seven days, a fibrous qranulation 
tissue formead around the inplant, approximately 50 pm 
thick, consisting of capillaries, fibroblasts and some 
pigment-containing nacrophages (probably containing hacm)ý- 
siderin). The cells of the hyaline cartilage aprx-. ared to 
be mainly healthy. Erosion of cartilage was not a feature 
of the articular surface but erosion of the subchondral 
plate was seen and was more apparent with time. Loss of 
metachromatic staining did not correspond with qross bio- 
chemical loss, presumably as enough proteoglycan still 
remained for a maximal staining reaction. Rie-re there 
appeared to be damage to the articular surface (eq, during 
initial cartilaqe removal, when Teres' ligament was torn 
away) there was subtantial erosion. Loss of mtachrcffatic 
staining was scn-etimes seen adjacent to the dxnaged areas. 
When present, Teres, ligament became incorporated into 
the surrounding granulation tissue, and scmatimas contained 
cartilage from the acetabulum. where this cartilage was 
seen to be over the femoral cartilage, the cells of the 
intervening granulation tissue appeared to take some chondro- 
cyte characteristics. 
When dead cartilage was implanted, there was a lack of 
staining of the cell nuclei with hacm-itoxylin. Vie erosion 
of the cartilage by soft tissue showal the same profile as 
with living cartilage. In particular it was noted that the 
articular surface was free frcm erosion unless there was 
scme obvious damage. 
Minced cartilage fragments showed increased erosion in 
comparison with whole cartilage. Ille increased erosion 
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occurred where the cut surface exposed the calcified layer 
of hypertrophied chondrocytes. Subchondral erosion wus 
much the same as with whole cartilage. 7he articular surface 
again appeared to be protected from substantial erosion. 
Sorm gradation from chondrocytes to fibroblast-like cells 
occurred at the cut surface of the hyaline cartilage, 
accaq)anied by a similar graded loss of matachrorntic 
staining. The chondrocytes at all tive points appeared 
healthy. When two fragments were sufficiently close that 
granulation tissue was adherent between them, some of 
these cells appeared to take on chondrocyte characteristics. 
Implantation into inflamed pouches 
Cartilage implanted into aArrageenan inflared pouches 
was nearly always found encapsulated within a large mass of 
what appeared to be degenerating macrophages wid carrageenanp 
which may or my not be adherent to the pouch wall. The 
morphology of chondrocytes in cartilage removed from inflamed 
animals vras no different to normal chondrocyto morphology. 
Erosion of the implanted cartilage was similar in profile 
to the erosion seen in non-influncd animals, but appeared 
less extensive at most time points. Again, the articular 
surface appeared to be protected from erosion unless Tares' 
ligament was absent or there was some other surface damage. 
Autoradiography shoý; ed that cartilage implanted into 
inflamed air pouches incorporated 
35 so 4 at all time 
points. 7he histological profile of minced cartilage 
implanted into inflax-ed pouches %-ras not significantly 
different to the profile seen in non-inflaaed pouches. 
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Effect of druc .1 
treatmnt on the proteoglycan, content of 
implanted articular cartilage 
Rat femoral head cartilage was implanted into 
carrageenan. inflame-d six day pouches of rats for two weeks. 
The effects of some anti-inflammatory and anti-arthritic 
drugs ware tested on this mdef . The anti-inf lamratory 
drugs were the non-steroidal indomthacin and the steroidal 
dexamthasone. The anti-arthritic drugs used were 
D-penicillamine and levamisole. 
Drug treatment was started on the same day as cartilage 
implantation and lasted throughout the in-plantation period. 
A single oral dose of each drug was given daily for fourteen 
days. 
Indomethacin 
Two doses of indanethacin have been used, 1 mgAg 
and 3 mgAg. Table ( 17 ) figure (24 ) show the results 
of experiments where the effects of treatment with indo- 
methacin on the loss of proteoglycan from implanted 
cartilage was studied. It was found that when indormthacin 
was used at 1 mg/kg, there was no protection to the 
inplants and the loss was about 30%. 3 mgAg showed 
a significant (P < 0.01) protection to the implanted 
cartilage, which lost about 12.7% proteoglycan. At the 
end of these experiments, examination of the gastro- 
intestinal tract showed that there were no ulcers. 
D-penicillamine 
D-penicillamine at both 25 mg/kg and 50 mgAg showed 
lbO 
Experiment proteoglycan 
content (pG) 
% change 
Normal cartilage 192.0 + 8.5 -- 
2 ml of 1% carrageenan 121.0 + 4.5 -37 
1 rrKjAg Indomethacin 134.0 + 5.0 -30.21 
3 mgAg Indcmethacin 167.5 + 13.0 -12.76** 
Table (17) 
Proteoglycan content (pg) of femral head cartilage 
irrplanted for 2 weeks into inflamcd 6 day pouches of 
anirrals treated daily with an oral dose of either 
1 mg or 3 mqAg indormthacin throughout inplantation 
period. 
Mean values + S. E. M. 
8 rats per group 
P<0.01 
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Fig. 24 
Proteoglycan content (pg) of femoral head cartilage implanted 
for 2 weeks into carrageenan inflamed 6 day pouches of 
animals treated with a daily oral dose of either I or 3mg/kg 
indomethacin throughout implantation period. 
11. )z 
a significant protection to the inplanted cartilage 
(table 18 , figure 25 ). IMIants obtained frcm 
the 25 mgAg treated group lost only 15.6% of proteo- 
glycan content, cmpared with a loss of 37% observed in 
the control group. The 50 mgAg treated. inplants showed 
a loss of 10.6% proteoglycan content. 
Dexamethasone 
A significant (P < 0-001) protection to the implanted 
cartilage was achieved with the two tested doses of 
dexarmthasone. There was only a 17.4% loss of proteoglycan 
content observed in 0.1 MAg treated group, coupared with 
a loss of about 46% observed in the control group. When 
0.2 n-g/kg mas used, the loss was only 10% and this showed 
that the protection observed was dose-dependent (table 10 
f igure 26 )- 
Levamisole 
Levamisole was used in both 2.5 mgAg and 5.0 mgAg 
doses. A mxim= significant (P < 0.001) protection was 
obtained with 5.0 vgAg and the proteoglycan loss frcm 
the implanted cartilage was less than 1% (table 209 
f igure 27 )- However, a significant (P < 0.01) 
protection was also obtained with 2.5 MAg treatment# 
but the loss was about 18.8% which was greater than that 
observed with 5.0 mgAg. 
EKperiment, proteoglycan 
content (pg) 
change 
Normal cartilage 192.0 + 8.5 - 
2 ml, of 1% carrageenan. 121.0 + 4.5 -37 
25 mg/kg D-penicillamine 162.0 + 6.5 -15.63* 
50 wgAg D-penicillamine 171.5 + 15.0 -10.68** 
Table (18) 
Proteoglycan content (pg) of femoral head cartilage 
inplanted for 2 weeks into inflamed 6 day pouches of 
anirals treated daily orally with a dose of cither 
25 or 50 MAg D-penicillamine throughout inplantation 
period. 
Mean values + S. E. M. 
8 rats per group 
P<0.001 P<0.01 
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Fig. 25 
Proteoglycan content (pg) of femoral head cartilage implanted 
for 2 weeks into carrageenan inflamed 6 day pouches of animals 
treated with a daily oral dose of either 25 or 50mg D-Penicillamine 
throughout implantation period. 
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Experiment proteoglycan 
content (pg) 
% ct%ange 
Normal cartilage 261.0 + 7.0 
2.0 ml of 1% carrageenan 140.5 + 4.0 -46.17 
0.1 migAg dexamethasone 215.5 + 10.5 -17.44* 
0.2 nigAg dexamethasone, 234.0 + 14.0 
1 
-10.35* 
Table (19) 
Proteoglycan content (pg) of femoral head cartilage 
inplanted for 2 weeý into inflamed 6 day pouches 
of animals who received an oral daily dose of either 
0.1 or 0.2 MAg dexamthasone throughout inplantation 
period. 
Mean values + S. E. M. 
8 rats per group 
P<0.001 
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Fig. 26 
Proteoglycan content (jug) of femoral head cartilage implanted 
for 2 weeks into carrageenan infl3Med 6 day pouches of animals 
treated daily orally with 0.1 or 0.2mg/kg dexamethasone through. 
out implantation period. 
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Experiment proteoglycan 
content (pg) 
change 
Normal cartilage 284.5 + 17.5 - 
2.0 ml of 1% carrageenan 189.0 + 9.0 -33.57 
2.5 mgAg levamisole 231.0 + 8.0 -18.81** 
5.0 mgAg levamisole 282.0 + 19.5 -0.88* 
Table (20) 
Proteoglycan content (Vq) of femoral head cartilaqc 
inplanted for 2 weeks into inflamed 6 day pouches 
of anirrals treated with a daily oral dose of either 
2.5 or 5.0 mg/kg levamisole throughout inplantatim 
period. 
Mean values + S. E. M. 
8 rats per group 
P<0.001 P< 0.01 
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Fig. 27 
Proteoglycan content (Pg) of femoral head cartilage implanted 
for 2 weeks into carrageenan inflamed 6 day pouches of animals 
treated with a daily oral dose of either 2.5 or 5mg/kg levamisole 
throughout implantation period. 
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Effect of drug treatment onproteoglycan content of 
articular cartilage implanted in subcutaneous tissue 
The effects of indomethacin, D-panicillamine, 
dexamethasone and levamisole vrere tested on the loss of 
proteoglycan fran femoral head cartilage caps implanted 
into subcutaneous tissue of rats. Effects of daily oral 
administration of single doses of the drugs on the loss 
of proteoglycan f ran cartilage implanted into subcutaneous 
tissue were illustrated in table ( 21) figure ( 28 ). 
Cartilage implanted into subcutaneous tissues of non- 
treated animls lost about 37.8% of proteoglycan content. 
Implants obtained from 3 mgAg indcmthacin treated 
animals lost nearly the same amount of proteoglycan as 
was observed in the non-treated group (37.2%). D-ponicilla- 
mine (50 nigAg) also failed to protect the implanted 
cartilage and the loss was about 35.8%. 7be loss of proteo- 
glycan from implants obtained from levamisole treated group 
(5 mgAg) was found to be greater than that observed with 
the non-treated group (43%). Dexamethasone (0.2 mj/kg) 
however, showed a protective activity townrds the inplanted 
cartilage. The loss of protcoglycan from implants obtained 
from dexamethasone treated animals was only 11.9%, carpared 
with 37.8% in the control group. The protective effect of 
dexan-ethasone on the implants uns significant (P < 0.001). 
Histological observations following drug treatment 
Histological examination of air pouch svplcs and 
implanted cartilage obtained from animals treated for two 
weeks, shaved no significant changes from the control sanples 
lt)v 
Experiment proteoglycan 
content (pg) 
S change 
Norrnal cartilage 243.5 + 17.5 -- 
subcutaneous tissue 151.5 + 12.5 -37.8 
3.0 mgAg indomthacin 153.0 + 16.0 -37.2 
50.0 n-gAg D-penicillandne 156.5 + 14.5 -35.8 
0.2 mgAg dexarmthasone 217.0 + 10.0* -11.9 
5.0 mgAg- levamisole 139.0 + 10.5 -43.0 
Table (21) Ef fect of a daily drug treatment for 14 clays on the 
proteoglycan content (pg) of ferwral head cartilage 
inplanted for 14 days into subcutaneous tissue of the 
rat. 
Mean values + S. E. M. 
6 rats per group 
*W P<0.01 
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Fig. 28 
Proteoglycan content (jig) of femoral head cartilage implanted for 2 weeks into subcutaneous 
tissues of rats treated daily orally with different therapeutic agents. 
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obtained from indaTethacin , D-penicillamine and levamisole 
treated animals. The only changes observed were with 
dexamethasone treated animals. Pouches obtained from 
0.1 mg/lzg and 0.2 mg/kg dexamethasone treated animals were 
macroscopically thinner than those from control animals. 
This finding was confirmed microscopically, where it was 
found that the pouch showed less fibrous connective tissue 
in the more superficial layer and was considerably less 
infiltrated by imflamrmtory cells- 
Immune inflammation in the rat air pouch 
Active synovitis of the joints is one of the main 
features of rheumatoid arthritis. In 1980, Ziff proposed 
that immune complexes localise in the joint cavities or 
across blood vessel walls, inducing inflanTmtion. The 
present study has examined utiether the increased reactivity 
of mature synovial-like lining tissue of the air pouch 
occurs when antigen-antibody complexes are the inflammatory 
stimuli. 
Active Arthus reaction 
After sensitisation of rats with 5 mg BSA and 
formation of one and six day pouches, animals were challenged 
with 1 mg BSA. Groups of animals were killed at four hours, 
3,5,7,9 and 14 days following antigen challenge, and the 
volumes of the inflamatory exudate and the total leucocyte 
numbers in the air pouches were measured. Table ( 22 ) 
shows the results of experiments where the total numbers 
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inflamed pouches were measured at different times following 
antigen challenge. It can be seen that one day pouches 
at 4 and 72 hours responded with only a low number of 
infiltrating leucocytes and a small volume of infla=tory 
exudate, and the figures were 1.8 X. 106 , 0.8 ml at four 
hours and 2.1 x 10 
6,0.9 
ml at 72 hours. In contrast, six 
day pouches became more reactive to the inflamnatory sti=li. 
The maximum cell number and exudate volume uns observed at 
four hours after antigen challenge and the figures were 
7.5 x 10 
6,3.6 
ml. At 72 hours, exudate volume and total 
cell nuTher were 3.1 x 10 
611.9 
mi. 
7he small inflmmtory reaction at 72 hours indicates 
that response to the antigen is an immdiate type hyper- 
sensitivity. Examination of different pouches at 5, -7,9 
and 14 days showed that there was no obvious inflmmtory 
response. Differential call counts of emxbte s=rs showed 
that the increase in leucocytes observed at four hours was 
due to an increase in influx of polymorphonuclear calls 
(90% PMN). 
Reverse passive Arthus reaction 
Twenty minutes after intravenous injection of 5 mg BSA, 
animals were challenged with anti-BSA by injection into 
their six day pouches. Six hours after initial injection, 
the animals were killed and the air pouches were opened to 
assess the inflaramtory reaction. Examination of the air 
pouches showed that there was no obvious inflammtory 
reaction following those procedures. There are many 
possibilities to explain this unexpected reaction. This was 
probably because the armunts of injected antigen or anti- 
boclies were not ideal enough to induce immdiate immno- 
logical reaction, le, either too high or too low. 7he time 
hetween the tý, o injections of antigen and itz antibody my 
also have been insufficient to trigger the rpaction. 
Prolonged 
_immme 
i'nf lamration in the rat six day pouch 
It was found that a prolonged irmme inf laim. ation could 
be produced by injecting the six day pouches of pertussis 
sensitised rats with pertussis vaccine. Tables ( 23 ) and 
( 24 ) and figure ( 21. ) ) show volums of exudate and total 
cell numbers observed in one and six day pouches of 
sensitised and non-sensitised rats at different ti=s 
following challenge with pertussis vaccine. 
Six day pouches of non-sensitised rats failed to respond 
to the injected antigen, whereas there was no inflamitory 
reaction detected throughout the experimnt. Assessment 
of inf lannation in one day pouches of sensitised rats showed 
that there was a weak inflanrmtory response and the volume 
of exudate reached its peak after six days of antigen 
challenge. At six days the volume of exudate Pv-ras 1.1 ml 
and the total leucocyte number also reached its peak at 
6 
six days, when it was 8.6 x 10 . Detection of inflan-ation 
in the one day pouches of sensitised rats shaied that these 
pouches failed to produce rmasurable inflaamation at periods 
over six days. 
Six day pouches of sensitised animls showed a steady 
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Fig. 29 
Volume of exudate (ml) and total cell count (00") in 
1 and 6 day air pouches in sensitised animals observed 
at different time intervals following challenge with 
Bordetella Pertussis organisms. 
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increase in exudate volumes up to nine days after antigen 
challenge, where the volume of exudate was 11.7 ml. On 
the other hand, total leucocyte nunber reached its maximm 
6 
at six days, where it was 130.7 x 10 . At thirteen and 
sixteen days, there was still a good infla = tory reaction 
where the volumes of exudate and total Coll numbers 
were 6.7 ml and 37.8 x 10 
6 (13 days) and 6.3 ml and 
13.8 x 106 (16 days). 7he inflammtory reaction persisted 
for up to twenty-one days after challenge with pertussis 
vaccine, however, this was a weak inflanmtory reaction 
(1.1 ml and 6.9 x 10 
6 ). At thirty days after the challenge, 
no inflammtory exudate could be detected in the six day 
pouches of sensitised animals. 
Differential cell counts made on exudate mrars 
(stained with May-ftziwald-Giansa) showed a predominance of 
polymorphonuclear leucocytes (polymorphs) up to three days 
after the challenge (table 25 , figure 30 ). One day 
after challenge, the ratio of polymorphs to mm=uclears 
was 86: 14 and was nearly unchanged (87: 13) at tuo days. 
The predominance of polymorphs rcmained upto the sixth &y 
after the challenge, where the ratio wns 54: 46. At the 
ninth day, the predominance reversed taurds the mononuclmrst 
where it became 46: 54. At the thirteenth dayl there wns 
an unexpected phancrremn where the polymrphs dcmim-ited 
again and the ratio was 67: 33. At sixteen days,, the ratio 
was 10: 90 and a conplete dominance of mononuclears 
(100%) was observed at twenty-one days. Tty1min blue 
exclusion tests showed that rare than 901 of the 
accumulating cells were viable. 
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Tirm after 
challenge (days) 
polymorphs M mononuclears 
1 day 86 14 
2 days 87 13 
3 days 81 19 
6 days 54 46 
9 days 46 54 
13 days 67 33 
16 days 10 90 
21 days 0 100 
30 0 0 
Table (25) Type of leucocyte W in the 6 day old 
pouch of sensitised animals observed at 
different tirre intervals following 
challenge with Bordetella pertussis organisms. 
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Fig. 30 
Type of leucocyte (%) in the 6 day old pouch of 
sensitised animals observed at different time intervals 
following challenge with Bordetella pertussis organisms. 
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Histology observations 
Air pouch histology 
Sections of air pouch tissue taken fran sensitised 
animls 24 hours after challenge, showed infiltration of 
the superficial connective tissue by migrating polymorpho- 
nuclear leucocytes with some clumping at the pouch surface. 
Migration of polymorphonuclear cells through the superficial 
layer at 48-72 hours was much reduced, but the pouch surface 
showed a mass of degenerating cells. These cells were 
intilTately associated with dense fibrin deposits, as judged 
by MSB staining. At six days, polymorphonuclear cells had 
largely disappeared from the tissue surface, leaving an 
unorganised lining of mononuclear cells. By nine days, a 
distinct surface layer of large pigmented cells was seen. 
These had abundant cytoplasm with a variable number of 
branching processes. Haen-atoxylin and eosin staining showed 
the cells to be more basophilic than the lining cells in 
carrageenan inflammtion and the majority of the cells were 
pyronin positive. This layer appeared approximately 1-3 cells 
thick, on sectioning at right angles to the surface, and some 
areas appeared hyperplastic - again, reminiscent of chronic 
synovitis (figure 31 ). The lining cells retained this 
character until thirty days. From six days, a zone of lyffpho- 
cyte and plasm cells were seen in clusters around the vascular 
layer. 
Histological examination of air pouch tissue from non- 
sensitised animals showed an inflammatory reaction, which was 
mild in conparison to the reaction in sensitised animals. 
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Lyrrphoid tissues 
Rat spleen was found to be difficult to assess for 
pathology because of its dual lyrrphoid and haerropoietic 
roles. However, no obvious histological changes were seen 
over the thirty days. Lymph nodes showed medullary and 
paracortical expansion. Granulomas were a feature of the 
lymph nodes at all time points. These cells had a large 
oval vesicular nucleus, usually with one or more prominent 
nucleoli. Their dimensions were approximately 15 x8 ýzn 
(as measured by stage micrometry). The cytoplasm was 
abundant and foamy and the cell borders were indistinct. 
The total dimensions of the cell were approximately 
25 x 10 ýtm. They were arranged in nests of cells with a 
pavementing character. Mitotic figures were frequently 
observed. Central necrosis was a feature of many of these 
granulomas at 1-3 days. In some specimens, the necrosis 
was so extensive as to occupy the bulk of the lymph node. 
By six days necrosis was no longer an obvious feature. 
Effect of drug treatment on pertussis induced prolonged 
inflanmtion 
Bordetella pertussis vaccine was found to produce a 
rmrked inflamTatory reaction when injected into six day 
pouches of previously sensitised rats. In this study, the 
effects of four different drugs on pertussis induced 
inflanrmtion in the six day pouch were investigated. These 
drugs were administered to rats daily orally, conrencing at 
the time of antigen challenge for three, seven and fourteen 
days. Indomethacin was given at a dose of 1 rng or 3 mgAg, 
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dexan-ethasone was given at a dose of 0.1 mg or 0.2 mgAg 
and D-penicillamine was given in a dose of 25 M or 50 mgAg. 
Levarnisole was also tested in both 2.5 mg or 5.0 mgAg. 
InflamTation observed in the pouches of control animals 
reached its maximum at seven days after antigen challenge. 
The mean values of exudate volumes and total cell numbers 
at three, seven and fourteen days in the control groups 
were 3.95 ml, 33.5 x 10 
6; 5.74 ml, 99 x 10 
6; 
and 6.2 ml, 
31.2 x 10 
6j 
respectively. The tested drugs had similar 
effects on this system to those seen on the model following 
carrageenan. 
Indorrethacin 
When indomethacin was tested in both 1 mg and 3, mg/kg, 
it reduced both the volume of e. --. udate and the total cell 
number significantly (P < 0.001). The significant anti- 
inflammatory effect was observed at all the tested times. 
Results summarised in table ( 26 )f igure ( 32 ) are for 
experiments where the inflammatory reactions observed in the 
indomethacin treated groups were compared with those in 
control groups. At seven days after antigen challenge, where 
the inflammatory response reached its maximLn, the volume 
of exudate dropped from 5.74 ml to 3.2 ml in 1 mg/kg 
treated group, and to 2.0 ml in the 3 mg/kg treated group. 
Total cell number was 99.6 x 10 
6 
at seven days in the control 
group and dropped to 57 x 10 
6 
and 40 x 10 
6 in 1 mg and 3 agAg 
treated groups. At the end of these experiments, the animals 
were killed and their gastro-intestinal tracts were examined 
for ulceration. No ulcers were detected either macroscopically 
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or microscopically. 
D-penicillamine 
D-penicillamine was found not to affect the inflammation 
produced in the six day pouches by pertussis antigen. There 
was significant (P < 0.01) increase in the number of 
inflammatory cells accLnulating., in the pouch at seven days 
in the 50 mgAg treated group. Results obtained from 
experiments where 25 ing and 50 n-gAg D-penicillamine were 
used, were sum-arised in table (27 ) figure ( 33 ). At 
three days both the tested doses of penicillamine reduced the 
volume of exudate and the total cell number. However, that 
reduction was insignificant. Seven days after antigen 
challenge, the tested dosesý of D-penicillamine were found to 
increase the inflammatory reaction insignificantly. The only 
significant (P < 0.01) action observed was with 50 mgAg on 
the total cell number. At two weeks, D-penicillamine seems 
to have no effect on the produced inflanimatory reaction. 
T_, evamisole 
Table ( 28 ) figure (34 ) represent a comparison between 
the inflammation observed in levamisole treated groups and 
that observed in non-treated control groups. At seven days 
following the antigen challenge, inflamnation reached its 
maximum in the control group. Volume of exudate was 5.87 ml 
6 
and the total cell number was 96 x 10 . Ievamisole was 
unable to alter exudate volumes or total cell numbers in all 
the tested groups, and this indicates that levamisole has no 
anti-inflammatory action when tested in this particular 
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inflammtory model. 
Dexarrethasone 
Dexamethasone again proved to beokpo+enL-anti-7inflammtory 
agent when tested in this model of im=e inf lammtion. 
At different times following the antigen challenge and drug 
treatment in both 0.1 mg and 0.2 mgAg, animals were killed 
and their pouches were opened. In general, all the animals 
of the dexamethasone treated groups showed weight loss, 
especially at seven and fourteen days of treatment. The 
tissues of their air pouches were thin when compared with 
those of control groups, or even compared with those of 
other drug treated groups. The pouches contained no exudate 
at all and hence it was impossible to count infla=atory cells. 
Leucocytes differential counts 
Differential counts mde on exudate smears obtained 
from control groups (non-treated), showed that there was a 
polymorphonuclear leucocyte doffdnance at all the tested 
time points. The ratio of polymrphs, to mononuclears at 
three, seven and fourteen days was 93: 7,54: 46 and 67: 33. 
The dominance of polywrphs rexmined at three days after 
treatment with the different drugs (table 21) ). At 
seven days, polymorphs still dominated after drug treatment, 
except with 2.5 MAg levamisole, where there was a =no- 
nuclear dominance (59%). At fourteen days, in the control 
group the ratio was 67: 33 and this was totally changed towards 
mononuclear dominance, except with 3 mgAg indcmethacin, where 
the ratio was in favour of polymrphs (66: 34). 
-L C) 0 
Tiffe 3 days 7 days 14 days 
Drug PMN MN PMN MN PMN MN 
Pertussis group 93 7' 54 46 1 
67 33 
1.0 mAg 92 8 76 24 27 73 indomethacin 
3.0 mg/kq 89 11 
1 
65 35 , 66 34. indomethacin 
25.0 n-g/kg 91 9 84 16 16 84 D-penicillamine 
50.0 mqAq 90 10 78 22 10 90 D-penicillamine 
2-s mg/kg 99 1 41 59 36 64 levamisole 
5.0 n-gAg 84 16 55 45 48 52 levan-Lisole 
Table (29)Effect of daily administration of drugs on the 
ratio of polymrphonuclears to mnonuclear 
leucocytes at different time periods, observed 
in pertussis inflaned 6 day pouches. 
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Implantation of articular cartilage into pertussis 
inflamed six day pouch 
Groups of animals were sensitised with emulsion 
containing equal volumes of bordetella pertussis vaccine 
and incomplete Freund's adjuvant. Seven days later, animals 
were injected with 20 ml air in the subcutaneous tissue of 
their backs. Three days following initial air injection, 
the animals were re-injected with 10 ml air to keep their 
pouches open. Twelve days following sensitisation with 
emulsion, animals were challenged with undiluted bordetella 
pertussis vaccine. On the thirteenth day, groups of animals 
of nearly the same weights and ages were killed and their 
fen-oral cartilage caps were removed and implanted into 
the preformed pouches for different time intervals. 
The rate of proteoglycan loss from the implanted 
cartilage was found to be directly proportional to the 
period of implantation, ie, the longer the time of 
implantation, the greater the proteoglycan loss. Analysis 
of the results in table ( 30 ) figure ( 35 ) shows that 
there was a slight insignificant loss of proteoglycan 
from implants recovered after three and seven days of 
implantation. Implantation for three days caused a loss 
in proteoglycan content of about 3% and the loss at seven 
days was 5%. A significant (P < 0.001) decrease in the 
proteoglycan content was, only observed at fourteen days 
and twenty-one days. Following fourteen days of implant- 
ation, the implants lost about 48% proteoglycan content. 
A massive loss was observed after twenty-one days and the 
in-Oanted cartilage lost about 61% proteoglycan content. 
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Fig. 35 
Amount of proteoglycan (jug) in rat femoral head cartilage 
at 3,7,14 and 21 days following implantation into 6 day 
pouches of pertussis sensitised animals. 
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The histological changes in cartilage implanted into 
pertussis and carrageenan inflamed pouches were essentially 
the same. one difference, however, was. that cartilage from 
pertussis inflcxred animals was usually found in the exudate 
and was not adherent to the pouch wall. 
Effect of drug_treatTmnt on proteoglycan content of 
articular cartil2ae implanted into pertussis inflamed pouches 
Rat femoral head cartilage caps were implanted into 
six day pouches of pertussis sensitised animals. Cartilage 
caps were implanted one day after the animals were 
challenged with the pertussis vaccine. Animals were 
treated with different therapeutic agents. The treatment 
comaenced on the day following cartilage implantation 
and the animals were given daily oral doses for fourteen 
days. The drugs used were indaTethacin (1 mg and 3 mg/kg), 
D-penicillaiýine (25 rg and 50 mgAg), dexamthasone 
(0.1 mg and 0.2 mgAg) and levamisole (2.5 mg and 5.0 mgAg). 
Implants obtained fran non-treated groups (control) lost 
about 43% proteoglycan content. 
Indomethacin 
Indomethacin was found to protect the irrplanted 
cartilage significantly (P < 0.001) and this protective 
effect was observed with 1 mg and 3 mgAg (table 31 
figure 36 ). This effect was observed to be dose- 
dependent. Cartilage recovered from 1 mgAg treated 
anirrals lost approxirrately 16% proteoglycan content, 
ccnipared with cartilage obtained frcm 3 mgAg treated 
Experinent proteoglycan 
content (pg) 
% change 
Norml cartilage 234.0 + 17.5 -- 
Bordetella pertussis 133.5 + 6.5 -42.95 
1.0 n-g/kg indormthacin 196.0 + 15.0** -16.24 
3.0 irg/kg indcn-ethacin 202.0 + 16.5** -13.68 
Table (31) 
Proteoglycan content (pg) of femoral head cartilage 
implanted for 2 weeks into pertussis inflamed 6 day 
pouches of animals treated with a daily oral dose of 
either 1 or 3 mg/kg indcmethýLcin throughout 
implantation period. 
Mean values + S. E. M. 
6 rats per group 
*j; P<0.01 
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** 
P<O. o 1 
Normal Control 1 mg/kg 3mg/kg ýnr+il- 
ýul LIICIUC; 
indomethacin 
Fig. 36 
Proteoglycan content (pg) of femoral head cartilage implanted for 2 weeks into pertussis inflamed 6 day pouches of animals treated daily with an oral dose of either 1 or 3mg/kg indomethacin throughout implantation period. 
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anbTals, which lost only 13% content. At the end of this 
experisnent the anin-als were killed and their gastro- 
intestinal tracts were examined for ulceration. No ulcers 
were detected, either nacroscopically or microscopically. 
D-penicillarine 
A significant (P < 0.01) protection to the implanted 
cartilage was also observed in samples obtained from 
50 mgAg D-penicillamine treated groups (table 32. 
f igure 37 ). Implants obtained from 50 rngAg treated 
groups lost approximately 15% proteoglycan content, while 
the loss observed in 25 mgAg treated groups was about 26%. 
Dexamethasone 
The same profile of protection was also observed ý7ith 
sanples frcn dexamethasone treated anirrals. No protection 
was observed with implants obtained fran 0.1 rngAg treated 
groups and the loss was approxirately 22%. On the other 
hand, there was a significant (P < 0.01) protection after 
fourteen days of treatment with 0.2 rngAg dexan-ethasone 
where the loss was only 16%, ccnpared with 43% observed 
in the control group (table 33 , figure 38 ). 
Levamisole 
Levandsole was the only tested drug which showed no 
protection to the inplanted cartilage, and this effect was 
observed with both 2.5 mg and 5.0 mgAg. Cartilage obtained 
from 2.5 rng and 5.0 mgAg treated anircals showed a loss in 
proteoglycan. content of approximately 23% and 25%(table 34, 
figure 39). 
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Experinent proteoglycan. 
content (pg) 
% change 
Normal cartilage 234.0 + 17.5 -- 
Bordetella pertussis 133.5 + 6.5 -42.95 
25.0 mgAg D-penicillan-Line 171.5 + 17.5 -26.71 
50.0 mgAg D-penicillanLine 197.5 + 19.0** -15.6 
Table (32) 
ProteocTlycan content (pg) of femoral head cartilage 
inplanted for 2 weeks into pertussis inflamed 6 day 
pouches of animals treated with a daily oral dose of 
either 25 of 50 MAg D-penicillaTrane throughout 
implantation period. 
Mean values + S. E. M. 
6 rats per group 
* *P < 0.01 
195 
Normal 
cartilage 
Control 25mg/kg 50mg/kg 
D-Penicillamine 
Fig. 37 
Proteglycan content (ug) of femoral head cartilage implanted for 2 weeks into pertussis inflamed 6 day pouches of animals treated daily with an oral dose of either 25 or 50mg/kg D. Penicillamine throughout implantation period. 
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Dq: )erimnt proteoglycan, 
content (pg) 
% change 
Norual cartilage 234.0 + 17.5 -- 
Bordetalla pertussis 133.5 + 6.5 -42.95 
0-1 n-vgAg 
dexamethasone 
180.5 + 17.0 -22.87 
0.2 rngAg 
dexamethasone 
196.5 + 15.0** -16-03 
Table (33) 
Proteoglycan content (Pg) of femoral head cartilage 
irrplanted for 2 weeks into pertussis inflamed 6 day 
pouches of animals treated daily orally with a dose 
of either 0.1 or 0.2 rrg/kg dexamethasone throughout 
inplantation, period. 
Mean values + S. E. M. 
6 rats per group 
** P<0.01 
197 
300 
250 
200 
150 
100 
50 
Normal Control 0.1 mg/kg 0.2mg/kg 
cartilage 
dexamethasone 
Fig. 38 
Proteoglycan content (pg) of femoral head cartilage implanted 
for 2 weeks into pertussis imflamed 6 day pouches of animals 
treated daily orally with a dose of 0.1 or 0.2mg/kg clexamethasone 
throughout implantation period. 
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ZKperiment proteoglycan 
content (pg) 
% change 
Normal cartilage 284.5 + 17.5 -- 
Bordetella pertussis 170.5 + 16.5 -40.08 
2.5 mgAg levarnisole 219.5 + 19.5 -22.85 
5.0 ingAg levamisole 214.0 + 22.0 -24.79 
Table (34) 
Proteoqlycan content (pg) of femoral head 
cartilage inplanted for 2 weeks into pertussis 
inflamed pouches of animals treated daily orally 
with a dose of either 2.5 or 5.0 mgAg levamisole 
throughout inplantation period. 
Mean values + S. E. M. 
6 rats per group 
199 
Normal 
cartilage 
Control 2.5mg/kg 5mg/kg 
levamisole 
Fig. 39 
Proteoglycan content (jug) of femoral head cartilage implanted for 2 weeks into pertussis inflamed 6 day pouches of animals 
treated daily orally with 2.5 or 5mg/kg levamisole throughout implantation period. 
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Histological obse-n. 7ations following drug treatment 
Histological examination of material obtained from 
drug treated anirmls showed no signifcant changes from control 
material with indomethacin, D-penicillamine and levamisole. 
There were gross changes observed following treatment with 
0.1 rng and 0.2 mg/kq dexamethasone. Pouches from 0.1 mq and 
0.2 rng/, kg treated animals seven and fourteen days after 
challenge, were macroscopically thinner than those from 
control animals. This finding was confirmed microscopically, 
where it was observed that the pouch showed less fibrous 
connective tissue in the more superficial layer and consid- 
erably less infiltration by inflammatory cells. 
Careful examination of lymph nodes from 0.1 mq and 0.2 
n-g/kg treated animals showed that they were macroscopically 
smaller than lymph nodes from control animals. There was 
an apparent reduction in granuloma content at three and 
seven days. 
Determination of alpha-l-acid glycopamtein 
Cooke et al in 1958, found that the levels of alpha-l- 
acid glycoprotein ( cý-l-GP) rise after trauma, in pregnancy, 
pneumonia, with sorne malignancies and in rheumatoid arthritis. 
In this study, the concentrations of (>(, -1-GP were measured 
in sera and exudates from pertussis and carrageenan treated 
animals. The results summarised in table ( 35 ) figure 
40 ) are for experiments where the concentrations of 
O< -1-GP in sera and exudates from pertussis sensitised 
and carrageenan treated animals were measured at different 
times. 
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21 
The concentrations of a-1 -acid glycoprotein in sera and exudates of pertussis sensitised 
and carrageenan inflamed animals at different times. 
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Pertussis groups 
Determination of the levels of o( -1-GP in sera and 
exudates collected from pertussis inflamed animals showed 
that c>( -1-GP peaked at three days. in both serum and 
exýidate, and was 5.9 and 7.5 pg/ml respectively. At seven 
and fourteen days, the serum levels were still high and they 
were 4.6 and 4.5 pg/ml. 'TWenty-one days after challenge 
with pertussis vaccine, the concentrations of C< -1-GP in 
serum and exudate dropped sharply to 0.9 pg/ml in serum 
and 1.8 pg/ml in exudate. 
Carrageenan groups 
Alpha-l-acid glycoprotein peaked three days after the 
injection of carrageenan, in both serum and exudate, and 
the concentrations were 4.4 and 6.8 pg/ml respectively. 
At seven days, the concentration dropped from 4.4 pg/ml to 
1.2 pg/ml in serum and 6.8 pg/ml to 4.15 pg/ml in exudate. 
At the fourteenth day, the concentration of C< -1-GP 
in serum rose again to its =imum and was 4.4 pg/ml. 
Measurement of C<-l-Gp in the inflamnatory exudate at* 
fourteen and twenty-one days, showed that the concentration 
was 2.2 pg/ml and 1.55 pg/ml. n%7enty-one days after 
carrageenan injection, (X -1-GP dropped to its minimum, where 
it was 1.5 pg/ml. 
Effect of drug treatment on the levels of 0( -1-GP 
Sera and inflammatory exudates were collected frCm 
animals of drug treated groups at different times. The 
tested drugs were indcmthacin (1 M and 3 mg/kg), 
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D-penicillamine (25 mg and 50 mc . 
jAg), dexamethasone (0.1 mg 
and 0.2 mgAg) and levamisole (2.5 mg and 5.0 mgAg). Assays 
were performed on sera and exudates frorn anin-als receiving 
the drug treatment as described above. It was found that 
alpha-l-acid glycoprotein levels failed to show any 
correlation with the drug effects on the inflanymtory process. 
Furthermore, there were considerable variations fran 
experiment to experiment. It was decided not to pursue 
this line of research further. 
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ISCUSS10N 
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Arthritis is characterised by inflawation of the 
synovial membrane of joints - Ultimately, the problem 
those who suffer from this disease, is destruction of thd- 
hard tissue, ie, cartilage and bone. Rheumatoid arthritis 7zzlý 
is a disease of joints where the hard tissue is eroded by 
a proliferative invasive tissue called pamus, which is 
derived from the synovial mertbrane and its microvasculature 
(Fasbender, 1975). The mechanisms involved in the destruction 
of joint tissue still remain unclear (Martel-Pelletier et al, 
1985). Major advances have been made, however, and these 
are primarily the result of studies based on in vitro 
techniques. Animal models are still of considerable importance, 
both for the determining of basic cellular control mechanisms 
and for detecting and understanding the pharmacological 
control. Billingham (1983) in a recent review, emphasises 
the importance of in vivo approaches for the discovery 
of novel disease modifying agents. Paulus and Whitehouse 
in 1973, pointed out the difficulties in searching for novel 
disease modifying drugs. Certainly the main difficulty 
arises in that no single aetiological factor has been found 
against which to target drugs. 
Many animal models of acute inflammation are available. 
Carrageenan-induced oedema is fregiently used to study anti- 
inflammatory drugs followed by systems such as ultraviolet 
erythema in guinea pig skin (Winder et al, 1958). Further 
evaluation of a ccnpound requires a chronic model such as 
adjuvant- induced arthritis (Billingham, 1983ý or a prolif- 
erative model, such as cotton pellet granulcrra (Meier et 
al, 1950). The main advantages of using an experimental 
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model of arthritis for examining pharrmcological agents, 
is that the chronic inflaumtory changes observed are likely 
to be useful in detecting novel carpounds. Such agents 
may be undetected in acute m: )dels of inflanimtion. 
The models of experimental arthritis currently 
available can be grouped under three categories (i) adjuvant- 
induced arthritis in the rat, (ii) chronic monoarticular 
arthritis induced by intra-articular injection of antigens, 
eg, fibrin (Dumonde and Glynn, 1962), and (iii) arthritides 
caused by infectious agents, eg, mycoplasm arthritides 
(Cole et al, 1971). Adjuvant-induced arthritis is restricted 
to the rat and it has been used for screening purposes. It 
is a useful model for the detection of certain kinds of 
drug activity but its real-value. as a model of rheumatoid 
arthritis remains to be justified. Although it detects 
compounds active against acute inflamnation and immuno- 
suppressive agents, there are sinpler-models. available for 
both purposes. It does not appear to detect the activity 
of disease modifying drugs like D-penicillarrtine, which seem 
to affect the human arthritic process. Antigen-induced 
chronic arthritis, as exenplifed by the model of Dumonde 
and Glynn (1962), closely resembles several aspects of 
rheumatoid arthritis, but its major drawback is that the 
only reliable method of assessment appears to be based on 
histological examination, which is acconpanied by problems 
with quantification. Similarly, arthritis caused by an 
infectious agent may represent a closer approximation of 
the human disease than does adjuvant disease, but there is 
very little information available on the effect of drug 
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treatment, since the assessment of the disease activity is 
difficult. 
The aim of the present study was to develop a novel 
animal model with relevance to human disease (arthritis), in 
, order 
to study the mechanisms of cartilage degradation which 
could be quantified. Many workers have previously examined 
the effects of drugs on inflammation in soft tissue, either 
by using cavity mcdels such as pleurisy (Willoughby, 1975) 
or polyester sponges (Higgs et al, 1980). Similarly, many 
workers have investigated the effects of soft tissue on 
cartilage degradation in vitro (Dingle, 1979). The present 
study has concentrated on bringing together these two 
approaches in one in vivo model. The model chosen to base 
these studies on was the air pouch. The air pouch qranulana 
technique was first introduced by Selye (1953) and modified 
by Robert and Nezarrds (1957). The basic procedure consisted 
of making an air pouch in the back of the rat by injecting 
25 ml air subcutaneously. Subsequently, dilute croton oil 
was introduced into the pouch to induce granulorratous tissue 
formation. The response was evaluated 4- 14 days later, on 
the basis of the volume of the fluid collected from the pouch 
and the weight or thickness of the pouch wall. Besides 
croton oil, several other irritants have been used, 
especially carrageenan (Highton, 1963; Fukuhara and Tsurufuji, 
1969). 
Edwards, Sedgwick and Willoughby in 1981, first noticed 
that injecting air in the subcutaneous tissue of the back 
of mice and rats, resulted after six days in the formation 
of lining structure which closely resembled synovium. 
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Although the linings of the subcutaneous air cavities my 
not be identical-with any particular piece ofJoint lining, 
they demonstrated all the essential features of a synovial 
lining. Moreover, these linings have similar cell sub-, 
. populations as 
judged by electron microscopy and light 
microscopy, using haematoxylin and eosin and Van Gieson 
stains, esterase activity and im-nunofluorescent staininq 
for Ia antigen. The lining cells were of two main types; 
the ccn=nest type (50 - 90%) were identified as fibroblasts 
and were indistinguishable from type B cells of the mouse 
knee synovial lining. The second major cell type (10 - 50%) 
took up the injected colloid carbon avidly and they could 
be described as n-acrophages or type A synovial lining cells. 
Such a systern differs from the traditional air pouch 
granuloma model, in that inflam-nation can be studied in a 
cavity similar to synovium. Fdwards and his colleagues 
(1981) presented for the first time an in vivo model 
suitable for studying the infla = tory process, and the 
process of cartilage degradation (hard tissue) 'in contact 
with lining cells (soft tissue). Sedgwick et al in 1983 
showed that the six day pouch responds to a greater degree 
than the one and the three day pouches to different 
inflammatory stimuli (carrageenan, calcium pyrophosphate 
dihydrate crystals and urate crystals). They attributed 
the increased inflanmtory reactivity in the lining of 
the six day pouch of the rat to the following possibilities: 
W an increase in the vascularity of the lining, which 
results in more inflamTatory cells recruited to the air 
pouch, (ii) the formation of an organised surface layer 
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of mononuclear phagocytes and fibroblastic cells, or (iii) 
the formation of an increasingly effective mechanical 
barrier that retains the irritants and the products of the 
inflanmtory response, 
Since the air pouch had features similar to synovium 
and could easily be inflamed, Sin et al (1984) introduced 
the idea that the introduction of cartilage into such a 
structure my provide information on hard tissue-soft tissue 
interaction. These workers used the muse six day pouch to 
study cartilage degradation, where autologous living or dead 
intact or minced mouse xiphisterna were irrplanted into the 
air pouches of the original donors. They showed that only 
a modest loss of proteoglycan and collagen occurred in the 
living intact cartilage. Severe loss of proteoglycan, however, 
was detected in the minced living and dead intact cartilage. 
The air pouch cartilage in-plant system seemed to have 
potential for the examination of pharmacological agents. 
The present-study, therefore, firstly verified the works of 
Sin et al (1984) in order to evaluate its use as a model for 
examining the rechanisms of actions of existing disease 
modifying agents and detecting novel agents. ' 
The data described confirms the findings of Sin and 
his colleagues. Living and dead cartilage were used in order 
to verify the in vitro observations of Fell and Jubb (1977), 
that synovial tissue, when placed in contact with either 
living or dead articular cartilage, caused the loss of 
proteoglycan and collagen from the tissue matrix. Fell and 
Jubb proposed that the damage observed was due to either 
direct enzyme degradation or to the indirect action of 
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substances released from synovium stimulating the 'living' 
chondrocytes to degrade their own extracellular matrix. 
These indirect substances they have termiad 'catabolins' 
and have been implicated as important mediators of 
cartilage degradation. Saklatvala et al (1984) recently 
confirmed that purified porcine mononuclear cell catabolin 
was in fact a form of interleukin-1. Minced samples were 
used in order to study the effect of mechanical trauma on 
cartilage degradation. Sin et al (1984) proposed two 
possible mechanisms by which mechanical trauma my trigger 
cartilage degradation. Firstly, trauma such as mincing 
may abolish the perichondrial protection and my cause the 
loss of stability of the ratrix in the damaged area and make 
it vulnerable to attack by. various types of mediators known 
to degrade cartilage. The second mechanism is that trauma 
may affect the activity of the chondrocytes, which have 
been known to play an anabolic role under certain circum- 
stances (Mitrovic, 1982) and also produce substances which 
inhibit the degradative activity of proteolytic enzymes 
(Sorgente et al, 1975). The observation that minced 
cartilage fragments attract leucocytes would also suggest 
that the release of matrix components after injury amplifies 
the inflammatory response. It has been shown that mechanical 
deformation of cell membranes in articular cartilage can 
activate phospholipase and induce the generation of arachi- 
donic acid (Mitrovic, 1982). The inflammatory response seen 
around fragments of cartilage may be due to the release of 
chemotactic prostanoids. 
The present study improved the system of Sin et al-to 
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examine the mechanism of action of non-steroidal anti- 
inflammatory drugs and disease modifying agents. Because 
of the small size of the cartilage fragments, retrieval of 
the cartilage was difficult. The present study in-proved . 
the muse xiphisternum model for the evaluation of pha=- 
cological agents by introducing the n-Lillipore-half chamber 
technique, where the cartilage fragments were introduced 
into the chamber prior to implantation. This allowed 100% 
retrieval of the cartilage fragments. The introduction of 
this technique (millipore-half chamber) facilitated the 
screening of different pharmacological agents on the process 
of cartilage degradation. Initially, different groups of 
anti-inflammatory and anti-rheumatic coq: )ounds were examined 
on the process of inflammation and cartilage degradation. 
This study was designed to, conpare for the first time the 
reduction of soft tissue inflamimation with the protection 
afforded on the cartilage. 
Several non-steroidal anti-inflammatory agents were 
selected. Aspirin and indonethacin were used because they 
are both potent inhibitors of arachidonic acid metabolism' 
affecting the cyclo-oxygenase netabolic pathway (Lcn-bardino, 
1983). In the present study, both these agents significantly 
reduced leucocyte accumulation into the mouse air pouch. 
These observations supportthose of others who showed that 
cyclo-oxygenase inhibitors could inhibit cell accumulation 
in experimental subcutaneous sponges (Higgs et al, 1980), 
carrageenan induced pleurisy (Mikami and Miyasaka, 1983), 
carrageenan. induced paw oedema (Higgs and Mugridge, 1982) 
and the carrageenan granulcrra pouch (Fukuhara and Tsurufuji, 
1969). 
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It is possible that both of these carpounds, by blocking 
the generation of prostaglandins, reduced the fomation 
of exudate and, therefore, the concentrations of chemotactic 
factors. Di Rosa et al (1971) showed previously that 
indomethacin suppressed the total number of leucocytes 
emigrating into the rat paw after carrageenan injection. 
In contrast, Ackerman et al (1980), showed that indcmthacin 
enhances the migration of mononuclear phagocytes into the 
pleural cavity three days after carrageenan injection. 
Ackerman and his colleagues explained their observations 
on the grounds that indomthacin, by blocking the cyclo-* 
oxygenase pathway of arachidonic acid metabolism, increased 
the generation of lipoxygenase products. The present study 
showed that with these doses of cyclo-oxygenase blockers 
in the muse, cell accumulation is reduced. The concept 
of substrate diversion and lipoxyqenase products has recently 
been reviewed by Higgs and Vane (1983). Esterified arachidonic 
acid is cleaved from membrane phospholipids by the action of 
phospholipase-A2 in response to a variety of stimuli and my 
then be converted either by cyclo-oxygenase to prostaglandins 
and thrcmboxanes, or. by lipoxygenase to leukotrienes. 
These metabolic pathways have been extensively reviewed 
(Bakhle, 1983 and Granstrom, 1984). Cyclo-oxygenase products 
have been detected in a variety of experimental inflaiTuutory 
lesions (Tissot et al, 1984) and in human chronic joint 
inflammation (Brodie et al, 1980). Leukotrienes have also 
been detected experimentally (Simmons et al, 1983) and in 
synovial fluid of rheumatoid arthritis (Davidson et al, 1982). 
Arachidonic acid metabolites are important mediators of 
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inflamration and have nurrerous and caTplex biological effects. 
Different arachidonic mtabolites may be released depending 
on stimulus and cell type, and their effects my vary frcm 
site to site (Higgs et al, 1983a). Many of the agents with 
anti-inflam-natory activity act via the blockade of the cyclo- 
oxygenase pathway of arachidonic acid (Higgs et al, 1983b). 
Benoxaprofen, however, is able to inhibit both cyclo-oxygenase 
and lipoxygenase'pathways with preferential activity against 
lipoxygenase (Walker and Dawson, 1979). 
In the present study, benoxaprofen also significantly 
reduced leucocyte accumulation in the mouse*air pouch. This 
supports previous observations of Meacock and Kitchen (1979). 
Piroxicam was chosen as an example of a reversible cyclo-* 
oxygenase blocker (Goodwin, 1984). This agent similarly 
inhibited cell accumulation. Although these non-steroidals 
blocked cell accumulation, thus inhibiting the secretion 
of cellular products, none of these agents has any effect 
on the implanted cartilage. These observations contrast 
to those of others using the adjuvant arthritis model. Non- 
steroidal anti-inflammtory agents have been shown to 
suppress 
effectively adjuvant arthritis. The effectiveness 
of NSAID on adjuvant arthritis appears to vary frcm 
laboratory to laboratory. Glenn (1966) obtained an ED50 
for indomethacin of 0.2 mg/kg using an arthritic score to 
measure effectiveness, whereas Di Pasquale et al (1975) 
found and ED50 of 2.0 mgAg. -It would appear from the present 
data that prostaglandins/eicosanoids are not important as 
mediators of cartilage degradation. 
In contrast to the findings using MAID , D-penicillamine 
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had no signficant effect on soft tissue cell accumulation, 
but significantly reduced proteoglycan loss from cartilage 
implants. The view that D-penicillamine is not an anti- 
inflammatory drug is supported by its lack of effect on 
other conventional models. Maddox (1973) showed that 
D-penicillamine failed to suppress carrageenan-induced paw 
oedema. Arrigoni-Martelli and Bramm (1975) found no effect 
on the prin-ary lesions of adjuvant arthritis, but an enhance- 
ment of the secondary lesions. Secondary lesions of adjuvant 
arthritis are usually regarded as a manifestation of cell- 
mediated immunity. This is supported by its effects in models 
of delayed hypersensitivity using pertussis vaccine as 
antigen (Dieppe et al, 1976). In this model, the inflam- 
matory reaction to pertussis vaccine in sensitised animals 
is enhanced by D-penicillamine. Also in support are enhance- 
ment of skin responsiveness to tuberculin in patients with 
rheumatoid arthritis after treatment with D-penicillamine 
(Berry and Huskisson,. 1976). These observations prcnpted 
various authors to speculate on the mode of action of 
D-penicillamihe via the modulation of T-cell function. 
These findings suggest that agents such as D-penicillamine 
can fundamentally reduce the degradation of cartilage. The 
final group of agents tested in this system were the'cortico- 
steroids. Previous in vitro studies have shown that 
D-penicillamine and corticosteroids can reduce cartilage 
degradation (Sheppeard et al, 1982). Apart frcm. the work 
of Hunneyball et al. '(1977) using the rabbit mcnoarticular 
arthritis, the mouse xiphisternal system is the first model 
reported to detect D-penicillamine. Similarly, hydrocortisone 
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reduced proteoglycan loss in this system. A detailed 
discussion on the mechanism of action of these drugs follows. 
A possible criticism of the model described was firstly that 
xiphisternum. is structurally. different from other cartilage 
surfaces, as it has a perichondrium. Mechanical damage is 
required to induce proteoglycan loss, and furthermore it is 
not articular. Since articular cartilage is the important 
tissue in arthritis, it was decided to try and further 
develop the model to overcome these problems. Furthermore, 
the cell numbers in the muse model were found to vary 
considerably from animal to animl. It was decided to n=e 
to the rat. 
In order to develop an improved system, the cartilage 
cap of the mouse femoral upper end was used. This, however, 
was found to be technically difficult. It was, however, 
found that the same cartilage obtained from rats proved to 
be a good source to study cartilage degradation. Initially, 
experiments were carried out to see whether femoral head 
articular cartilage, if implanted into inflamed or non-inflamed 
soft tissue, degraded. one of the problems of the rat 
femoral head system is that the cartilage transplantation 
cannot be autologous. Firstly, therefore, it was necessary 
to examine whether cartilage was degraded by the soft tissue 
inflawation or stimulation of the inTrune system. 
Cartilage has been, considered to be immunologically 
privileged since it survives longer after transplantation 
than any other tissue, except the cornea (Brown and Cruess, 
1982). In the present study, cartilage from donor rats 
had been implanted into pouches of recipient animals 
217 
(allografts) on the basis that cartilage is so weakly 
antigenic (Gertzbein and Lance, 1976). The findings 
that outhred and inbred strains of rat degraded cartilage 
to the same degree, leads to the conclusion that no 
auto-inume rejection process is involved. This was 
further supported by the histological findings of this 
study, that there was no regional lymphoid tissue involve- 
ment. Malseed and Heyner (1976) successfully elicited 
an imnune response with isolated chondrocytes. These 
authors suggested that chondrocytes were not weakly antigenic 
but could induce a significant serological response. 
Yoshiyoka et al (1982) also found that they could detect 
delayed hypersensitivity in animals imnunised with articular 
cartilage antigens. Surprisingly, animals immunised against 
articular cartilage degraded implants to the same degree 
as non-imnunised animals, -and this further supports the 
conclusion that the air pouch cartilage-inplant model is 
not measuring tissue rejection. 
Carrageenan was initially chosen as irritant in this 
study, in order to examine the effect of-soft tissue inflam- 
nation on cartilage degradation. Carrageenan is able to 
induce both acute and chronic inflammation (Di Rosa, 1972). 
Sedgwick et al (1983) showed that if the air pouch is formed 
for six days, it behaves differently in response to carrageenan. 
The present study was able to to examine the effects of 
prolonged inflammatory lesions on cartilage degradation, using 
the six day pouch system. It has been shown that carrageenan 
is rapidly taken up by mononuclear phagocytes with the 
resultant release of. hydrolytic enzymes (Allison et al, 1966, 
Cantazaro et al, 1971). Thus, carrageenan can induce an 
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environment of tissues and cells which have been proposed 
to induce cartilage degradation (Decker et al, 1982, Starky 
et al, 1977) 
The results described in this study suggest that the 
presence of an inflanratory reaction, of the type induced 
by carrageenan, is unable to accelerate proteoglycan loss 
from cartilage. Since loss of matrix is a primary factor in 
rheurratoid arthritis, it would appear that the type of 
inflammtion used in this study is not representative of 
the rheumatoid disease process. The findings that proteo- 
glycan loss occurs in 'normal' , ie, non-inflamed tissue, 
is not understood. However, it could be due to the direct 
contact of. cartilage with the soft connective tissue cells. 
The six. day pouch tissue, which has previously ]ý_-en shown 
to have an organised layer of lining cells (macrophages 
and fibroblastic cells), was not found to degrade cartilage 
to a greater extent than subcutaneous tissue. It is of 
great inportance in. such experiments to provide 'normal' 
tissue controls. Subcutaneous implantation-following blunt 
dissection may itself induce tissue damage and the generation 
of inflanrnatory mediators. Fell and Jubb (1977) showed that 
catabolin-acts as a messenger which is capable of stimulating 
chondrocytes in living cartilage to -resorb their own , 
'extracellular matrix. If catabolin was generated during 
carrageenan inflammtion, dead cartilage would be expected 
to degrade at a slower rate than living. The results described 
in this study, showed that dead cartilage lost proteoglycan 
substantially after only one week. Furthermore, no difference 
was observed between implantation into 'normal' or 'inflamed' 
tissue. This suggests that degradation of cartilage is more 
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likely due extrinsic (damaged tissue) cells rather than 
by intrinsic (viable chondrocytes) enzymes. 
Sin and his colleagues (1984) proposed that cartilage 
is not normally broken down because it has self-protective 
mechanisms. This protection could be reduced by trauma 
induced mechanically. In the articular cartilage system, 
mincing of cartilage induced greater loss of proteoglycan 
but the effects were not as dramatic as with xiphisternal 
cartilage. These results my have been observed because 
articu lar cartilage has no perichondriun. The perichondrium 
of xiphisternal cartilage my afford some protection. It is 
possible that the loss of cartilage matrix seen in this 
system is more closely related to soft tissue adhesion than 
to inflamTation. The fact that implanted cartilage is 
present in an immovable state, could be an important factor 
in the process of cartilage degradation. In this respect, 
the work of Salter et al (1980) is of interest. These authors 
showed that movement has a major protective role for-cartilage 
in joints injured by infection or trauma. 
It was decided to assess the value of the air pouch as 
a site for immune inf lanmtion. Immune complexes have been 
proposed to localise, in joint cavities or across blood vessel 
walls, inducing inflanmtion, (Ziff, 1980). In this study, 
an active Arthus reaction was induced first, which persisted 
for about 72 hours, giving-a predominantly cellular response 
peaking at four hours, with the dominance of polymorpho- 
nuclear leucocytes. It was decided also to atterpt a reverse 
passive arthus reaction. This, however, proved difficult to 
produce in the air pouch. 
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In order to determine the pathological mechanisms 
involved in rheumatoid arthritis, it was necessary to 
develop a chronic imm; ne model in animals which simulate 
the disease. Bordetella pertussis vaccineý has for a long 
time been used as an antigen for producing hypersensitivity 
in the rat. Rowley et al (1959) showed that pertussis 
vaccine could produce a severe active cutaneous hypersensitivity 
in the rat. These authors showed that this hypersensitivity 
could be transferred by lymph node cells but not with serun. 
Willoughby in 1966, confirmed these findings by showing that 
inflammation could be induced in the paw of animals previously 
sensitised with pertussis. Willoughby found that the paw 
oedema reached a maximum after 24 hours and that on histo- 
logical examination the lesion-was characterised by massive 
rononuclear cell invasion. Because of the problems in 
quantification of paw oederra, Dieppe et al (1976)induced 
j? ertussis hypersensitivity in the pleural cavity of rats. 
These authors attenpted to design a system which would detect 
drug activity useful for the treatment of rheumatoid arthritis. 
The rationale for these studies was that rheumatoid arthritis 
was thought to have a delayed hypersensitivity conponent 
(Yu and Peter, 1974). 
Ideally, an experimental mDdel of inflamnation with 
relevance to rheumatoid arthritis should be prolonged and 
have an im-aune carponent. The present study has atteMted 
to use the previous knowledge of the structure of the six 
day pouch and bordetella pertussis vaccine to produce such 
a model. The present findings have shown that it is 
necessary to use the six day old pouch to produce a 
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prolonged inflammatory response to pertussis vaccine. 
Using this aged pouch, a single challenge of pertussis 
vaccine into previously sensitised rats can produce an 
inflammatory reaction which persists over a 21 day period. 
Cell transfer experiments were not attempted but histological 
studies of the lymph nodes revealed activation of paracortical 
areas with large numbers of small lymphocytes and also 
activation of medullary areas with large tracts of irTMmo- 
blasts and plasma cells being present. 
Turk (1980) had previously classified, the changes 
occurring in the lymph nodes. during cell mediated imn-u-Lity 
and immediate hypersensitivity. Turk showed that in pure 
cell mediated reactions, only changes in the paracortical 
areas were observed. Whereas ' immediate hypersensitivity 
changes in the medullary area were seen leading to the 
formation of plasma cells. Turk also showed the 'mixed 
reaction I where both types of histological dye were seen 
in the lymph nodes. ýIt seems probable that with the histo- 
logical changes that were noted during th ese experiments, 
bordetella pertussis was leading to a mixed hypersensitivity 
reaction, ie, both immediate and delayed. This my be 
important since, in rheumatoid arthritis, both types of 
hypersensitivity reaction are seen often together. (Ziff, 1973). 
In this study, the level of one of the acute phase 
reactants (oý-l-glycoprotein) has been measured in the 
exudate and sera of animals with carrageenan and pertussis- 
induced inflammation. Billingham (1983) suggested'that 
biochemical changes can-provide a considerable amount of 
information about the extent of an ongoing chronic inflammation. 
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With the inplication that interleukin-1 released from 
active mnonuclear phagocytes can elevate acute phase 
. reactants, 
it would seem that the level of these proteins 
is a good measure of cell activity (Bornestein, 1982). In 
the present study, the peak of both serurn and exudate 
cý( -1-glycoprotein was seen when the lesion was dandnated 
by polymorphonuclear leucocytes. This was to some extent 
! ýurprising, since it would be expected that c4 -1--glyco- 
protein concentration would be at its hiqhest when mono- 
nuclear cells dcminate the lesion. These results my 
indicate that mnonuclear cells present in larqe nunbers 
are relatively non-active. This does not aqree, howeverf 
with the work of Spector (1969), who showed qranulon-as 
produced with pertussis were hiqh in cell turnover, inplying 
that these cells were hiqhly active. 
The advantage of the present system over other inmune 
air pouch systems, is the prolonged life of the lesion. 
Tsurufuji et al (1981) induced an allergic air pouch inflam- 
mtion using azobenzenearsonate c6njuqated acetyl bovine 
serum. Tsurufuji et al (198X) produced with this antigen a 
cellular reaction which peaked 1-2 days after challencre, 
rapidly waning thereafter. Further n-ore, the antigen itself 
in non-sensitised animls was able to induce an oedematous 
reaction and cell accumulation. In this study, the reaction 
is highly specific, no inflammtion being produced in response 
to challenge in-non-sensitised animals. Recently, - Yoshino 
et al (1984) have proposed a persistent antigen induces 
chronic inflamnation in the-rat air pouch. This model, 
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j, has the disadvantaq although being interestinc e of 
requiring continuous acute inflammatory insults. Their 
system had the added complication of using carboxy methyl 
cellulose as the irritant vehicle. 
Because inf larnnation caused by dif ferent irritants 
can induce very different chemical mediator release (Turk 
and Willoughby, 1978), we have con-pared the loss of proteo- 
glycan by cartilage implanted into non-imune and immune 
lesions. Articular. cartilage was implanted into pertussis- 
inflamed six day pouches for different times. In this 
type of prolonged inflamnation, the loss of proteoglycan 
from the implanted cartilage was not significantly different 
from the loss seen by tissue in normal pouches. It seems 
that, at least at the level of inf lammation and cartilage 
breakdown mediators present in the carrageenan and pertussis- 
inflamed pouches, cartilage degradation-is not accelerated 
by direct effect of these mediators. 
The effects of indomethacin, dexamethasone and the 
DMARD's (D-penicillamine and, levamisole), on inflammation 
and proteoqlycan loss of in-planted articular cartilage Unre 
investigated using the two inflammatory models in the rat 
(carrageenan and pertussis-inflan-ed six day pouches). 
Indomethacin was found to suppress carraqeeenan and 
pertussis-induced inflamnation in both the tested doses 
1 mg and 3 mq Protection of the implanted cartilage Ag 
was observed after fourteen days of a daily treatment with 
3 mqAq in carraqeenan system and with both the tested doses 
in pertussis system. Dexamethasone was found to be a 
potent anti-inflammatory agent, both types of inflammation 
224 
being stronqly suppressed and the pouch linings were thinner 
than those of control groups. There was a significant 
protection observed in implants recovered from both carra- 
geenan and pertussis-infl&ned pouches. 
on the other hand, the DMARD (D-penicillamine and 
levamisole) were found to have no anti-inflammatory activity. 
Furthermore, there was a trend towards potentiation for the 
inflammatory process. However, this did not reach signifi- 
cance. Surprisingly, these two drugs showed a significant 
protection to the implants recovered fran carrageenan- 
inflamed pouches. There was also a protection to the implanted 
cartilage recovered from pertussis-inflared pouches after 
treatment with D-penicillatine and levamisole, however, the 
sicinificant protection was only observed with 50 MqAg 
D-penicillamine. 
The effects of indamethacin, dexamethasone, D-penicil- 
lamine and levamisole on the loss of proteoglycan frm 
articular cartilage'irTplanted into norTral subcutaneous- 
tissue were also investigated throughout this study. It 
was only dexan-ethasone which showed a sic ificant protection . jn 
to the implanted cartilage after fourteen days of treatment, 
while the rest of the tested druqs failed. 
The anti-inflammatory action of the NSAID tested 
on the different models of this study is in agreement *ith 
published data in other inflammtory rmdels, like sponge 
inplantation (Doyle et. al, 1983), carrageenan-induced 
pleurisy (Mikami and Miyasaka, 1983), carrageenan-induced 
paw oedem (Higgs et al, 1980), pertussis-induced pleurisy 
(Dieppe et al, 1976), pertussis-induced paw oederra 
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(Arrigoni-Martelli et al, 1976) and carrageenan qranulam 
pouch (Fukuhara. and Tsurufuji, 1969). Non-steroidal anti- 
inflammatory drugs were also found to inhibit adjuvant- 
induced arthritis (Billingham, 1983) and collagen type-II 
induced arthritis (Phadke and Nanda, 1982). As described 
earlier, NSAID act'via the blockade of the cyclo-oxygenase 
pathway of arachidonic acid (Higgs et al, 1983b). Whether 
this effect represents their exclusive site of action is 
uncertain (Weissman, 1983). Arachidonic acid mtabolites 
are important mediators of inf lanration and have numerous 
and ccrrplex biological effects. Different arachidonic 
metabolites my be released, depending on stimulus and 
cell type, and their effects my vary from site to site 
(Higgs et al, 1983a). Prpstanoids have been implicated in 
the cartilage damage, since these substances have been shown 
to induce and potentiate synovial inflam-nation (Robinson 
et al, 1975). In vitro, the NSAID' have been reported, 
to inhibit polymorphonuclear leucocytes' adherence (Buchanan 
et al, 1983), chemotaxis (Rivkin et al, 1976), aggregation 
(Kaplan et al, 1984), lysosomal enzyme release (Smith and 
Iden, 1980) and superoxide anion formation (Larbardino, 
1983). Some of these effects are drug specific and suggest 
. jenase 
that the NSAID have effects unrelated to cyclo-oxyc. 
inhibition (Kaplan et al, 1984). Indeed, phospholipase-A2 
inhibition has been reported for indormthacin (Kaplan et 
al, 1978). 
Although a reduction in both fluid exudation and total 
cell nun-ber was observed in aninals treated with MAID , 
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only the steroidal anti-inflammatory drugs tested throughout 
this study totally inhibited the formation of the granuloma. 
There was also a marked histological change in the pouch 
linings following treatment with steroidal anti-inf lamnatories. 
Originally, Selye (1953) used the granuloma pouch technique 
for the study of antiphlogistic cortic6ids. He showed 
that the. introduction of small amounts of hydrocortisone 
directly into the wall of the pouch completely prevents 
jically, the granuloma production. Furthermore, histoloc 
animlls pouch wall seemed extremely thin. Steroids have 
been shown to inhibit cotton pellet granuloma (Lerner et 
al, 1964), carrageenan-induced pleurisy (Mikami and Miyasaka, 
1983), carrageenan-4nduced oedera (Higgs et al, 1980). 
Steroidal anti-inflammatory compounds have been shown to 
inhibit leucocyte migration in vitro and in vivo (Koh et 
al, 1979). The steroidal anti-inflammatory dexan-ve-thasone 
was found to inhibit leucocyte migration to allergic 
inflamed air pouch (0huchi'et alf 1982). Steroidal anti- 
inflanTmtories have been shown to stabilise cell membrane 
(Pollock and Brown, '1971). It is therefore possible that 
the stabilisation of-these drugs on blood vessel walls and 
leucocytes may prevent*'leakage of exudate and migration of 
cells into the air pouch. 
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The potent anti-inflamTatory action of the steroids 
is due to inhibition of the release of arachidonate substrate. 
This action has been explained by the discovery that steroids 
induce intracellular synthesis of an endogenous phospholipase 
inhibitor called nacrocortin (Blackwell et al, 1980) or 
lipcn-odulin (Hirata et al, 1980). Partially purified macro- 
cortin inhibits the formation of arachidonate metabolites in 
vitro and in vivo (Parente et al, 1984). 
Steroids have been shown to inhibit all phases of 
adjuvant-induced arthritis in the rat (Billingham, 1983) 
and monoarticular arthritis (antigen-induced arthritis) in 
the rabbit (Pitt and Lewis, 1984). According to Hunneyball 
(1981) steroids may exert their anti-arthritic effect by 
suppressing cell-irediated immme responses within the 
synovium. Tissue culture studies have provided inforrration 
on the possible molecular events that occur in arthritic 
joints. Interactions between T-lyrrphocytes and monocytes 
produce a molecular cell factor, which stimulates the 
biosynthesis and release of collagenase and prostaglandins 
from rracrophage-type synovial cells (Dayer et al, 1979). 
Corticosteroids indirectly lower both prostaglandins and 
collagenase levels by inhibitng the production and release 
of mononuclear cell factor (McGuire et al, 1981). Collagenase 
and other metallo-proteins are inhibited by the anti- 
proteinase TIMP (tissue inhibitor of mtallo-proteinases). 
Corticosteroids stimulate TIMP synthesis in synovial cells 
(McGuire, Murphy, Reynolds and Russell, 1981). Dexamethasone 
was found to, inhibit the plasminogen activator activities 
of both unstimulated and, stiMlated (natogen) peripheral 
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blood mononuclear cell stimulated fibroblasts (Hamilton 
et al, 1981). Plasmin is generated after interaction of 
another neutral protease,, plasminogen activator, with the 
substrate plasminogen. Plasmin can degrade cartilage (Lack 
and Rogers, 1958), and activate'latent collagenase (Werb 
et al, 1977). Martel-Pelletier. et al (1985) showed that 
steroids induced suppression of the active neutral metallo- 
proteoglycan degrading enzym activity'in the cartilage of 
rheumatic patients. 
In this study, D-penicillamine showed a protection to 
the implanted cartilage and was found to have no anti- 
inflammatory effect. ý Maddox (1973) showed that penicillamine 
failed to suppress carrageenan-induced paw oederra. The 
same effect of penicillamine on inflammtion was also 
observed in pertussis-induced paw oedema (Arrigoni-Martelli 
et al, 1976), pertussis-induced pleurisy (Dieppe et al, 
1976). D-penicillamine also tends to improve the diminished 
neutrophil chemotaxis observed in rheumatoid arthritis 
(Lyle, 1983). - D-penicillamine has been shown to diminish 
antigen-induced arthritis'in the rabbit, as assessed by 
both measurement of joint circumference and histological 
examination (Hunneyball et al, 1977). Liyanage and Currey 
(1972) were unable to inhibit adjuvant-induced arthritis 
with a dose of D-penicillamine up to 200 mgAg. 
Moreover, D-penicillan-Line has, been shown to markedly inhibit 
the radiographic destruction of the joint and bone with 
concomitant lowering of acute phase protein levels in 
serum (Sloboda et al, 1981). 
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A number of observations in-treated patients have 
suggested that D-penicill&nine might exert an im-nuno- 
suppressive action and, thus, act'by suppressing the 
on-going immune response that underlies the chronic 
inflammation (Lipsky, 1984). Direct confirmation of this 
conclusion will require assessment of T-lymphocyte function 
in treated patients. Therapy with, D-penicillandne often 
results in decreased rheurnatoid factor titers, decreased 
levels of circulating immune complexes (Jaffe, 1965) and 
diminished levels of serum. immmoglobulins (Bluestone and 
Goldberg, 1973). Moreover, Hunneyball and his colleagues 
(1978) found that prolonged administration of D-penicillamine 
to rabbits could suppress, both humoral immune response and 
delayed-type hypersensitivity. 
In this study, levamisole was also shown to have nearly 
the sarne effects on inf lanmtion and proteoglycan loss as 
those observed with D-penicillamine treatrent. ' The activity 
of D-penicillamine in rheumatoid arthritis is similar to 
that effected by a number of other agents, including 
levamisole (Multicentre Study Group, 1978). However, while 
D-penicil lamine showed scme im=osuppressive activity, 
levamisole was-found to be immmostimulant (Stecher and 
Carlson, 1983). However, a nunber of indirect clinical 
observations support this point of view. Huskisson in 1979, 
showed that levarnisole was able to restore depressed cell- 
mediated irmune - par&Tr-ters both, in vitro and in vivo through 
effects on macrophage and lyn#iocyte populations. Levamisole 
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also stimulates precursor T-lyrrphocytes to differentiate 
into mature T-cells and restores to normal the depressed 
effector functions of peripheral T-lymphocytes and phago- 
cytes (Sym: )ens and Rosenthal, 1977); Levamisole does not 
directly stimulate B-cells, it does not increase their 
proliferative response to mitogens and it has no direct 
effect on antibody production, (Symoens and Schuenuans, 
1983). 
Fran the experiments described here, it seems reasonable 
to attempt to form a working hypothesis as to their various 
modes of action. one thing is evident inflammation per se 
in the model used in this thesis appears not to induce 
proteoglycan loss from cartilage in-plants. It is conceivable 
that cartilage floats, free in the exudate and does not sit 
in juxtaposition to macrophage and fibroblasts of the lining 
cells. This is possible since, De Brito (unpublished results) 
has found that increasing granulation tissue around implanted 
cartilage enhances breakdown., This lends support to the 
key role of macrophage and fibroblast interaction. 
Indomethacin is known to inhibit cyclo-oxygenase and 
block formation ofýprostaglandins. It reduces cell infil- 
tration and volu-ne of exudate., In this series of experiments 
it has been shown to protect'femoral head cartilage from 
proteoglycan loss. This is probably independent of its 
anti-inflammatory activity, - as reduction of inflanTmtion 
could be supposed to enhance proteoglycan loss. It has 
Previously been reported that-indomethacin in granuicrratous 
type inflaffmtion will, inpaik, the function of normal 
n1acrophages. Di Rosa et aL(1971) observed that macrophages 
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in vivo in animals treated with indamthacin, engaged in 
autophagocytosis and lysosoms could be seen to be fusing 
with n-Litochondria within the same macrophages. Possibly, 
the protection afforded by indcmthacin may be attributed 
to impaired racrophage function. Thus, the macrophage 
could fail to secrete interleukin-1 to act on the fibro- 
blasts and thus attack the cartilage. 
When we turn to dexamethasone, this has a general 
inhibitory effect on cells. It inhibits movement and 
secretion of cellular products. It is interesting that this 
drug reduces the thickness of the pouch wall, suggesting 
that the integrity of the pouch wall is rraintained by a 
proliferative process and not merely by migration of cells, 
as this effect was not observed with indon-ethacin, which 
would reduce cell migration. , In the 
implant experiments 
described here, dexamethasone protected cartilage from 
proteoglycan loss. It se(ns likely that this phenomenon 
was brought about by a, different mechanism to that postulated 
for indomethacin. Thus,, dexamethasone, by reducing the 
thickness of the pouch wall, ýis reverting the pouch to an 
inrature pouch, which has-less reactivity and fewer macro- 
phages; and fibroblasts'to interact. In addition, those 
cells that are present would be secreting fewer products. 
Once again, it is proposed that this is not related to the 
anti-inflanmtoryýeffect of the steroid on the exudate. 
D-penicillamine would, 'appear imro-diately to have 
separate mechanisms. ýIt is. evident that in the present 
experiments it potentiates the inflammtory response. We do 
know that in man,, D-penicillamine lower acute phase proteins 
(McConkey, 1976). In addition, Billingham (1983) has shown 
that in the rat, acuteýphase proteins move in direct correl- 
ation with interleukin-l,, ie,, acute phase proteins increase 
equally with a rise-in interleukin-1, and conversely fall 
with an equal decrease., 
It seems possible that this represents the key to the protective 
effect of D-penicillardne, namly-a drop in interleukin-1 
production by niacrophages will, fail to activate fibroblasts. 
This drug also supports the concept of the relative non-inport- 
ance of inflamwtion in bringing about cartilage degradation. 
Loevamisole., which has been described as a disease modi- 
fying drug (Stecher, 1983),, fails to exert a demonstrable 
effect on the inflamnatory-response, as shown in the air 
pouch models. Yet this drug protects cartilage against proteo- 
C 
. jlycan 
loss. Levamisole, like D-penicillamine, also causes 
a drop in acute phase proteins in man (McConkey, 1976). Thus, 
we could speculate a similar mode'of action to that described 
for D-penicillamine. However,, in addition to their properties, 
it has been suggested that"levamisole can, under certain 
conditions, increase T-suppressor cell activity. It is 
interesting to recall that Rothwell'and Spector (1972) showed 
that granulation requires T-cell participation, and neonatal 
thymectomy can block the-forration of cotton pellet granulowas. 
This type of activity should be inhibitory towards granulcm 
formation, ie, interation', of macrophages and fibroblasts. 
The recurrent, theine-in this speculation is the inter- 
action of macrophagýs and fibroblasts. Indeed, Ieibovich 
and Ross (1975) have shown previously that wound healing 
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cannot proceed in the absence of rracrophages and -hey SuqZest 
that rracrophages occupy the key role in directing the fibro- 
blasts to their appropriate function. Another support for 
this speculation comes frm the work of Vaes (1980), who 
for many years has proposed the interaction of macrophages 
and fibroblasts to be all important in chronic inf lamTation. 
If this hypothesis is correct regarding the mode of action of 
these therapeutic agents, it could have some irportance in 
the search for new ccapounds. Ideally, one would seek a 
caTpound that my have clear activity in acute phase proteins. 
Unfortunately, in the present work, drug action on acute 
phase protein was not pursued to fruition. The results 
obtained were variable and it was not deen-ed reasonable to 
repeat all these experiments. It now seems important to 
return to this aspect as soon as possible, and also to 
examine the effect of drugs on macrophage /fibroblast 
interaction. It is interesting that this hypothesis embraces 
interleukin-1. Dingle (1979) has suggested catabolin as the 
inportant factor in causing chondrocytqs to destroy cartilage, 
as has been discussed earlier. Should interleukin-1 and 
catabolin be found to be identical, possibly in the experin-ents 
described in this thesis, catabolin my be important but not 
from the point of view held by the Cambridge group, ie, on 
chondrocytes but instead by its action on fibroblasts. 
To conclude, this thesis describes the developn-y--nt of 
a novel. in vivo system for examining soft tissue-hard tissue 
interaction. This system may be suitable for elucidating the 
234 
underlying mechanisms of arthritic bone and cartilage ' 
erosion and for detecting and evaluating new therapeutic 
agents. 
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